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Resumen 
 
La presente tesis doctoral que lleva por título “Encapsulación de ácido fólico 
en soportes porosos de óxido de silicio: una aproximación nutricional y 
tecnológica” está centrada en el desarrollo de nuevos sistemas inteligentes de 
liberación controlada de ácido fólico para aplicaciones nutricionales.  
 
La primera parte de la tesis muestra la encapsulación de ácido fólico en 
matrices porosas de óxido de silicio funcionalizadas con poliaminas desde una 
aproximación nutricional. En ella se ha evaluado la influencia del método de 
cargado y del tipo de soporte de óxido de silicio utilizado (MCM-41, SBA-15, UVM-
7 y Hollow Silica) en la eficacia de encapsulación de ácido fólico. En esta primera 
parte, también se ha evaluado la influencia de la morfología y el sistema de poros 
de los diferentes soportes en el perfil de liberación del ácido fólico desde los 
mismos. Los estudios de liberación de ácido fólico desde los diferentes soportes a 
diferentes valores de pH han demostrado que los sistemas diseñados son capaces 
de modular inteligentemente la liberación de ácido fólico en función del pH del 
medio (inhibición de la liberación a pH ácido -estómago-; liberación controlada a 
pH neutro -intestino-).  
 
Esta capacidad convierte a los sistemas liberación desarrollados en una 
alternativa excelente a la fortificación directa para modular exitosamente la 
bioaccesibilidad del ácido fólico a lo largo del tracto gastrointestinal. Por otra 
parte, se ha evaluado la estabilidad de los soportes durante un proceso de 
digestión in vitro, demostrando que si bien algunos soportes pueden ser atacados 
durante la digestión, la funcionalización con moléculas que actúan como puertas 
moleculares previene dicho ataque. Por último, los estudios de viabilidad celular 
llevados a cabo en cuatro tipos de líneas celulares demuestran que ni los 
soportes, ni los productos de degradación de los mismos durante el proceso de 
digestión in vitro promueven ningún tipo de toxicidad inespecífica.  
 
Resumen 
 
 
 
En la segunda parte se ha evaluado la influencia de la adición de diferentes 
soportes de óxido de silicio a dos matrices alimentarias, geles de gelatina y 
yogures. Esta aproximación tecnológica ha permitido conocer que la capacidad de 
estos sistemas inteligentes para liberar controladamente el ácido fólico a lo largo 
de un proceso de digestión in vitro se mantiene incluso tras su incorporación en 
yogures batidos. Por otra parte, se ha comprobado que el efecto de las matrices 
sobre las propiedades físicas de los geles, es dependiente tanto del tamaño de las 
partículas, como de su funcionalización y concentración. Por último, se ha 
comprobado que debido a la optimización del cargado de ácido fólico alcanzada 
en la primera parte de la tesis, se puede lograr una fortificación de un yogur con el 
100% de la cantidad diaria recomendada de ácido fólico con una cantidad tan 
pequeña de sistema que ni las propiedades físico-químicas del yogur, ni la 
viabilidad bacteriana se ven comprometidas.  
 
En resumen, se puede concluir que la presente tesis ha abordado de una 
manera global la encapsulación de ácido fólico en matrices porosas de óxido de 
silicio para ser utilizados en aplicaciones nutricionales incluyendo estudios de 
optimización de cargado, estudios de liberación en función del pH, digestiones in 
vitro, estudios de estabilidad de las matrices utilizadas, estudios de 
biocompatibilidad, así como estudios de la influencia de la adición de estos 
sistemas inteligentes en matrices alimentarias. Los resultados obtenidos han 
puesto de manifiesto que los sistemas inteligentes de liberación de ácido fólico 
desarrollados abren la puerta a una nueva manera de fortificar los alimentos sin 
comprometer sus características físico-químicas. 
Resum 
 
 
 
 
Resum 
 
La present tesi doctoral, que porta per títol “Encapsulació d’àcid fòlic en 
suports porosos d’òxid de silici: una aproximació nutricional i tecnològica” està 
centrada en el desenvolupament de nous sistemes intel·ligents d’alliberament 
controlat d’àcid fòlic per a aplicacions nutricionals.  
 
La primera part de la tesi mostra l’encapsulació d’àcid fòlic en matrius 
poroses d’òxid de silici funcionalitzades amb poliamines des d’una aproximació 
nutricional. En esta part, s’ha avaluat la influència del mètode de carrega i del 
tipus de suport d’òxid de silici que s’ha emprat (MCM-41, SBA-15, UVM-7 i Hollow 
Silica) en l’eficàcia de l’encapsulació d’àcid fòlic. En esta primera part, també s’ha 
avaluat la influència de la morfologia i el sistema de porus dels diferents suports 
en el perfil d’alliberament de l’àcid fòlic des dels mateixos.  Els estudis 
d’alliberament d’àcid fòlic des dels diferents suports a diferents valors de pH han 
demostrat que els sistemes dissenyats són capaços de modular intel·ligentment 
l’alliberament d’àcid fòlic en funció del pH del medi (inhibició de l’alliberament a 
pH àcid -estómac-; alliberament controlat a pH neutre -intestí-).   
 
Esta capacitat fa dels sistemes desenvolupats una excel·lent alternativa a la 
fortificació directa per a modular amb èxit la bioaccessibilitat de l’àcid fòlic a 
través del tracte gastrointestinal. D’altra banda, s’ha avaluat l’estabilitat dels 
suports en un procés de digestió in vitro, demostrant que mentre que les 
partícules menudes poden ser atacades durant la digestió, la funcionalització amb 
molècules orgàniques que actuen com a portes moleculars prevé aquest atac.  Per 
últim, els estudis de viabilitat cel·lular duts a terme en quatre tipus de línies 
cel·lulars demostren que ni els suports, ni els productes de degradació dels 
mateixos durant el procés de digestió in vitro promouen cap tipus de toxicitat 
inespecífica.  
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En la segona part, s’ha avaluat la influència de l’addició de diferents suports 
d’òxid de silici a dos matrius alimentàries, gels de gelatina i iogurts. Esta 
aproximació tecnològica ha permés conéixer que la capacitat d’aquests sistemes 
intel·ligents per alliberar controladament àcid fòlic durant un procés de digestió in 
vitro es manté fins i tot després de ser incorporats en iogurts batuts. D’altra 
banda, s’ha comprovat que l’efecte de les matrius sobre les propietats físiques 
dels gels, és dependent tant de la grandària de les partícules, com de la seua 
funcionalització i concentració.  
 
Per últim, s’ha comprovat que a causa de l’optimització del carregat d’àcid 
fòlic assolida en la primera part de la tesi, es pot aconseguir una fortificació d’un 
iogurt amb el 100% de la quantitat diària recomanada d’àcid fòlic amb una 
quantitat tan baixa del sistema que ni les propietats físico-químiques del iogurt, ni 
la viabilitat bacteriana se’n veuen compromeses.  
 
En resum, es pot concluir que en la present tesi s’ha abordat d’una manera 
global l’encapsulació d’àcid fòlic en matrius poroses d’òxid de silici per a ser 
utilitzades en aplicacions nutricionals i alimentàries, que inclouen estudis 
d’optimització de carregat, estudis d’alliberament en funció del pH, digestions in 
vitro, estudis d’estabilitat de les matrius utilitzades, estudis de biocompatibilitat, 
així com estudis de la influència de l’addició d’aquests sistemes en matrius 
alimentàries. Els resultats obtinguts han posat de manifest de forma positiva que 
els sistemes intel·ligents d’àcid fòlic que s’han desenvolupat obrin una porta a una 
nova manera de fortificar els aliments sense comprometre les seues 
característiques físico-químiques.  
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Abstract 
 
The present PhD thesis, entitled “Encapsulation of folic acid in silica porous 
supports: a nutritional and technological approach”, focuses on the development 
of new smart systems for the controlled delivery of folic acid for nutritional 
applications.  
 
The first part of the thesis shows folic acid encapsulation in polyamine-
functionalized silica porous matrices from a nutritional approach. The first part 
evaluates not only the influence of the loading method and the type of silica 
support employed (MCM-41, SBA-15, UVM-7 and Hollow Silica) on the efficiency 
of folic acid encapsulation, but also the influence of the morphology and porous 
system on the folic acid delivery profile from different supports. Folic acid release 
studies from different supports with various pH values have demonstrated that 
the designed systems are capable of smartly modulating the delivery of the folic 
acid dependent on the pH of the medium (inhibition of the release at an acidic pH 
-stomach-, controlled release at a neutral pH -intestine-).  
 
This capacity makes these developed delivery systems an excellent 
alternative to direct fortification to successfully modulate the bioaccessibility of 
folic acid along the gastrointestinal tract. The stability of the supports during an in 
vitro digestive process was evaluated, and demonstrated that not only small 
particles can be attacked during the digestion process, but also the 
functionalization with organic molecules, which act as molecular gates, prevents 
this attack. Finally, the cell viability studies carried out with four different cell lines 
revealed that neither the supports nor their degradation products caused any 
specific toxicity during the in vitro digestive process. 
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The second part evaluates the influence of adding different silica supports to 
two food matrices: gelatin gels and yoghurts. This technological approach enabled 
us to know that the capacity of these smart systems to deliver folic acid in a 
controlled manner during an in vitro digestive process is mantained even after 
their incorporation in stirred yoghurt. The effect of the matrices on the gel’s 
physical properties depends on the particle size, functionalization and 
concentration. 
 
Finally, this thesis tested that the optimization of folic acid loading, achieved 
in the first part of the thesis, allowed the fortification of yoghurt with 100% of the 
dietary reference intake of folic acid with a very low  amount of the system. This 
fortification affected neither the physico-chemical properties of the yoghurt, nor 
bacterial viability.  
 
In summary, it was concluded that the present thesis globally deals with folic 
acid encapsulation in silica porous matrices to be used in nutritional and food 
applications, which include the optimization of loading, release studies at diferent 
pH, in vitro digestions, stability studies of the employed matrixes, biocompatibility 
studies, and studies into the influence of their addition to food matrixes. The 
obtained results positively demonstrate that the developed smart folic acid 
delivery systems open up a new way of fortifying food without endangering the 
physico-chemical properties of the food to which they are added.   
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1. PREAMBLE 
 
This PhD thesis forms part of the project "Improvement of the stability and 
control release of biomolecules by using microcapsules functionalized with 
molecular gates (AGL2012-39597-C02-01)", funded by the 2013-2016 National 
Research Plan of the Spanish Ministry of Economy and Competitiveness. 
 
Protecting bioactive molecules is a subject of much interest in food 
technology. To date, scientific studies have concluded that the functional activity 
of a molecule, demonstrated by in vitro models, does not guarantee the same 
biological effects in the human body, mainly as a result of the transformations 
that this compound undergoes during processing, conservation, and even during 
digestion. Sometimes, handling some bioactive components is extremely 
complicated.  Other times the bioactive molecule is simply not compatible with 
the food matrix in solubility or sensory properties terms. This has led to increased 
interest in protecting certain bioactive molecules so they can be easily consumed, 
and effectively absorbed and assimilated in the body. 
 
In this context, the main objective of the project is to improve the stability 
and the release of bioactive substances of nutritional interest by encapsulating 
them in hybrid materials based on porous or hollow silicon oxide matrices, 
functionalized with organic molecules that act as a molecular gates. The 
aforementioned molecular gates should be able to maintain the substances of 
interest confined, and to release them in the intestinal tract, possibly at a 
controlled rate. 
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This main objective of this project is subdivided into several specific objectives: 
 
1. To obtain suitable carriers (MCM-41, SBA-15, UVM-7, Hollow Silica, and 
other low-cost porous materials) capable of being used in the preparation 
of different encapsulation systems. 
2. To functionalize carriers with organic molecules capable of hindering or 
allowing cargo delivery in a controlled and triggered manner (molecular 
gates). 
3. To optimize the loading process of three bioactive molecules: folic acid, 
caprylic acid and garlic extracts.  
4. To study the release rate of the encapsulated bioactive molecules in the 
presence of different triggering stimuli. 
5. To examine the stability of the encapsulated bioactive molecules in the 
presence of different environments. 
6. To evaluate the biocompatibility of the developed smart delivery systems 
using both cell cultures and the nematode Caenorhabditis elegans. 
7. To assess the compatibility of the delivered smart delivery systems with 
different food matrices.  
 
The doctoral thesis "Encapsulation of folic acid in porous silica supports: a 
nutritional and technological approach" is the first doctoral thesis developed as 
part of this framework. 
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2. OBJECTIVES 
 
The main objective of this PhD thesis was to design, fabricate and evaluate 
different porous silica supports capped with molecular gates responsive to 
changes in pH to act as smart delivery systems (SDS) able to modulate the 
bioaccessibility of folic acid (FA) along a digestion procedure when incorporated in 
food matrixes. 
 
To achieve this main objective, the following partial objectives were set: 
1. The study of the possibilities of mesoporous silica particles to develop SDS 
capable of controlling and targeting the release of bioactive molecules in 
the gastrointestinal tract. 
2. The synthesis and characterization of different porous silica supports with 
different morphologies and porous systems. 
3. The optimization of the loading procedure to obtain SDS capable of 
delivering large amounts of FA with a minimum amount of support. 
4. The evaluation of the capability of the developed SDS to modulate FA 
delivery according to pH (i.e. hinder release at an acid pH and allow a 
sustained release at a neutral pH). 
5. The in vitro evaluation of the biocompability of the developed SDS. 
6. The evaluation of the stability of the developed SDS during simulated in 
vitro digestion. 
7. The determination of the effect of incorporating the developed SDS into 
different food matrices. 
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To reach these objectives, the present thesis was divided into two different 
approaches: 
a. The nutritional approach. It was addressed to evaluate all the aspects 
related to the development of SDS (including their stability in the 
gastrointestinal tract) capable of loading large amounts of FA and 
delivering it in a controlled manner to solve current nutritional problems. 
 
b. The technological approach. It addressed the study of the influence of 
genuinely adding the developed SDS to food matrices in terms of the 
delivery efficiency and modification of the physico-chemical properties. 
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3. GENERAL INTRODUCTION1 
                                                          
1General Introduction is based on the article: Pérez-Esteve, É., Ruiz-Rico, M., 
Martínez-Máñez, R., & Barat, J. M. (2015) Mesoporous silica-based supports for 
the controlled and targeted release of bioactive molecules in the gastrointestinal 
tract. Journal of Food Science (DOI: 10.1111/1750-3841.13095).  
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1. Mesoporous silica particles as encapsulation supports 
 
Mesoporous silica particles (MSPs) are structures of silicon dioxide (SiO2) 
which are arranged so that they create pores of 2-50 nm (Zhao, 2006). The first 
described porous silica with a uniform pore size, called folded sheet mesoporous 
material (FSM-16), was reported by Kuroda and co-workers in 1990 (Yanagisawa 
et al., 1990). A few years later, in 1992, researchers of the Mobil Company 
reported the synthesis of a family of mesoporous silica materials called M41S 
(Beck et al., 1992), which include hexagonal MCM-41, cubic MCM-48 and lamellar 
MCM-50.  
 
Since their discovery, applications of MSPs have grown exponentially as a 
result of their unique properties. Specifically, MSPs have demonstrated to have 
huge applications in the food sector, where they could be employed as catalysts in 
the synthesis of nutrients and bioactive molecules (Márquez-Ávarez et al., 2004), 
in sensor technology (Climent et al., 2009) and also as carriers in the design of 
smart delivery systems (Bernardos et al., 2008, Pérez-Esteve et al., 2015). Of these 
applications, the design of smart delivery systems is viewed as challenging given 
the possibility of improving the handling and utilization of different bioactive 
molecules or functional ingredients, and the subsequent formulation of functional 
food (Bernardos & Kourimská, 2013).  
 
Although there is neither a regulatory nor a standard definition of 
“functional foods” (Aryee & Boye, 2015), this term refers to the foods and food 
components that may offer health benefits beyond basic nutrition (Bech-Larsen & 
Grunert, 2003). The terms food components and bioactive ingredients with 
beneficial biological activity include basic nutrients (i.e. carbohydrates, proteins, 
lipids, vitamins, minerals, etc.), bioactive components (i.e., omega-3 fatty acids, 
amino acids and peptides, and phytochemicals), sensory appeal compounds (i.e. 
organic acids, flavors and pigments), as well as pre- and probiotics, healthy oils, 
spices and herbs (Fang  & Bhandari, 2012). 
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Despite the increase in functional products in markets and the scientific 
literature, the incorporation of these functional ingredients into existing food 
formulations is still viewed as challenging. On the one hand, most studies on the 
functionality of food compounds have been done in vitro, which thus excludes 
studying changes in potential active compounds during food processing, storage, 
ingestion and interaction with gut microflora. On the other hand, some bioactive 
components are most complicated to be handled or are not compatible with the 
food matrix in terms of solubility (lipophilic compounds), sensorial properties (i.e. 
fish oils or garlic extracts), or are very susceptible to degradation (vitamins, 
antioxidants). The desire to overcome these limitations has increased the interest 
in the encapsulation of bioactive components because after encapsulation, they 
could be released in a particular site-of-action of the digestive tract and/or be 
absorbed in their native form, which thus avoids problems related to instability or 
to unpleasant sensory properties (McClements, 2012).  
 
Typically, food applicable encapsulating systems are based on 
carbohydrates, proteins or lipids (Fathi et al., 2012; Wang et al., 2012; Fathi et al., 
2014). However, these systems exhibit low structure stability while food is 
processed and stored, a poor capability to control the release rate or to provide a 
targeted delivery, and a very poor effect on the protection of the encapsulated 
substance while it passes through the stomach. Some of these problems could be 
avoided if mesoporous silica particles (MSPs) are used as encapsulating supports. 
Compared to other organic polymer-based carriers, MSPs are more stable, rigid 
and biocompatible. They also better resist the harsh conditions of the stomach 
and microbial attack. MSPs are also able to protect entrapped guest molecules 
against enzymatic degradation or denaturation induced by pH or temperature 
(Arcos & Vallet-Regí, 2013). 
 
This introduction critically assesses the possible use of mesoporous silica 
materials to design site-specific smart delivery systems capable of encapsulating, 
protecting, transporting and releasing bioactive molecules in a controlled fashion 
in the gastrointestinal tract (GIT). 
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2. Requirements for folic acid encapsulation and controlled release 
 
2.1 Folic acid: history, chemical structure and physic-chemical properties 
 
Folates have been and remain a subject of unending research. Despite 
being one of the most studied dietary compounds, their multiple roles in 
metabolism and the controversy on whether their nutritional supplementation 
has on the population leaves a number of research gaps to be filled.  
 
Folates received their name in 1941 when were isolated from spinach 
(folium is the latin word for leaves) and were shown to be growth factors for 
Streptococcus lactis. In 1962, Victor Herbert used self-experimentation to prove 
that dietary folate deficiency could cause megaloblastic anaemia. From that study, 
he developed his hypothesis for the sequential stages in the development of 
folate deficiency and dietary reference intake (Golding, 2014).  
 
Folate (also known as vitamin B9, folacin and folinic acid) is a generic term 
for a water-soluble group of vitamins including folic acid (FA) and naturally 
occurring folates. In general, FA refers to the oxidized form, which is almost non-
existent in plant and animal foods but is present in supplements and fortified 
foods; folate refers to the reduced forms, such as 5-methyltetrahydrofolate, 5-
formyltetrahydrofolate, 10-formyltetrahydrofolate which are present in food and 
biological tissues (Ginting & Arcot, 2004).  
 
All the folates have in common the pteroylmonoglutamic acid (PteGlu or 
PGA) structure composed by a bicyclic 6-methylpterin ring connected by a 
methylene bond to a residue of p-amino benzoic acid, linked at the same time to 
a single molecule of L-glutamic acid by an amide bond (Fig 1). The different folates 
differ in the pteridine ring, which can have different reduced forms and various 
types of substitutions, and the p-aminobenzoglutamate residue that can be linked 
to the peptide bond a variable number of glutamate residues (Vora et al.,  2002) 
being the most common in the organism the mono-, penta- and hexa-glutamates 
(Mataix, 2002). Nearly 80% of natural folates in foods exist as polyglutamates. 
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Figure 1. Chemical structures of folic acid and folates 
 
FA is tasteless, odourless and displays a yellow-orange crystalline 
appearance in the solid state. Despite being considered a hydrosoluble vitamin, its 
solubility in water is only 1.6 mg L-1, increasing its solubility in weak acid and 
alkaline solutions. It is insoluble in alcohol, acetone, ether and chloroform. FA is a 
photosensitive compound that is degraded in aqueous solution by sunlight, 
ultraviolet and visible light (Akhtar et al., 2003). The susceptibility of FA to 
cleavage under acidic conditions and high temperatures has long been 
established. However, the degree and rate of destruction has been shown to be 
influenced by the pH of the medium, reducing agents in the buffer, folate 
derivatives, type of buffer, and food system. Under neutral to alkaline conditions, 
FA displays increased solubility, and stability particularly in solutions of alkali 
hydroxides and carbonates, as well as a limited number of organic solvents. In 
aqueous solution, FA is stable at 100 °C for 10 h in a pH range of 5.0-12.0 when 
protected from light, but becomes increasingly unstable as the pH decreases 
below 5.0 (Cheung et al., 2008). 
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2.2 Folic acid in human nutrition 
Folate intake is vital in human subjects for normal cell division, 
homeostasis, proper growth, prevention of anaemia, and also for normal foetal 
development. Its importance is related to the role of folate coenzymes in nucleic 
acid (DNA and RNA) synthesis, synthesis of the amino acid methionine from 
homocysteine, and in the shuttling, oxidation and reduction of one-carbon units 
required for normal metabolism and regulation (Wagner, 1995).  
 
Folate requirements have historically been defined as the quantity of intake 
necessary to prevent a severe deficiency with clinical symptoms. More recently, 
the focus has shifted to identifying intakes associated with maintenance of normal 
one-carbon transfer reactions as described above (Bailey & Gregory, 1999). In the 
USA, the Dietary Reference Intake (DRIs) for FA is stablished as 400 µg folate per 
day in adults and 600 µg folate per day in pregnant women (USDA, 2010). In 
Europe, the European Food Safety Authority (EFSA) recommends a daily intake of 
200-400 µg folate per day for adults and an additional 400 µg folate per day 
(ESFA, 2009) in pregnant women. Because the bioavailability of synthetic FA is 
approximately twice that of folate found in food, the dietary folate equivalent 
(DFE) system established the relationship between dietary folate and FA from 
supplements. One DFE is defined as 1 μg of dietary folate, 0.6 μg of FA from 
fortified food or as a supplement taken with meal, or 0.5 μg of of a supplement 
taken on an empty stomach (Suitor & Bailey, 2000).  
 
An adequate folate status during pregnancy prevents birth defects (Branum 
et al., 2013). In other life stages, an optimal folate status may provide health 
benefits in the general population by preventing cardiovascular diseases (Lucock, 
2000; Choi & Mason, 2002; Pitkin, 2007), Alzheimer (Clarke et al., 1998), 
atherosclerosis (Hoag et al., 1997), or a disruption of the nucleotide biosynthesis 
which can result in colon and colorectal cancer (Choi & Mason, 2002; Stover, 
2004).  
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Folates can only be synthetized by microorganisms and plants. Thus, 
humans depend on a variety of dietary sources for the vitamin, including liver, egg 
yolk, fresh, dark green and leafy vegetables such us spinach or broccoli, beans 
such as lentils, citrus fruits, wheat germ, and yeasts (Hau Fung Cheung et al., 
2009; Lubecka-Pietruszewska et al., 2012).  Folates synthesised by intestinal 
bacteria do not contribute significantly to folate nutrition in humans because 
bacterial folate synthesis is usually restricted to the large intestine (colon), 
whereas absorption occurs mainly in the upper part of the small intestine 
(jejunum) (Spitzer, 2007).  
 
In the diet, folate exists in the form of mono- (10%) and polyglutamates 
(90%). Before absorption, folate polyglutamates are hydrolysed to folate 
monoglutamates. This digestion process occurs mainly in the proximal part of the 
small intestine where the enzyme folylpoly-glutamate carboxypeptidase                      
(EC 3.4.17.21) present in the enterocyte brush border transform polyglutamates 
to the corresponding monoglutamate forms (Said, 2011).  
 
FA and reduced monoglutamates are then absorbed mainly in the proximal 
small intestine (jejunum) by a saturable, carrier-mediated, pH and energy-
dependent transport mechanism which, unlike other epithelial tissues, appears to 
be unique in its lack of hierarchy of transport, having a similar affinity for both 
oxidised (e.g. FA) and reduced folate forms. Absorption of FA is almost 100% 
when consumed under fasting conditions. When FA is consumed with a portion of 
food, bioavailability is estimated from experimental data to be 85% compared 
with free FA. The bioavailability of food folates is variable and incomplete, and has 
been estimated to be no more than 50% that of FA (Spitzer, 2007). 
 
After absorption, FA has to be transformed into the biologically active 
folate. The process occurring within the intestinal mucosal cells involves the 
conversion of FA into dihydrofolate and a subsequent reduction to the 5-
methyltetrahydrofolate by the enzyme dihydrofolate reductase. Absorbed folates 
are subsequently transferred via the mesenteric veins to the hepatic portal vein 
and carried to the liver where they are stored or removed (Wright et al., 2007). 
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From the liver, folates are widely distributed in tissues, most of them as 
polyglutamate derivatives. The process is summarized in Figure 2.  
 
 
Figure 2. Folate-folic acid metabolic pathway in mammalian cells  
 
2.3 Folate deficiency and disease prevention 
Folate deficiency has been demonstrated to initiate an onset of several 
diseases and disorders in humans. Early symptoms of folate deficiency are non-
specific and may include tiredness, irritability and loss of appetite. Severe folate 
deficiency leads to megaloblastic anaemia, cancers, and increased plasma 
homocysteine concentration, the latter being associated with an elevated risk of 
cardiovascular disease. Deficiency during pregnancy may result in premature 
birth, infant low birth weight and foetal growth retardation. In children, growth 
may be retarded and puberty delayed (Moat et al., 2004; Reynolds, 2006; Spitzer, 
1997).  
 
The most important factor contributing to folate deficiency is insufficient 
dietary intake. Although folates are widely distributed in food, they are in relative 
low density and moreover, are very sensitive to physical factors such as 
temperature, pressure, and exposure to light. This provokes losses of folate during 
food processing and home preparation by oxidation, leaching by aqueous cooking 
media, or both (Gregory, 2007). 
Folic acid
Dihydrofolate
Tetrahydrofolate
Dietary folates i.e. 5-Formyltetrahydrofolates
…
5-Methyltetrahydrofolate
5,10-Methylenetetrahydrofolate
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Other factors contributing to folate deficiency are defective absorption 
generated by intestinal diseases, drug intake or hereditary folate malabsorption; 
acquired metabolic impairments (i.e presence of dihydrofolate reductase 
inhibitors, alcohol or sulfasalazine); genetic metabolic impairments (i.e deficiency 
of methylenetetrahydrofolate reductase or glutamate formiminotransferase, 
polymorphism in methylenentretrahydrofolate reductase); and increased 
requirements, such as hemodialysis, prematurity, pregnancy and lactation 
(Combs, 2008). 
 
Folate deficiency is very common in many parts of the developing world 
and is a part of the wider problem of poverty and malnutrition (Talaulikar & 
Arulkumaran, 2001). In developed countries, nutritional folate deficiency may be 
encountered above all in economically underprivileged groups. Reduced folate 
intake is also often seen in people on special diets (i.e. weight-reducing diets). 
Disorders of the stomach (i.e. celiac disease, sprue, Crohn’s disease) may lead to 
folate deficiency as a result of malabsorption. Folate deficiencies also occur in 
conditions with a high rate of cell turnover such as cancer, certain anaemias and 
skin disorders. This is also the case during pregnancy and lactation, due to rapid 
tissue growth occurring in pregnancy and to losses through the milk in lactation. 
People undergoing drug treatment (i.e. epilepsy, cancer or an infection) are at 
high risk of developing a folate deficiency, as are patients with renal failure who 
require regular haemodialysis as folate is loosely bound to proteins in serum and 
thus is lost from body. Finally, acute folate deficiencies have been reported to 
occur within a relatively short time in patients undergoing intensive care, 
especially those on total parenteral nutrition (Spitzer, 1997). 
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The 400 g per day of dietary folate equivalents recommended for adults 
are best provided by a healthy diet with plenty of vegetables and other foods rich 
in folate such as wholemeal products, which are independently associated with a 
reduced risk of cardiovascular disease and cancer. However, the 
recommendations are not easily achieved because people are not willing to 
change their diet. In these cases, recommendations can be also met by taking FA 
from foods fortified (on a voluntary or mandatory basis), supplements, or both. 
When planning a pregnancy, benefits of FA in prevention of neural tube defects 
has been pointed out since 1992, leading many health organisations to issue 
recommendations for women to maintain a healthy diet and take FA supplements 
(Eichholzer and others 2006). In this context, in 1998, the USA implemented 
mandatory FA fortification to reduce neural tube defects (Lucock and Yates, 
2009). Many other countries such as Canada and UK have joined this mandatory 
proposal with the objective of ensuring a 400 g intake for adults and an 
additional 200 g for pregnant women. 
 
2.4 Encapsulation of folic acid: towards enhancing its bioavailability 
 
Although there is irrefutable evidence of the benefits of FA 
supplementation to reduce neural tube defects, homocysteine blood levels, 
certain cancers, etc., recent studies suggest that a massive exposure to high 
lybioavailable FA is a double-edged sword (Lucock & Yates, 2009).  
 
Although folate is safe and almost free of toxicity, there is concern that high 
doses of FA may mask symptoms of vitamin B12 deficiency, primarily in the 
elderly population, and may lead to progression of neurological symptoms 
(Cornell et al., 2009). Moreover, some data suggest the possibility that high FA 
intakes may be associated with increased risks of cancer. A possible role of FA in 
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cancer development is supported by biologically plausible mechanisms. Folate is 
essential in biological methylation reactions and nucleotide synthesis and 
impairment of these processes are thought to be involved in cancer development 
(ESFA, 2009). Some authors also report that excess of FA may affect cognitive and 
immune function and interfere in anti-folate chemotherapy (Wright et al., 2007).  
 
Recent studies suggest that these side-effects might be related to the 
presence of unmetabolized FA in blood. Humans have a reduced dihydrofolate 
reductase activity and a poor ability to reduce FA. Thus, oral doses of FA of about 
260-280 μg (589-634 nmol) have been reported to lead to the direct appearance 
of untransformed FA in the systemic circulation (Lucock & Yates, 2009). 
 
As stated, controlling FA dosage and modulation of FA bioavailability (i.e. by 
adjusting its bioaccessibility along the gastrointestinal tract) appear to be 
essential to keep positive effects of fortification while avoiding problems related 
to massive exposition. For this purpose, design of smart delivery systems to 
encapsulate, transport and dosage FA in the small intestine sustainably over time 
is a challenge for current nutrition science. An adequate smart delivery system for 
FA encapsulation should be able to encapsulate a large amount of FA, protect it 
from degradation, hinder its release during its pass through the stomach and 
gradually deliver the cargo during its pass through the intestine.  
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3. Fabrication of gated MSPs 
 
3.1 Synthesis and features of the inorganic support 
MSPs are synthesized using two main elements: a) a template whose 
function is to direct the construction of the high ordered (crystalline) porous net; 
b) a polymeric precursor which self-organizes around the template and, upon 
polymerization, builds up the final rigid structure. Synthesis starts with the 
polymerization, in an aqueous solution, of the inorganic siliceous precursor                
(i.e. tetraethyl orthosilicate) around surfactant micelles (i.e.                                              
N-cetyltrimethylammonium bromide -CTABr-). The mesoporous inorganic scaffold 
obtained under these conditions presents cylindrical unidirectional empty 
channels of approximately 3 nm in diameter (when CTABr is used as a surfactant), 
arranged in a hexagonal distribution. Mesoporous materials are obtained by the 
subsequent removal of the surfactant by extraction with appropiate solvents or by 
aerobic high temperature calcination (500-600 °C) (Hoffman et al., 2006). Figure 3 
schematically represents the complete synthesis procedure. 
 
Figure 3. Schematic representation of the synthesis of mesoporous silica particles by structure-
directing agents. 
 
Minor changes in the synthesis route make it possible to modify final key 
features in the solid to produce other types of mesoporous silica, such as 
hexagonal mesoporous silica (HMS) (Tanev & Pinnavaia, 1995), Michigan State 
University material (MSU) (Bagshaw et al. 1995), Santa Barbara Amorphous Silica 
(i.e. SBA-15) (Zhao et al. 1998 a,b), Technische Universiteit Delft material                     
(i.e. TUD-1) (Jansen et al. 2001), Universidad Valencia Material (i.e. UVM-7) (el 
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Haskouri et al. 2002), and a wide variety of hollow silica spheres (Li et al. 2004; 
Zhang et al. 2009; Cao et al. 2013). TEM and FESEM pictures of some of these 
particles are provided in Figure 4.   
 
 
Figure 4. TEM and FESM images of different mesoporous silica particles. 
 
 
Given the potential application of MSPs to develop oral controlled delivery 
systems, different attempts to synthesize MSPs from food-like precursors have 
been successfully made. On the one hand, rice husk ashes have been employed as 
a silica source for the synthesis of different mesoporous silicas (Jang et al., 2009; 
Bhagiyalakshmi, 2010). On the other hand, polyglycerol esters of fatty acids, 
myristic acid ester of pentaglycerol and oleic acid have also been employed as 
food grade structures directing agents (Kapoor et al., 2010; Han et al., 2011; Ishii 
et al., 2012).  
 
In any case, different MSPs share their composition, which is based on a SiO2-
network, an ordered mesostructure and the presence of silanol groups on the 
particle surface. Some differ from others in size, shape, porous size and volume, 
specific surface area and density of silanol groups on the surface to provide 
different surface charges (Pérez-Esteve et al., 2014). The morphology and porosity 
of different MSPs are determined by processing parameters: type of surfactant 
template, silica source, pH, temperature, aging time, additives, and solvents 
(Kierys et al., 2010). The textural properties of different MSPs have been 
previously reviewed and compared in different publications (Wang et al., 2011; 
Wright, 2008). 
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In general, MSPs stand out for being supports that can be synthesized with 
a controlled size from 50 nm to a few microns. This range in size is important in 
scope. While small MSPs can cross epitheliums and can be distributed in the body 
to be non-specifically internalized by certain cells, oversized particles cannot 
easily cross physical membranes in the body. As particle size has been 
demonstrated to play a key role in the distribution and behavior of particles in 
living systems, large particle sizes are preferred for developing orally 
administrated controlled release devices (Arcos &Vallet-Regí 2013). 
  
MSPs can also be synthesized with uniform tunable porosity. Pore size can 
be tailored between 2-10 nm (Aznar et al., 2009a). The presence of a mesoporous 
network provides large surface areas (700-1000 m2 g-1) and a great loading 
capacity due to large pore volumes (0.6-1 cm3 g-1) (Colilla et al., 2013). Pore size, 
pore volume and a proper surface charge are essential for encapsulating a 
sufficiently large amount of a certain bioactive component and for efficiently 
retaining it during storage. Adsorption of bioactive molecules into mesoporous 
silica is governed by size and charge selectivity. Only the molecules with a size 
smaller than the porous size of the silica support can be entrapped by the porous 
structure (Arcos et al., 2013). Other factors that determine adsorption and the 
release kinetics of a bioactive compound in a certain media are pore length and 
pore ordering (Izquierdo-Barba et al., 2009a; Burguete et al., 2012), particle 
morphology (Manzano et al., 2008), surface area (Balas et al., 2006), macroscopic 
form (Izquierdo-Barba et al., 2009b) and modification or functionalization of the 
silica surface with functional groups (Nieto and others 2008).  
 
Finally, the surface of MSPs can be easily functionalized with 
molecular/supramolecular ensembles to develop gated MSPs that show “zero 
delivery” and are capable of releasing their cargo on-command in response to 
specifically designed external stimuli (Mondragón et al., 2014). These unique 
features of MSPs make them excellent candidates for developing smart delivery 
systems. 
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3.2 Functionalization of MSPs to develop triggered delivery systems 
The surface of MSPs presents a high concentration of structural defects in the 
form of silanol (Si-OH) groups that can easily react with trialkoxysilane derivatives 
((R’O)3-Si-R) and allow the possibility of generating organic-inorganic hybrid 
materials (Vinu et al., 2005).  
 
In this area, one appealing concept is the development of molecular gates. 
Molecular or supramolecular gates are defined as nanoscopic supramolecular-
based devices that are attached to certain solid supports, in which mass transport 
can be triggered by a target external stimulus that can control the state of the 
gate (closed or open) at will (Aznar et al., 2009). In particular, and depending on 
the type of stimulus applied, it is possible to modify the properties of anchored 
molecules (i.e. polarity, conformation, size, interaction with other species, bond 
hydrolysis etc.) which, in turn, results in controlled delivery (Coll et al., 2007; 
Casasús et al., 2008; Aznar et al., 2009b; Bernardos et al., 2012). A schematic 
representation of a gate-like superstructure is shown in Figure 5. 
 
Figure 5. Representation of a nanoscopic molecular gate system working principle 
 
As observed, smart delivery systems based on gated MSPs contain two 
components: a suitable inorganic support which acts as a nanocontainer (for 
loading the cargo); a switchable “gate-like” ensemble capable of being opened or 
closed when certain external stimuli are applied. Both components are important, 
and their selection determines the controlled release performance of the hybrid 
support (Bernardos et al., 2010; Burguete et al., 2012). The first example of a 
molecular gate was reported by Fujiwara and co-workers in 2003 (Mal et al., 
2003). Since then, a number of gated systems that have used mesoporous silica 
supports which respond to a wide variety of stimuli have been described (Aznar et 
al., 2009a; Coll et al., 2013; Arcos & Vallet-Regí, 2013).  
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4. Design of site-specific delivery systems that act along the gastrointestinal 
tract through gated MSPs 
 
As previously stated, the encapsulation and later administration of 
bioactive molecules at a particular site-of-action of the digestive tract (mouth, 
stomach, intestine or colon) offers huge possibilities to develop new functional 
foods or medical therapies. Hence the design of systems capable of controlling the 
release of basic nutrients, bioactive components, sensory appeal compounds, and 
pre- and probiotics, and even drugs, is a very challenging strategy that can be 
easily achieved by using capped MSPs. 
 
When designing a site-specific delivery system based on hybrid organic-
inorganic supports, there are two factors that should be taken into account. On 
the one hand, the porous system of the inorganic support should be able to 
entrap the target molecule. On the other hand, the capping molecule should be 
responsive to a triggering stimulus that is present in a particular cavity of the 
gastrointestinal tract. Moreover, the capping molecule must remain unchanged in 
the cavities that proceed. An overview of these stimuli is provided in Figure 6.  
 
Figure 6. Summary of chemical and biological stimuli able to trigger caped-MSPs during digestion 
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4.1 A brief physicochemical description of the digestive system 
This section describes the suitable stimuli found along the gastrointestinal 
tract that could be employed in developing site-specific delivery systems and all 
the approaches developed to date to design molecular gates responsive to these 
stimuli. 
 
4.1.1 Mouth 
Gastrointestinal tract activity begins in the mouth where the ingested food is 
chewed and mixed with saliva to allow bolus formation and to enhance taste 
(Humphrey & Williamson, 2001; Chen, 2009). Saliva is a complex heterogeneous 
clear fluid (pH 5.6-7.6) that consists in roughly 98% water and 2% organic and 
inorganic substances, including electrolytes, mucus, glycoproteins, proteins, 
antibacterial compounds, enzymes, and others (Levine et al., 1987).  
 
Of all the enzymes contained in saliva, α-amylase is the most important. The 
interaction of amylase with starch-based ingredients produces a breakdown of 
starch into simpler sugars (i.e. maltose and dextrins), which can be further broken 
down in the small intestine. Salivary α-amylase is most active at its optimum pH of 
7.4, and is inactivated in the stomach because of gastric acid. Thus, even though 
enzyme interaction begins almost immediately after food ingestion, its 
contribution to full starch breakdown is relatively insignificant. Most starch 
digestion results from pancreatic amylase rather than from salivary amylase 
(Chen, 2009). Salivary glands also secrete salivary lipase that starts the 
degradation of dietary triglycerides into fatty acids and diglycerides that start with 
fat digestion. However, salivary lipase does not play a digestive role in adult 
humans. Recent studies have suggested that it only plays a role in fat taste and 
texture perception (Drewnowski & Almiron-Roig, 1997).  
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The residence time in the oral cavity is short, and varies by 2-5 min  
depending on saliva swallowing and water intake. Thus the main suitable 
triggering stimuli in the buccal cavity are pH (neutral) and presence of α-amylase 
and salivary lipase. However, due to the short residence time and low enzyme 
activity, the influence of the mouth on the action of molecular gates could be 
considered negligible. 
4.1.2 Stomach 
Once food is swallowed, it passes into the stomach. In the stomach, food 
stuffs encounter gastric juice secretion. Gastric juice provides a harsh 
environment characterized by a very acid media (pH 1-2) that is rich in 
electrolytes, proteases (pepsin, renin and gastric lipase) and lipases (Chiras, 2015). 
Microflora in the stomach is predominantly Gram-positive and aerobic, and the 
bacterial concentration is usually <103 colony-forming units (CFU) mL-1 (Campieri 
& Gionchetti, 1999). The redox potential in the stomach is +150 mV (Friend, 
1992). The residence time of food in the stomach depends on the digestibility of 
meals; while light meals based on carbohydrates may be ready to pass into the 
small intestine through the pyloric valve in 2 h, heavy meals that contain proteins 
and fats may require up to 6 h to perform the same action. After this period, 
proteins are transformed into large polypeptides, and about 10-30% of dietary fat 
has been hydrolyzed (Krohn et al., 2008). The digestion process is thus completed 
in the small intestine.  
 
4.1.3 Small intestine 
In the small intestine, the hydrolysis of all the majority food structures and 
macronutrients occurs by the combined action of small intestine and accessory 
organs (pancreas and liver) secretions.  
 
Once the chyme arrives to the duodenum, the pancreas secretes pancreatic 
juice. Pancreatic juice is a liquid that contains water, sodium chloride, sodium 
bicarbonate and a number of digestive enzymes (i.e. amylases, lipases, proteases, 
ribonucleases and deoxyribonucleases) that help finish the digestive process that 
started in the stomach. Sodium bicarbonate neutralizes the high acidity of the 
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chyme. In this manner, the duodenum pH is 6.0 (within the 5.7-6.2 range) and 
gradually increases through the small intestine to pH 7.5 (within the 7.3-7.7 
range) (Fallingborg, 1999). This difference with the stomach pH allows the design 
of pH-responsive devices. The enzymatic profile of pancreatic juice is completed 
by enzymes of microvilli that constitute the brush border (i.e. saccharidases, 
peptidases and nucleases). Working together, both types of enzymes are able to 
hydrolyze almost all large molecules into absorbable food components.  
 
The duodenum also receives a fluid though the bile duct which is produced in 
the liver and stored in the gallbladder, and is known as bile. Bile is composed of 
water, cholesterol, lecithin (a phospholipid), bile pigments (with no digestive 
function), bile salts (sodium glycocholate and sodium taurocholate) and 
bicarbonate ions. The powerful surfactant activity of bile components helps with 
the digestion and adsorption of lipophilic components.  
 
Regarding microflora, the proximal small bowel is similar to that of the 
stomach. The bacterial concentration is 103-104 CFU mL-1. However, the distal 
ileum is able to support anaerobic bacterial flora. Consequently, the 
concentration of microorganisms increases in the distal ileum to levels of 105-109 
CFU mL-1 and the redox potential in the small intestine lowers from -50 mV in the 
duodenum or jejunum to -150 mV in the ileum (Friend, 1992; Campieri & 
Bionchetti, 1999).   
 
After this complete digestive process, which lasts between 2-5 h, most food 
structures have been disintegrated into absorbable molecules. Undigested food 
remains pass through the ileocaecal valve to the large intestine. 
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4.1.4 Large intestine 
The large intestine, which comprises the caecum, colon and rectum, is the 
last part of the digestive tract. Its main functions are to absorb the water and 
electrolytes that escape from absorption in the small intestine, and to store and 
remove feces during defecation. Understanding the last part of the GIT offers 
different possibilities to design triggered responsive MSPs for controlled release in 
the large intestine. 
 
The large intestine pH varies according to the food ingested. In general, the 
pH in the ascending colon is 6-7.1 due to fermentation processes, and varies along 
the large intestine length. The transverse colon exhibits a pH of 7.4, descending 
colon, pH 7.5, sigmoidal colon, pH 7.4, and rectum, pH 7.2. The shallow pH 
gradient between the small intestine and the colon does not allow the design of 
colonic delivery drug carriers based on pH changes (Milabuer et al., 2010). 
 
However, the large intestine is the natural habitat for a huge microbial 
community. The colon contains 1011 to 1012 CFU mL-1. Predominant species 
include Bacteroides, Bifidobacterium and Eubacterium. Anaerobic gram-positive 
cocci, as well as Clostridium, enterococci, and various species of 
Enterobacteriaceae are also present. The final digestion stage can be considered 
to be carried out by a wide variety of metabolic processes, including 
fermentation, enzyme-mediated reactions, and the reduction of a wide range of 
organic functional groups. Among the different extracellular enzymes produced by 
colonic bacteria, azoreductases, oxidoreductases, ureases, dextranases and a 
number of saccharidases capable of breaking indigestible carbohydrates, stand 
out.  
 
The total metabolic and bacterial activity in the large intestine generates a 
characteristic redox potential (-200 mV) that can be used as a highly selective 
mechanism for targeting in the colon (Friend, 1992; Chourasia & Jain, 2003). The 
residence time in the large intestine ranges from 2-72 h. In most individuals, 
mouth-to-anus transit times are usually longer than 24 h. More detailed 
information is provided in Table 1. 
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Table 1. Summary of digestive stimuli suitable for the design of triggered MSPs-based delivery 
systems. 
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Table 1. Continuation. 
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4.2 Strategies to develop site-specific smart delivery devices 
After discussing the most significant digestive stimuli that could be used to 
design capped MSPs for controlled release purposes in the gastrointestinal tract, 
the current MSP-based systems that can be opened using these triggering 
principles are presented in this section. 
4.2.1 pH-responsive molecular gates 
The first strategy to develop pH-responsive gated materials is based on using 
ionizable simple molecules anchored to the material surface, which undergo 
conformational and/or solubility changes in response to environmental pH 
variation, which modifies its conformation. Based on this approach, Martínez-
Máñez and co-workers developed the first pH-driven molecular gate in 2004 
(Casasús et al., 2004). Their mechanism was based on the 
protonation/deprotonation processes of polyamines grafted onto the pore outlets 
of the mesoporous inorganic scaffolds. At an acid pH, the columbic repulsions 
between the protonated amino groups hinders pore access (gate closed), while at 
a neutral pH, unprotonated amines tend to interact with each other, which favors 
pore access (gate open). Figure 7 illustrates the action mechanism of this 
reversible smart delivery system. Bearing in mind all these concepts, Bernardos et 
al, (2008), developed the first controlled release system mediated by a 
gastrointestinal stimulus. Given the objective of protecting riboflavin from acidic 
stomach conditions and of releasing the load in the intestine, these authors 
encapsulated vitamin riboflavin in an MCM-41 type support and functionalized its 
surface with the described pH-controlled gate-like scaffolding. They found a zero 
release under the stomach-like conditions (acid pH, gate closed) and a time-
modulated delivery under the intestine-like conditions (neutral pH, gate open). 
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Figure 7. Schematic representation of a pH driven molecular gate-like material based in the use of 
polyamines. 
 
A second strategy involves modifying the chemical interactions among the 
molecules covalently anchored to the surface of the mesoporous silica as a result 
of changes in pH. Following this approach, Lee et al. (2008) described the use of 
mesoporous silica nanoparticles loaded with sulfasalazine (an anti-inflammatory 
prodrug used for bowel disease) and functionalised with trimethylammonium 
functional groups via direct co-condensation of a trimethylammonium silane. At 
acidic conditions, the cargo remained inside the voids of the porous support. 
However, at neutral conditions deprotonation of silanol groups generated a 
strong electrostatic repulsion that triggered a sustained release of the loaded 
molecules. 
 
The third strategy comprises the design of devices capped with molecules 
anchored with acid-sensitive bonds whose cleavage enables the release of cargo 
molecules. Bearing in mind this principle, Zhao et al. (2010) developed a pH-
responsive nanoparticle able to be opened under acid conditions. The design 
strategy involved the use of mesoporous silica nanoparticles loaded with 
rhodamine B and functionalized with β-cyclodextrins through imine double bonds. 
The β-cyclodextrin rings on the surface of the nanoparticles served as gates for 
the storage of cargo molecules (i.e., rhodamine B) inside the nanopores of the 
nanoparticles under neutral conditions. At acidic pH, the cleavable imine bonds 
that attach the β-cyclodextrines to the particles surface were hydrolysed and the 
cargo released.   
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Besides polyamines, trymetylammonium groups and cyclodextrins, other 
capping molecules (such as polymers, peptides, proteins and DNA) have been 
used as gatekeepers in pH-triggered capped materials based in mesoporous silica 
(see Table 2).   
 
4.2.2 Redox-responsive molecular gates 
As occurred with changes in pH, the evolution of the redox potential along 
the gastrointestinal tract might allow the design of redox-driven gated 
mesoporous materials, especially for colon-targeted delivery. To date, no specific 
system based on naturally-occurring in redox potential changes along the GIT has 
been provided to modulate the delivery of bioactive molecules. However, there 
are a number of approaches that could be the basis for future developments.  
 
Lai et al. (2003) prepared a controlled delivery system to encapsulate several 
pharmaceutical drug molecules and neurotransmitters inside an organically 
functionalized mesoporous silica framework. In particular, this nano-device was 
prepared using MCM-41-type mesoporous silica nanospheres as an inorganic 
support and cadmium sulfide (CdS) nanocrystals as chemically removable caps. 
Addition of disulfide-reducing molecules, such as dithiothreitol (DTT) and 
mercaptoethanol (ME), to the aqueous suspension of the particles triggered a 
rapid release of the mesopore-entrapped cargo by breaking the chemically labile 
disulfide linkages between the MSP and CdS nanoparticles. Also based on disulfide 
linkages, Liu et al. (2008) prepared a calcined MCM-41 support loaded with dye 
molecules, with the surface functionalized by the grafting of a poly(N-
acryloxysuccinimide). The openings of the resulting hybrid material remained 
blocked due to the cross-linked reaction between the N-oxysuccimide groups 
along the polymer chain and the cystamine of the media. In contrast, the 
presence of disulfide-reducing agents, such as DTT cleavage the disulfide bond of 
cystamine, inducing pore opening and controlled dye release. 
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A different approach was published by Hernandez et al. (2004). These 
authors described the use of a MCM-41 mesoporous scaffold loaded with an 
iridium complex dye and functionalized with a 1,5-dioxynaphtalene derivative 
(DNPD) as a redox-responsive delivery system. The addition of cyclobis-(paraquat-
p-phenylene) (CBPQT4+) induced the formation of a pseudorotaxane on the 
external surface of the solid. This new non covalent supramolecular ensemble 
blocked pores and prevented dye delivery. When a reductive agent was added to 
the mixture (cyanoborohydride in this case), the reduction in DPND started a 
spontaneous dethreading of the CBPQT4+ ring to allow guest release.  
 
The evolution of that gated system was the achievement of a total reversible 
hybrid material capable of being open or closed on command in a reversible 
manner. In this case, Nguyen et al. (2005) firstly synthesized a [2]rotaxane-
containing DNPD and a tetrathiafulvalene moiety (TTF) as a redox centre to link 
each other through a oliogoethylenglycol chain. Rotaxane was completed by the 
presence of a rigid spacer and a CBPQT4+ as the movable molecule. Preference for 
CBPQT4+ for TTF or DNPD groups as a result of the oxidation state of TTF 
(dependent on the addition of oxidant or reducing species) caused gate 
movement, which changed from a closed to an open conformation.  
 
4.2.3 Surfactant-responsive molecular gates 
The surfactant-induced molecular gates concept was introduced by Giménez 
et al. (2014). This new material consisted of nanoparticles of MCM-41 
functionalized on the external surface with 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC). The presence of DOPC created a lipid bilayer around pore 
outlets that inhibited cargo release. However, the system released its cargo after 
the addition of dodecyltrimethylammonium bromide (DTAB), a single-chain 
cationic surfactant whose activity is similar to phosphocholine (lecithin).  
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4.2.4 Enzyme-responsive molecular gates 
The wide variety of enzymes present along the gastrointestinal tract, and 
their selective location (stomach, brush border, colon,) allows the design of very 
specific site release systems. One of the first examples of gated MSPs capable of 
delivering an entrapped cargo in the presence of saccharases was described by 
Bernardos et al. (2009). These authors designed a mesoporous silica particle 
capped with a covalently anchored lactose derivative. Cargo delivery from 
aqueous suspensions was negligible because the formation of a dense network of 
lactose groups linked through the hydrogen-bonding interaction around pore 
outlets. The addition of -D-galactosidase enzyme (lactase) induced progressive 
cargo release, which was clearly related to the enzymatic hydrolysis of the 
glycosidic bond in disaccharide lactose. This is a clear example of the potential use 
of an enzyme-responsive molecular gate to hinder cargo release during food 
processing, storage and the first part of the digestion in the stomach, and one that 
is able to release the guest molecule in the small intestine in the presence of 
enzymes of brush border mucosa. 
 
In line with this, the same authors functionalized the surface of a loaded 
MCM-41 support with three different commercially available hydrolyzed starches 
(Glucidex 47, 39 and 29) via the derivatization of starch with an alkoxysilane. 
Cargo release was achieved by enzymatic hydrolysis in the presence of pancreatin 
(an enzyme cocktail that contains pancreatic amylase), which showed different 
release kinetics according to the the degree of starch hydrolysis (Fig 8). The lower 
the hydrolysis rate of starch, the lower the delivery rate (Bernardos et al., 2010). 
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Figure 8. Schematic representation of a pH driven molecular gate-like material functionalised with 
hydrolysed starch. 
 
Bein and co-workers prepared the first molecular gate opened by the 
presence of a protease (Schlossbauer et al., 2009). Capping systems consisted in 
attaching avidin to a biotinylated MSP. The addition of protease trypsin induced 
the hydrolysis of the attached avidin and cargo release. Along the same lines, Coll 
et al. (2011) employed a click chemistry reaction to functionalize the external 
surface of an MSP with a peptide to develop a nanodevice capable of hampering 
cargo release. Delivery was observed in the presence of proteases (Fig 9). 
 
 
Figure 9. Schematic representation of a enzyme driven molecular gate-like material capped with a 
peptide. 
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Some examples of deoxyribonuclease-triggered delivery systems have also 
been reported. Zhu and coworkers presented an oligodeoxynucleotide-capped 
material using hollow MSPs that was opened in the presence of DNase I (Zhu et 
al., 2011a). Zhang et al. (2014) reported the use of a porous material loaded with 
the drug colchicine and capped with oligodeoxynucleotides that was able to be 
uncapped also when DNase I was used. 
 
The possibility of using enzymes secreted from colonic microflora to design 
smart delivery systems has been previously reported. Agostini et al. (2012a) 
described an ethylene glycol-capped hybrid material for the controlled release of 
a certain cargo in the presence of esterase. In the absence of an esterase enzyme, 
the steric hindrance imposed by bulk ester glycol moieties inhibited cargo release. 
Upon the addition of the esterase enzyme, cargo delivery occurred due to the 
hydrolysis of the ester bond. In another work, the same authors prepared MSPs 
loaded with Rhodamine B and functionalized with an alkylgluconamine derivative 
of a galacto-oligosaccharide (GOS) capable of delivering its cargo in the presence 
of -galactosidase (Agostini et al., 2012b). Mas et al. (2013) reported the synthesis 
of a hybrid material capped with an azopyridine derivative. This material was 
designed to show "zero delivery" in the absence of enzymes and to display cargo 
release in the presence of azo-reductases, which are usually present in the colon.  
 
More examples of enzyme-responsive gated materials are shown in Table 3.  
The profound analysis of all the reported examples allowed a conclusion to be 
drawn. The most extended enzymes used as triggering stimuli are amylases, 
proteases, peptidases and deoxyribonucleases (which can be used for delivery in 
the small intestine) and reductases, esterases and ureases (which can be used for 
controlled cargo delivery in the colon). However, the real development of 
enzyme-responsive gated materials with applications in the design of site-specific 
delivery systems that act along the gastrointestinal tract is still in its incipient 
steps.  
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4.2.5 Dual stimuli-controlled release 
One step forward in the design of gated mesoporous supports is the 
possibility of preparing gated materials that could be opened by using two 
different stimuli. For instance, Casasús et al. (2008) studied pH- and anion-
responsive gated-like ensembles in anion complex formation terms with 
polyamines. This study came to the conclusion that larger anions pushed tethered 
polyamines toward pore openings and reduced the pore aperture. More recently, 
Popat et al. (2014) reported the use of silica nanoparticles that were responsive to 
multiple digestive stimuli (pH and enzymes). Their system consisted of an MCM-
48-type structure loaded with sulfasalazine, and functionalized with amino groups 
coated with a succinylated soy protein isolate (SSPI). The resultant delivery system 
showed both pH and enzyme responsiveness, depending on the location of the 
nanoparticles in the GIT. In both the stomach and duodenum, the low 
environmental pH (pH 1.2 and ca. 5, respectively) restricted the release of 
sulfasalazine due to the capping effect of the SSPI. In contrast, when the delivery 
system reached the small intestine (pH 7.4) the change in pH induced the 
hydrolyzate destabilization, which favors protein hydrolysis by the pancreatin 
enzyme. The result was a controlled, slow and sustained drug release in the small 
intestine.  
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Table 2. Summary of suitable pH-driven molecular to be used in oral control delivery 
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Table 3. Summary of suitable enzyme-driven molecular to be used in oral control delivery 
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5. Benefits and potential current limitations of MSPs for their use in human 
food  
 
As previously demonstrated, delivery systems based on hybrid organic-
inorganic MSPs show most of the desired properties for a smart delivery system: 
high loading capacity, controlled release rate of a bioactive molecule at a 
particular site in response to a particular trigger, good biocompatibility, low-cost 
fabrication given its composition, easy handling, etc. Yet, given its novelty, some 
limitations (toxicological, technological, semantic, legal and sociological) still need 
to be overcome, before starting to use MSP as smart delivery systems in food and 
nutrition.  
5.1 Toxicological: lack of conclusive studies 
Despite silica not being considered harmful for humans, it is known that 
engineered nanomaterials are not governed by the same laws as larger particles 
(Pérez-Esteve et al., 2013). If we bear in mind that change in size affects the 
functionality of particles, it could also affect people exposed to newly developed 
particles. In this context, in recent years, several studies have addressed the 
toxicological and biocompatibility properties of MSPs.  
 
The impact of nanoparticles generally depends on certain properties, such as 
particle size, size distribution, shape, solubility, reactivity, mass, chemical 
composition, surface properties (area and charge) and aggregation state (Chau et 
al., 2007; Athinarayanan et al., 2014).  
 
He et al. (2009) studied the effect of particle size (nano- and microparticles), 
concentration, biodegradation products, and residual surfactant on the 
cytotoxicity of human breast-cancer cell lines (MDA-MB-468) and African green 
monkey kidney cell lines (COS-7). These authors observed that 190 nm and 420 
nm particles showed significant cytotoxicity at concentrations above 25 mg mL-1, 
while microscale particles of 1220 nm showed only slight cytotoxicity due to 
reduced endocytosis. In line with this, in an in vivo study with male nude mice, 
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Souris et al. (2010) confirmed that after oral administration, silica nanoparticles 
located in the liver could be excreted into the intestine by the hepatobiliary 
excretion process. Later, Fu et al. (2013) demonstrated with female ICR mice that 
silica nanoparticles (110 nm in size) are absorbed into the body at 24 h of oral 
administration. Yet once absorbed, particles are transported via the portal vein to 
the liver and are then eliminated during a 7-day period by fecal excretion, and 
also through urine, without changing the kidney microstructure. These results 
agree with the studies done into tissue distribution and excretion kinetics of orally 
administered silica nanoparticles in rats carried out by Lee et al. (2014). These 
authors reported that after ingestion, particles are distributed to kidneys, liver, 
lungs and spleen. However, silica particles are easily decomposed and eliminated 
via urinary and fecal excretion after oral exposure. The smaller the particles, the 
more rapidly they are secreted, presumably because they are more easily 
decomposed.  
 
As well as particle size, particle shape seems important when talking about 
potential toxicology. Tao et al. (2008) evaluated the effect of two types of 
mesoporous silica particles on mitochondrial O2 consumption. For this purpose, 
the effect of SBA-15 (irregular rods of ca. 1000 nm in length and aspect ratio of 
1:5) and MCM-41 (spheres of 300-1000 nm in diameter) on mitochondrial O2 
consumption (respiration) was evaluated in HL-60 (myeloid) cells, Jurkat 
(lymphoid) cells, and isolated mitochondria. These authors observed that while 
SBA-15 inhibited cellular respiration at 25-500 μg mL-1, MCM-41 had no noticeable 
effect on the respiration rate.  
 
Finally, surface properties also seem relevant for potential toxicology (Tang 
et al., 2012). Specifically, van Schooneveld et al. (2008) reported the improved 
biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid 
coating. In their extensive study on bare and lipid-coated silica nanoparticles in 
mice, these authors concluded that coating porous silica with organic molecules 
can increase the biocompatibility and half-lives of cells by more than 10-fold 
compared to bare silica mesoporous supports.  
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Thus despite adverse effects having been observed in some cells or animals 
treated with different concentrations of some MSPs, other in vitro and in vivo 
studies have suggested that certain particles are well tolerated by both cells and 
superior animals. Therefore, it is hard to draw conclusive conclusions about the 
biocompatibility and toxicity of MSPs as a unique concept. In any case, the use of 
mesoporous silica microparticles functionalized on their surface with 
biocompatible organic molecules seems a good strategy to minimize the risks 
associated with using MSPs as supports to develop smart delivery systems.  
5.2 Technological problems: mass production and impact of MSPS-based 
delivery systems on the food matrix 
There is no doubt that the application of MSP-based delivery systems to the 
formulation of novel functional foods opens up new strategies for the food 
industry. However, before launching foods that contain MSPs to the market, some 
technological problems should be solved.  
First problem is related with the mass production of MSPs. To date, 
processes for the synthesis, loading and functionalization of MSPs are being 
developed on a laboratory scale. As a result, production costs are high and mass 
production is practically underdeveloped.  
The second technological problem is related to the compatibility of these 
devices with the food matrix. Generally, introducing new ingredients or additives 
to a food matrix can affect the physico-chemical and sensory properties of the 
product. However, it is considered that a delivery system suitable for a particular 
application should be compatible with the food or beverage matrix that it is to be 
incorporated into, and should cause no adverse effects on product appearance, 
flavor, texture, mouth feel or shelf life.  
Despite the importance of this aspect, as far as we know, there is only one 
publication that has dealt with determining the influence of MSPs on physical 
properties of the food matrix to which they could be included (Pérez-Esteve et al., 
2014). However, since MSPs have a high load capacity and bioactive compounds 
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exhibit their functional properties at very low concentrations, it is assumed that 
the amount of support needed to release an adequate concentration of the 
component is very low. Thus it is foreseeable that the physicochemical features of 
the matrix that is to incorporate these supports should not be affected by the 
presence of encapsulating systems.  
5.3 Semantic: Disharmonized and changing and denominations 
As previously described, the MSPs concept involves structures of silicon 
dioxide (SiO2) arranged in such a way that they are able to create pores of 2-50 
nm. This structure on the nanoscale is the key to design molecular or 
supramolecular capped materials. Its design, fabrication, manipulation and 
characterization are possible thanks to nanotechnology. Therefore, should MSPs 
be considered nanomaterials? It is clear that mesoporous silica nanoparticles are 
nanomaterials. But what happens with mesoporous silica microparticles? By 
taking into account only European recommendations and regulations, 
denominations are disharmonized and have changed over the years. 
 
Regulation (EC) No. 1169/2011, on the provision of food information to 
consumers, defined the engineered nanomaterial concept as intentionally 
produced materials that have one dimension or more in the order of 100 nm, or 
less, or is composed of discrete functional parts, either internally or on the 
surface, many of which have one dimension or more in the order of 100 nm, or 
less, including structures, agglomerates or aggregates, whose size above the order 
may be 100 nm, but retain characteristic properties of the nanoscale. 
Characteristic of the nanoscale includes: (i) those related to the large specific 
surface area of the materials considered; and/or (ii) the specific physico-chemical 
properties that differ from those of the non nanoform of the same material. 
According to this definition, and regardless of size, MSPs can be considered 
nanomaterials as they are intentionally produced to modify their physico-
chemical properties and to create nanoporous structures to increase their specific 
surface area. 
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In the same year, the European Commission defined nanomaterials as 
natural, incidental or manufactured material that contains particles, in an 
unbound state, or as an aggregate or agglomerate, where for >50% of the 
particles in the number size distribution, one external dimension or more falls 
within the 1-100 nm size range (EU, 2011). This definition is in line with the 
opinion of the Scientific Committee on Emerging and Newly Identified Health 
Risks (SCENIHR), included the size distribution of a material as a defining element, 
and excludes other types of nanostructured materials, such as nanoporous or 
nanocomposite materials, since there is not enough evidence to guide what 
materials should be included. 
These definitions, apart from being technical, affect regulatory aspects and 
food labeling. Thus, they are vital for the future of these systems. The NanoDefine 
Project (FP7) is expected to deliver an implementable test scheme for regulatory 
purposes to distinguish nano from non nanomaterials by 2017. 
5.4 Legal: Lack of specific regulations 
According to their composition (SiO2), MSPs should be authorized for use in 
food. SiO2 is “Generally Recognized as Safe” (GRAS) by FDA regulations. It is also 
an authorized additive in Europe and achieves the E-551 classification (Contado et 
al., 2013). In the food industry, synthetic amorphous silica has been used for 
many years to clear beers and wines, as an anti-caking agent to maintain the flow 
properties of powder products, and as a carrier agent for flavorings and aromas, 
and to thicken pastes.  
 
However when we consider their physical features, MSPs could be classified 
as novel food ingredients based on engineered nanomaterials. Thus in order to 
place a specific MSP as a food ingredient in the Community market, the applicant 
should submit a request to the Member State in which the product would be 
placed (Regulation (EC) No. 258/97). If approved, the presence of the engineered 
nanomaterial should be clearly indicated in the list of ingredients by writing the 
word “nano” in brackets (Regulation (EC) No. 1169/2011).  
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5.5 Sociological: in the face of the unknown, the precautionary principle 
The uncertainty in purely semantic aspects and in conclusive toxicological 
studies has not only consequences at a regulatory level, but also influences 
consumers’ risk perception and acceptance. Although very little research has been 
conducted in developing countries on consumer attitudes toward foods that 
contain nanostructured ingredients, recent studies point out that lack of 
information about the impact of nanotechnology on environmental and health 
consequences leads consumers to apply the precautionary principle and, 
therefore, to reject such products (Chau et al., 2007). 
For novel foods to be accepted, consumers must perceive that any potential 
benefits outweigh potential risks or negative effects (for example, potential for a 
negative impact on the environment, human and animal health, or ethical 
concerns, such as animal welfare or social equity) (Frewer & Fischer, 2010).  
For this to happen, information about the potential benefits and potential 
risks should not only be accurate, but also very clear. This entails properly 
regulating the use of nanotechnologies in food and publishing conclusive studies 
about the potential risks of each type of MSP by considering all the variables that 
can affect their toxicity. Until this time comes, generalizations, doubts or risk 
perceptions will outweigh the real benefits.   
6. Conclusions 
Gated MSPs have the potential to encapsulate bioactive molecules and, 
consequently, to protect them from the environment during production, storage 
and digestion, to mask their odor and taste, to improve their compatibility with 
the food matrix, and to amend their bioaccessibility along the GIT. This review 
reports the most recent research into the design of gated mesoporous siliceous 
materials for controlled release along the GIT using physiologic stimuli. It also 
highlights the possibilities of naturally-occurring stimulus along the GIT that could 
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be used to develop new gated systems. Applications for these capped materials 
can be found in the design of novel functional foods.  
 
Nevertheless, given their novelty, the incorporation of gated-MSPs into food 
still poses major challenges (i.e. technological, toxicological, legal, sociological...) 
that need to be overcome by researchers and regulatory bodies. Researchers have 
the task of evaluating the potential hazards of MSPs-gated systems in human 
health and the environment, and to design specifically designed systems to be 
triggered in the gastrointestinal tract. Regulatory bodies should provide specific 
regulations and criteria to be followed when evaluating the safety of this new 
smart delivery system to be used in food applications. Collaborative work from 
those groups will be essential in forthcoming years to generate confidence in 
industry and consumers. Only then will functional foods developed by this new 
technology be available in the food chain.  
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F., Soto, J., Barat, J. M., Perez-Paya, E., Guillem, C.,  & Amorós, P. (2010). Enzyme-
responsive intracellular controlled release using nanometric silica mesoporous supports 
capped with “saccharides”. Acs Nano, 4(11), 6353-6368. 
Bernardos, A., Mondragón, L., Javakhishvili, I., Mas, N., de la Torre, C., Martínez‐
Máñez, R., Sancenón F., Barat, J. M., Hvilsted, S., Orzaez, M., Pérez-Payá, E., & Amorós, P. 
(2012). Azobenzene Polyesters Used as Gate‐Like Scaffolds in Nanoscopic Hybrid 
Systems. Chemistry-A European Journal, 18(41), 13068-13078. 
Bernardos, A., & Kourimská, L. (2013). Applications of mesoporous silica materials in 
food-a review. Czech Journal of Food Science, 31(2), 99-107. 
Bhagiyalakshmi, M., Yun, L. J., Anuradha, R., & Jang, H. T. (2010). Utilization of rice 
husk ash as silica source for the synthesis of mesoporous silicas and their application to CO 
2 adsorption through TREN/TEPA grafting. Journal of hazardous materials, 175(1), 928-
938. 
Branum, A. M., Bailey, R., & Singer, B. J. (2013). Dietary supplement use and folate 
status during pregnancy in the United States. The Journal of nutrition, 143(4), 486-492.  
Burguete, P., Beltrán, A., Guillem, C., Latorre, J., Pérez‐Pla, F., Beltrán, D., & Amorós, P. 
(2012). Pore length effect on drug uptake and delivery by mesoporous 
silicas. ChemPlusChem, 77(9), 817-831. 
Campieri, M., & Gionchetti, P. (1999). Manipulation of intestinal microflora. In: 
Rutgeerts, P. (Ed.),  Advances in inflammatory bowel disease (pp. 297-300). London: 
Kluwer Academic. 
Cao, Z., Yang, L., Yan, Y., Shang, Y., Ye, Q., Qi, D., Ziener, U., Shan, G., & Landfester, K. 
(2013). Fabrication of nanogel core-silica shell and hollow silica nanoparticles via an 
interfacial sol-gel process triggered by transition-metal salt in inverse systems. Journal of 
colloid and interface science, 406, 139-147. 
Casasús, R., Marcos, M. D., Martínez-Máñez, R., Ros-Lis, J. V., Soto, J., Villaescusa, L. A., 
Amorós, P., Beltrán, D., Guillem, C., & Latorre, J. (2004). Toward the development of 
ionically controlled nanoscopic molecular gates. Journal of the American Chemical 
Society, 126(28), 8612-8613. 
Casasús, R., Climent, E., Marcos, M. D., Martínez-Máñez, R., Sancenón, F., Soto, J, 
Amorós, P., Cano, J., & Ruiz, E. (2008). Dual aperture control on pH-and anion-driven 
supramolecular nanoscopic hybrid gate-like ensembles. Journal of the American Chemical 
Society, 130(6), 1903-1917. 
  
General introduction 
 
50 
 
Cauda, V., Argyo, C., Schlossbauer, A., & Bein, T. (2010). Controlling the delivery 
kinetics from colloidal mesoporous silica nanoparticles with pH-sensitive gates. Journal of 
Materials Chemistry, 20(21), 4305-4311. 
Chau, C. F., Wu, S. H., & Yen, G. C. (2007). The development of regulations for food 
nanotechnology. Trends in Food Science & Technology, 18(5), 269-280. 
Chen, C., Pu, F., Huang, Z., Liu, Z., Ren, J., & Qu, X. (2010). Stimuli-responsive 
controlled-release system using quadruplex DNA-capped silica nanocontainers. Nucleic 
acids research, 39, 1638-1644. 
Chen, J. (2009). Food oral processing—a review. Food Hydrocolloids, 23(1), 1-25.. 
Cheng, S. H., Liao, W. N., Chen, L. M., & Lee, C. H. (2011). pH-controllable release using 
functionalized mesoporous silica nanoparticles as an oral drug delivery system. Journal of 
Materials Chemistry, 21(20), 7130-7137. 
Cheung, R. H. F., Morrison, P. D., Small, D. M., & Marriott, P. J. (2008). Investigation of 
folic acid stability in fortified instant noodles by use of capillary electrophoresis and 
reversed-phase high performance liquid chromatography.Journal of Chromatography 
A, 1213(1), 93-99. 
Chiras, D. D. (2015). Nutrition and digestion. In: Human biology. (pp. 131-164). Jones & 
Bartlett Learning. Sudbury. 
Choi, S. W., & Mason, J. B. (2002). Folate status: effects on pathways of colorectal 
carcinogenesis. The Journal of nutrition, 132(8), 2413S-2418S. 
Chourasia, M. K., & Jain, S. K. (2003). Pharmaceutical approaches to colon targeted 
drug delivery systems. Journal of Pharmaceutical Sciences, 6(1), 33-66. 
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998). 
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer 
disease. Archives of neurology, 55(11), 1449-1455. 
Climent, E., Marcos, M. D., Martínez‐Máñez, R., Sancenón, F., Soto, J., Rurack, K., & 
Amorós, P. (2009). The determination of methylmercury in real samples using organically 
capped mesoporous inorganic materials capable of signal amplification. Angewandte 
Chemie, 121(45), 8671-8674. 
Colilla, M., González, B., & Vallet-Regí, M. (2013). Mesoporous silica nanoparticles for 
the design of smart delivery nanodevices. Biomaterials Science, 1(2), 114-134. 
Coll, C., Casasús, R., Aznar, E., Marcos, M. D., Martínez-Máñez, R., Sancenón, F., Soto, 
J., & Amorós, P. (2007). Nanoscopic hybrid systems with a polarity-controlled gate-like 
scaffolding for the colorimetric signalling of long-chain carboxylates. Chemical 
Communications, (19), 1957-1959. 
  
General introduction 
 
51 
 
Coll, C., Mondragón, L., Martínez‐Máñez, R., Sancenón, F., Marcos, M. D., Soto, J., 
Amorós, P.,  & Pérez‐Payá, E. (2011). Enzyme‐Mediated Controlled Release Systems by 
Anchoring Peptide Sequences on Mesoporous Silica Supports. Angewandte Chemie 
International Edition, 50(9), 2138-2140. 
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Abstract 
 
A study on the controlled release of folic acid (FA) from pH-responsive gated 
mesoporous silica particles (MSPs) is reported. The MCM-41 support was 
synthesized using tetraethyl orthosilicate (TEOS) as hydrolytic inorganic precursor 
and the surfactant hexadecyltrimethylammonium bromide (CTAB) as porogen 
species. Calcination of the mesostructured phase resulted in the starting solid. 
This solid was loaded with FA to obtain the initial support S0. Moreover, this FA-
loaded material was further functionalized with N1-(3-
Trimethoxysilylpropyl)diethylenetriamine (N3) in order to obtain the gated 
polyamine-functionalised material S1. Solids S0 and S1 were characterized using 
standard solid state procedures. It was found that the functionalization process 
and the inclusion of FA on the pores did not modify the mesoporous structure of 
the starting material. FA delivery studies in water with solids S0 and S1 were 
carried out in water at pH 2 and 7.5. S0 was not able to completely inhibit FA 
delivery at acidic pH yet a rapid FA release at neutral pH was observed in few 
minutes. In contrast, S1 was tightly capped at pH 2 and displayed a sustained 
delivery of FA when the pH was switched to 7.5. In the second part of the study, 
FA loading and functionalization of S1-like supports was optimized. In particular, 
solids loaded with FA in phosphate buffered saline (PBS) and capped with N3 in 
acetate buffer at pH 2 exhibited a delivery capacity up to 95 μg FA mg-1 solid. 
Finally, FA release from the selected optimized supports was studied following an 
in vitro digestion procedure. The results showed that amine-capped MSP were 
not only able to hinder the release of the vitamin in gastric fluids (pH 2), but were 
also capable of deliver progressively the FA in presence of a simulated intestinal 
juice (pH 7.5) offering a suitable mechanism to control the bioaccessibility of the 
vitamin. 
 
Keywords: Folic acid, bioaccessibility, loading optimization, controlled release, 
mesoporous silica particles.  
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1. Introduction 
 
Folate is a generic term by which is known a group of water-soluble 
compounds with B9 vitamin activity and with chemical structures similar to 
synthetic pteroyl monoglutamic acid (PGA), commonly known as folic acid (FA). 
Folates are essential to numerous bodily functions, including DNA synthesis and 
repair, cell division and cell growth (Lucock, 2000). Main folate sources include 
green leafy vegetables, yeast extracts, liver, kidney, and citrus fruit. Despite this 
wide distribution, folate deficiency is a common finding that can be caused by a 
variety of factors such as malabsorption of folate from the diet, an increased 
utilization by the body or a significant loss up to 50% during cooking processes 
(Younis et al., 2009). FA deficiency is such important in humans that it can cause 
neural tube defects in developing embryos (Czeizel et al., 1992), is associated with 
elevated plasma homocysteine (an emerging risk factor for vascular diseases), 
with cognitive decline and neurodegenerative diseases such as Alzheimer and also 
is risk factor for certain tumours (acute lymphoblastic leukaemia, breast cancer, 
and gastric cancer) (Wright et al., 2001; Koike et al., 2012) 
 
To prevent the occurrence of these and other diseases, food supplementation 
with folates is mandatory in certain countries such as USA (FDA, 1996), Canada 
(Health Canada, 1997) or UK (Lucock & Yates, 2009) with the objective of ensure a 
400 μg intake for adults and an additional 200 μg for pregnant women (Eichholzer 
et al., 2006). To achieve this supplementation, the most employed molecule is FA, 
due to its high stability and bioavailability (Sanderson et al., 2003). 
 
Although there are irrefutable evidences about the benefits of FA 
supplementation to prevent some diseases, recent studies suggest that the 
margin of the benefit is very narrow, and despite the necessity of the 
supplementation, a massive exposition to high bioavailable FA could be a double-
edged sword (Lucock & Yates, 2009). In particular it has been reported that 
biotransformation processes of FA are saturated at doses of 266-400 μg of FA and 
up to this amount unmetabolized FA is found in plasma, which could be correlated 
with the increase of cancer risk, insulin resistance, preneoplastic and neoplastic 
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lesions (Kim, 2004). In this context, the design of systems to dosage FA along the 
digestion and therefore modulating its bioaccessibility and bioavailability is a 
challenge for current nutritional science. 
 
The bioaccessibility of a nutrient is defined as the amount of the nutrient that 
is released from a food matrix during digestion and made accessible for 
absorption into the intestinal mucosa (Hedrén et al., 2002). One possibility to 
modulate bioaccessibility of a molecule consists of its encapsulation and later 
controlled release under suitable stimuli. Organic-based ensembles using lipids or 
carbohydrates have been reported as classical encapsulation systems (Tomiuk et 
al., 2012). However, they have some important drawbacks, such as the difficulty 
for a scale production (Chen et al., 2006; Fathi et al., 2012), low stability of the 
structure during food processing and storage, difficulty of controlling the release 
rate and also a poor capability to protect the encapsulated substance through the 
harsh stomach conditions (McClemens & Li, 2010). As an alternative, systems 
based in polyalcohols, polyamides, celluloses (Mastromatteo et al., 2010) or in 
mesoporous inorganic materials (Vallet-Regí et al., 2004), have been recently 
developed as suitable systems for controlled delivery applications. In particular, 
mesoporous silica particles (MSP) exhibit unique features as supports for 
controlled release, such as high stability (Ghedini et al., 2010), biocompatibility (Al 
Shamsi et al., 2010), no apparent toxicity (Suh et al., 2009), large load capacity 
(Coll et al., 2011), and the possibility to include gate-like scaffoldings on the 
external surface. This last characteristic allows the design of carriers for on-
command delivery in the presence of target physical (such as light, temperature) 
(Mal et al., 2003; Aznar et al., 2012), chemical (pH-changes, redox potential) (Park 
et al., 2007; Guillet-Nicolas & Popat, 2013; Jiao et al., 2013; Tian et al., 2013; Zhao 
et al., 2013) and biomolecules stimuli (enzymes, antibodies, DNA) (Patel et al., 
2008; Climent et al., 2009; Agostini et al., 2012; Li et al., 2013). Of those, several 
gated MSP have proved to show “zero” delivery yet are able to release the cargo 
under digestive stimuli (Bernardos et al., 2008; Bernardos et al., 2011). In 
particular, gated ensembles based in amines have been reported to be suitable 
systems for cargo delivery upon pH changes. 
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The purpose of this study is, on one hand, to evaluate the use of MSP capped 
with amines as suitable pH-responsive systems capable to modulate FA delivery 
and bioaccessibility in in vitro digestion assays and on the other hand, to optimize 
the loading process in these materials to achieve the release of dietary reference 
intake of folic acid using the minimum amount of inorganic matrix. As far as we 
know, this is the first time that an optimization of folic acid loading in MSP and a 
study of in vitro delivery from MSP of this molecule of nutritional interest is 
reported. 
 
2. Materials and methods 
 
2.1 Chemicals 
Tetraethyl orthosilicate (TEOS), n-cetyltrimethylammonium bromide 
(CTABr), sodium hydroxide (NaOH), triethanolamine (TEAH3), the organosiloxane 
derivative N1-(3-Trimethoxysilylpropyl)diethylenetriamine (N3), sodium 
phosphate dibasic (Na2HPO4), tetrabutylammonium hydrogen sulphate (TBAHS) 
and all chemicals for the digestive fluids were provided by Sigma-Aldrich (Poole, 
Dorset, UK). Folic acid was purchased from Schircks Laboratories (Jona, 
Switzerland). Acetonitrile HPLC grade was provided by Scharlau (Barcelona, 
Spain). 
 
2.2 FA molecular structural mechanics simulations 
Theoretical calculations of the structure of FA were carried out by using 
HyperChem 8.0.6 Molecular Modelling System (Hypercube Inc., Gainesville, FL, 
USA). The calculation of geometry was performed using molecular mechanics 
MM+ in a first step and AMBER in a second step. Full geometry optimizations 
were carried out in vacuum employing the Polak-Ribiere conjugate gradient 
method until an RMS gradient of 0.1 kcal mol-1 was reached. The final 3D 
structure was refined by optimization of the geometry using molecular dynamics 
methods at a simulation temperature of 300 K. QSAR properties of the vitamin 
were determined. 
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2.3 Synthesis of MCM-41 
The mesoporous MCM-41 support was first synthesized using the so-called 
“atrane route” in which 4.68 g of CTAB were added at 118 °C to a solution of 
TEAH3 (25.79 g) containing 0.045 mol of a silatrane derivative (11 mL of TEOS). 
Next, 80 mL of water was slowly added with vigorous stirring at 70 °C. After few 
minutes, a white suspension was formed. This mixture was aged at room 
temperature overnight. The resulting powder was collected by filtration and 
washed with water and ethanol. Finally, the solid was dried at 70 °C. To prepare 
the final mesoporous material, the as-synthesized solid was calcined at 550 °C 
using an oxidant atmosphere for 5 h in order to remove the template phase. 
 
2.4 Synthesis of S0 and S1 
100 mg of MCM-41 and 0.035 g (0.08 mmol) of FA were suspended in 7 mL of 
phosphate buffered saline (PBS) inside an amber round-bottom flask in an inert 
atmosphere. The mixture was stirred for 24 h at room temperature to achieve the 
maximum loading in the pores of the MCM-41 scaffolding. The loaded solid (S0) 
was isolated by vacuum filtration, washed with 300 mL of water adjusted to pH 2, 
and dried at room temperature for 24 h. This loading process was optimized in 
further assays (vide infra in 2.5). 
 
To obtain S1, 100 mg of S0 were suspended in 4 mL of acetonitrile and an 
excess of N3 (0.43 mL, 0.015 mmol) was added. The final mixture was stirred for 
5.5 h at room temperature. The loaded and functionalized solid (S1) was isolated 
by vacuum filtration, washed with 300 mL of water adjusted to pH 2, and dried at 
room temperature for 24 h. 
 
2.5 Folic acid release studies 
To determine the effect of pH in FA release from the non-gated (S0) and 
amine-gated (S1) mesoporous silica particles, 10 mg of the corresponding solids 
(S0 or S1) were placed in 25 mL of water at pH 2 and pH 7.5. At a certain times 
aliquot were separated, the suspension filtered and the solution analysed by 
HPLC. 
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2.6 Folic acid loading optimization 
With the aim of optimize the amount of FA loaded inside the MSP, two 
different loading methods were tested: immersion (A) and impregnation (B). 
Table 1 summarizes the 8 loading conditions assayed. Solids were synthesized by 
triplicate. 
 
Table 1. Conditions employed in loading optimization assays: immersion method (A) and 
impregnation method (B). 
Loading 
mechanism 
Solid MCM 
(mg) 
Folic 
(mg) 
PBS 
(mL) 
Cfolic           
(mg mL
-1
) 
Cycles (amount of 
solution per cycle) 
       
Immersion A1 100 35 7 5  
A2 100 35 3.5 10  
A3 100 70 7 10  
A4 100 70 3.5 20  
Impregnation B1 100 10 1 10 1 (1 mL) 
B2 100 10 1 10 2 (0.5 mL) 
B3 100 15 1.5 10 3 (0.5 mL) 
B4 100 20 2 10 4 (0.5 mL) 
 
For the immersion method (A), 100 mg of MCM-41 were immersed into a 
PBS solution containing 4 different amounts of FA, stirred for 24 h, filtered and 
washed. Then, loaded solids were functionalized with 0.43 mL of N3 in acetonitrile 
following the procedure described in the synthesis of S1. Using this method, 4 
different loaded and functionalized solids were obtained (A1-4). 
 
For the impregnation method (B), FA dissolved in PBS (10 mg mL-1) was 
added to 100 mg of MCM-41 employing 4 different FA amounts and cycles of 
addition (see Table 1). After each addition cycle, solids were dried at 30 °C to 
eliminate water content. Then, each of the loaded solids (B1-4) were 
functionalized with 0.43 mL of N3 using different media; i.e. water at pH 2 (solids 
BW#), acetate buffer at pH 2 (BB# solids) or acetonitrile (BA# solids). The loaded 
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and functionalized solids were isolated by vacuum filtration, washed with 300 mL 
of water adjusted to pH 2 with HCl, and dried at room temperature for 24 h. 
Finally, 12 solids were obtained: 4 functionalized in water at pH 2 with HCl (BW1-
4), 4 functionalized in acetate buffer at pH2 (BB1-4) and 4 functionalized in 
acetonitrile (BA1-4). 
 
2.7 Loading efficiency evaluation 
Loading efficiency of each of the 16 obtained solids was determined by 
quantification FA delivered in PBS after 5 h by HPLC. The “relative loading 
efficiency” was calculated according to the following equation: 
 
Relative loading efficiency (%) = FAD/FAL x 100 
 
where FAD are the mg of folic delivered per 1 mg of loaded solid and FAL are the 
mg of folic acid employed for the loading of 1 mg of MCM-41. 
 
2.8 Determination of in vitro folic acid bioaccessibility 
FA bioaccessibility (FA delivery from the prepared solids) was determined by 
simulating a human digestion in the stomach and small intestine adapting the 
procedure described by Versantvoort1 et al. (2005) (Fig 1). The large intestinal 
track was not taken into account since in vivo folic acid absorption occurs 
throughout the jejunum (Lucock, 2000). In a typical experiment, 10 mg of the 
corresponding solid were suspended in 12 mL of gastric juice and incubated for 
2 h at 37 °C. Finally, 12 mL of duodenal juice, 6 mL of bile, and 2 mL of bicarbonate 
solution (1 M) were added simultaneously. After the addition, the mixture was 
maintained under stirring at 37 °C for 2 h. All digestive juices were heated to 37 °C 
before being mixed. During this period aliquots were taken, filtered and analysed 
by HPLC. 
 
                                                          
1
 See composition of the fluids in appendix 3 (page 257) 
Article 1 
 
74 
 
 
Figure 1. Schematic representation of the in vitro digestion model. 
 
2.9 Folic acid determinations 
FA was determined by reversed-phase gradient HPLC method according to 
the method described by Póo-Prieto et al. (2011) with minor modifications. The 
HPLC instrument consisted of a Hitachi LaChrom Elite liquid chromatograph 
(Hitachi Ltd., Tokyo, Japan) equipped with an auto-sampler and UV detector 
(model L-2400). A Kromaphase 100 C18 (250 mm × 4.6 mm i.d., 5 μm particle size 
analytical column) (Scharlab, Barcelona, Spain) was used for the separations. 
Mobile phase consisted of (A) 0.125 mM of NaH2PO4, 0.875 mM of Na2HPO4 and 
0.4 mM of TBAHS in water and (B) acetonitrile-phase A 65:35 (v/v). The flow rate 
employed is described in Table 2. The wavelength of UV detector was set at 280 
nm. Solutions for preparation of calibration standards were made at 1, 5, 10, 25, 
50, 75, 100 μg FA mL-1 in PBS.  
Chapter 1 
 
75 
 
Table 2. Elution program for HPLC analysis. 
Time 
(min) 
Flow (mL min
-1
) Mobile phase A (%) Mobile phase B (%) 
0 1.0 90 10 
5 1.0 90 10 
15 1.0 64 36 
30 1.0 40 60 
35 1.0 90 10 
40 1.0 90 10 
A: NaH2PO4 (0.125 mM), Na2HPO4 (0.875 mM) and TBAHS (0.4 mM) in water. 
B: Acetonitrile-Phase A 65:35 (v/v) 
 
2.10 Solids characterization 
X-ray diffraction (XRD), transmission electron microscopy (TEM), N2 
adsorption-desorption isothermes and thermogravimetric analyses (TGA) were 
employed to characterize the synthesized materials. XRD were performed on a 
BrukerD8 Advance diffractometer using CuKα radiation. TEM images were 
obtained with a JEOL JEM-1010. The N2 adsorption-desorption isotherms were 
recorded by a Micrometrics ASAP2010 automated sorption analyser. Samples 
were degassed at 90 °C in vacuum, overnight. The specific surface areas were 
calculated from the adsorption data within the low pressure range using the BET 
model. Pore size was determined following the BJH method. Thermogravimetric 
analyses were carried out on a TGA/SDTA 851e Mettler Toledo balance, using an 
oxidant atmosphere (air, 80 mL min-1) with a heating program consisting of a 
heating ramp of 10 °C per minute from 393 to 1273 K and an isothermal heating 
step at this temperature for 30 min. 
 
2.11 Data analysis 
The results of the FA delivery from the different solids prepared were 
statistically processed using Statgraphics Centuriun XV (Manugistics Inc., Rockville, 
MD, USA). Statistical analysis on FA concentrations was made using an analysis of 
variance (One-Way ANOVA). 
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3. Results and discussion 
 
3.1 FA molecular modelling and geometrical dimensions 
 
Molecular dynamics calculations on FA were carried out. The molecular 
structure of FA is shown in Figure 2. As it can be seen, FA (pteroyl monoglutamic 
acid) consists of a pteridin ring linked to the para-amino benzoic acid (PABA) and a 
molecule of glutamic acid. In the larger dimension, FA exhibits a length of 1.45 
nm, whereas the calculated volume is 1.16 nm3. These calculations were used to 
determine the total theoretical amount of vitamin that could be encapsulated in 
the silica mesoporous matrix (vide infra). 
 
Figure 2. 3D FA molecular structure and geometrical dimensions. 
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3.2 Design, synthesis and characterization of the gated particles 
 
For the design of the proposed pH-controlled and sustained release system 
described above MCM-41 mesoporous silica microparticles were selected as an 
inorganic support due to its high loading capacity, homogeneous porosity in the 2-
3 nm range, high inertness, and ease of functionalization. This starting support 
was loaded with FA to obtain solid S0. Moreover, this FA-loaded material was 
further capped with a pH-responsive ensemble (i.e. N1-(3-
Trimethoxysilylpropyl)diethylenetriamine, N3) in order to obtain the gated 
polyamine-functionalised material S1. In this work pH was chosen as a suitable 
digestive stimulus for the modulation of FA release from the inner of the MCM-41 
voids. In stomach, pH is very acid (pH 1-2) to help the degradation of proteins and 
to provide a non-specific immunity, retarding or eliminating various pathogens. In 
the small intestine, the duodenum provides critical pH balancing to activate 
digestive enzymes. The liver secretes bile into the duodenum to neutralise (pH 7-
7.5) the acidic conditions from the stomach. Also the pancreatic duct empties into 
the duodenum, adding bicarbonate to neutralize the acidic chyme, thus creating a 
neutral environment. FA is known to be mainly absorbed in the small intestine 
(jejunum; pH 7.5) from where it is distributed to the tissues through the 
bloodstream and stored in the liver. 
 
As stated above, pH has been chosen in this paper as triggering stimulus. In 
this particular system changes in the pH are expected to modulate FA delivery in 
two different ways. On the one hand, it is known that FA under neutral/basic 
conditions is about 1000 times more soluble than FA in an acidic environment due 
to protonation (acid) and deprotonation (neutral/basic) of FA in aqueous 
environments (Wu, 2010). On the other hand, it has been reported that MSP 
functionalised with the polyamine derivative N1-(3-
Trimethoxysilylpropyl)diethylenetriamine (N3) are suitable pH-responsive 
controlled release systems able to allow or inhibit delivery as a function of pH 
changes due to the transformation of amines (open gate at neutral/basic pH) to 
polyammonium groups (closed gate at acidic pH). These two mechanisms of 
action are illustrated in Figure 3. 
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Figure 3. Illustration of the synthetic procedure for the preparation of solids S0 and S1, and the 
mechanism of FA delivery at neutral or acidic conditions. 
 
The different solids prepared were characterized according to standard 
techniques. X-ray patterns of the solids MCM-41 as synthesized (a), calcined (b), 
loaded with folic acid (S0) (c) and loaded with folic acid and functionalized with 
amines (S1) (d) are shown in Figure 4. Curve a shows the expected four peaks of a 
hexagonal ordered array indexed as (1 0 0), (1 1 0), (2 0 0) and (2 1 0) Bragg 
reflections. A significant shift of the (1 0 0) reflection in the XRD powder of the 
MCM-41 calcined sample is clearly appreciated in the curve b, corresponding to a 
cell contraction related to condensation of silanols during the calcination step. 
Curves c and d show that reflections (1 1 0), (2 0 0) and (2 1 0) are lost, most likely 
due to a reduced contrast that can be attributed to the presence of FA in the pore 
voids and the anchored N3 molecule. Nevertheless, the existence in all cases of 
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the (1 0 0) peak in the XRD patterns indicated that the process of pore loading 
with FA, and the additional functionalization with the polyamine, did not modify 
the typical porosity of the mesoporous MCM-41 scaffold. 
 
 
Figure 4. Powder X-ray patterns of the solids (a) MCM-41 as-synthesized, (b) MCM-41 calcined, (c) 
the uncapped solids containing the vitamin B9 (S0) and (d) the capped mesoporous system (S1). 
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The MCM-41 mesostructure mesostructure after loading with FA and 
functionalization with polyamines was also confirmed by TEM images (Fig 5). 
 
 
Figure 5. TEM image of (a) MCM-41 calcined and (b) solid S1 showing the typical porosity of the 
MCM-41 matrix. 
 
The N2 adsorption-desorption isotherms of the starting MCM-41 calcined 
material are shown in Figure 6. The curve shows a well defined and sharp 
adsorption step at P/P0 values between 0.1 and 0.3, corresponding to a type IV 
isotherm, which is typical of mesoporous materials, attributed to nitrogen 
condensation in the mesopore inlets. With the Barrett-Joyner-Halenda (BJH) 
model on the adsorption curve of the isotherm, pore diameter and pore volume 
were calculated to be 2.52 nm and 0.92 cm3 g-1, respectively. The absence of a 
hysteresis loop in this interval and the narrow BJH pore distribution suggested the 
existence of uniform cylindrical mesopores. The application of the BET model 
resulted in a value of 1040 m2 g-1 for the total specific surface. From the XRD, 
porosimetry and TEM studies, the a0 cell parameter (3.98 nm), the pore diameter 
(2.52 nm), and a value for the wall thickness of 1.69 nm were calculated. 
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Figure 6. Nitrogen adsorption-desorption isotherms (a) and pore size distribution (b) for MCM-41 
mesoporous material, S0, and S1 materials. 
 
Considering the pore size of the MCM-41 support and the FA structure (see 
Section 3.1), it can be stated that FA can be perfectly encapsulated in pores of 
2.52 nm of diameter. Moreover, bearing in mind the volume of the FA molecule 
(1.16 nm3), the specific volume of the MCM-41 (0.92 cm3 g-1) and tentatively 
assuming that ca. 75% of the pore volume in the mesoporous support can be 
occupied by FA, it can be roughly established that 1 mg of MCM-41 could host as a 
maximum 436 μg (0.98 mmol) of FA in its porous network. 
 
Table 3 also shows the change on the textural properties of the starting silica 
after the vitamin adsorption (S0) and the functionalization with the N3 molecule 
(S1). The incorporation of the FA leads to a decrease of ca. 37% and 46% for the 
BET surface area and the BJH mesopore volume, respectively. This evolution 
indicates that the FA molecules must be incorporated inside the mesopores. 
Under the pH conditions used for the drug uptake (7.5), the two carboxilate 
groups must be deprotonated, and consequently, the interaction with the silanol 
groups at the silica surface must be mediated by H+ species. Taking into account 
the presence of partially filled mesopores in the solid S0 together with the 
relatively large arm of the N3 molecule, the incorporation of these last species 
preferentially must occurs in the external surface at the mesopore entrances. As 
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expected, the incorporation of the N3-gates leads to an additional decrease of 
both the surface area as the volume of 31 and 57%, respectively. In a parallel way, 
the size of the mesopores decreases after FA inclusion. A large variety of FA 
aggregates on the silica are possible which is consistent with the wider peak 
observed in the pore size distribution curve. An additional mesopore size 
reduction occurs after functionalization with N3 groups. Hence, solid S1 shows a 
wide pore size distribution with a principal peak centred at 1.82 nm and a residual 
signal at ca. 2.38 nm. The first peak could be associated to a majority of the 
mesopores well surrounded by N3 molecules and the residual peak must be 
attributed to a small proportion of mesopores showing some deficiencies respect 
to an optimum presence of N3 groups. 
 
Table 3. Textural parameters from N
2
 adsorption-desorption isotherms. 
 SBET (m
2
 g
-1
) Pore volume (cm
-3
 g
-1
) Pore size (nm) 
MCM-41 1040 0.92 2.52 
S0 653 0.49 2.28 
S1 451 0.21 1.82 (2.38) 
 
 
3.3 pH gate-like mechanism confirmation 
 
FA delivery from the uncapped solid S0 in acid and neutral conditions was 
studied. In a typical experiment 5 mg of S0 were suspended in 25 mL of two 
different aqueous solutions (pH 2 and pH 7.5) in an attempt to reproduce the pH 
of gastric or intestinal fluids. The release profile of S0 is shown in Figure 7. 
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Figure 7. Release profiles of folic acid from the pores of solid S0 in water at pH 2 (unfilled marker 
points) and pH 7.5 (filled marker points). Values are Means ± SD, n = 3. 
 
As observed in the Figure 7, the asymptote of the release curve was achieved 
in the first few minutes of the delivery at pH 7.5. According to TGA experiments, 
the maximum delivery achieved (indicated in the figure as 100%) corresponds to 
32% of the FA content in the solid. This indicated that, under the experimental 
conditions, not all the FA loaded was able to be released. In contrast, only a 14.9 ± 
1.2% of the maximum delivery capacity was achieved at pH 2 (which corresponds 
to ca. 5% of the total FA content determined by TGA). Considering that the 
increase of FA concentration in the water phase is proportional to the delivery of 
the vitamin from the pores and that FA release is not inhibited by the presence of 
functional molecular groups on the surface of the MCM-41, the effect of solubility 
in FA bioaccessibility (release) is confirmed. At pH 2, FA is in the form of acid with 
low solubility, while at pH 7.5 folic is in the form of salt, increasing its solubility, 
and enhancing the delivery (Moffat, 1986) from the pore voids of S0 to the 
solution. However, as it can be seen in Figure 7 this pH-induced “solubilisation 
mechanism” is insufficient to modulate a sustained release of FA, a fact that 
would not allow a proper absorption of FA in the jejunum. 
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In a second study, delivery of FA from S1 was tested using similar delivery 
conditions; i.e. 5 mg of S1 were suspended in 25 mL of two different aqueous 
solutions at pH 2 and pH 7.5. As shown in Figure 8, FA delivery after 4 h at pH 2 
achieved values 0.22 ± 0.03% of the maximum delivery capacity of S1 (which 
corresponds to ca. 0.09% of the total FA content determined by TGA). In contrast, 
at pH 7.5, a progressive delivery of the vitamin was observed, achieving ca. 100% 
of the release capacity in the performed conditions after 1 h (which corresponds 
to 40% of FA content determined by TGA).  
 
In this case, the pH-dependent release behaviour can be explained by 
considering the different FA solubility as a function of the pH and the presence of 
the gate-like ensemble based in polyamines. To explain this latter effect, it has to 
be taken into account that at acidic conditions (pH 2), amines anchored to the 
surface of the pores are fully protonated. This fact favours Coulombic repulsions 
between closely located polyammonium groups, so that tethered polyamines 
tend to adopt a rigid-like conformation that blocks the pores and practically no 
release occurs. At pH 7.5, a lower proportion of polyamines are expected to be 
protonated, favouring hydrogen bond interactions between the different amine 
chains. As a consequence, pores unblock and vitamin release is produced. 
Moreover, in amine-based gated ensembles a second cooperative anion-
dependent effect occurs. In general polyamines are well-known pH-responsive 
molecules that can additionally complex anions via electrostatic forces and by 
formation of hydrogen-bonding interactions in a wide pH range. Additionally, the 
relative amine/ammonium ratio can control the interaction with anionic species. 
If electrostatic forces are taken into account (which in general are stronger than 
hydrogen bonding interactions) the presence of a large percentage of ammonium 
groups (acidic pH) will favour the interactions of the “gate” with anions in the 
solution resulting in an additional pore blockage that is not observed at neutral or 
basic pH (Casasús et al., 2008). 
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Comparing the delivery profiles at pH 2 and 7.5 of the uncapped (S0) and 
capped (S1) materials it is apparent that S0 is not able to completely inhibit FA 
delivery at acidic pH being the delivery very fast at neutral pH. In contrast, S1 is 
tightly capped at pH 2 and displays a sustained delivery (in 1 h) when the pH is 
switch to 7.5. It can be concluded that the gated support S1 might be a suitable 
prototype for the development of orally applicable FA delivery systems designed 
to block cargo delivery in the acidic conditions of the stomach (acid pH, gate 
closed) yet be able to display a sustained FA release at the intestine (basic pH, 
gate open). 
 
 
Figure 8. Release profiles of folic acid from the pores of solid S1 in water at pH 2 (unfilled marker 
points) and pH 7.5 (filled marker points).  Values are Means ± SD, n = 3. 
 
Comparing the delivery profiles at pH 2 and 7.5 of the uncapped (S0) and 
capped (S1) materials it is apparent that S0 is not able to completely inhibit FA 
delivery at acidic pH being the delivery very fast at neutral pH. In contrast, S1 is 
tightly capped at pH 2 and displays a sustained delivery (in 1 h) when the pH is 
switch to 7.5. It can be concluded that the gated support S1 might be a suitable 
prototype for the development of orally applicable FA delivery systems designed 
to block cargo delivery in the acidic conditions of the stomach (acid pH, gate 
closed) yet be able to display a sustained FA release at the intestine (basic pH, 
gate open). 
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3.4 Loading/releasing optimization process 
 
After studying the delivery of FA from the polyamine-functionalised (S1) and 
unfunctionalised (S0) materials, this section deals with a detailed study of FA 
loading optimization for the preparation of functionalised solids (S1-like 
supports). For this purpose, 16 solids differing in the loading (immersion and 
impregnation) and the functionalization media used to anchor the polyamine N3 
(water at pH 2, acetate buffer at pH 2 or acetonitrile) were prepared. Delivery 
effectiveness of each solid was evaluated by the determination of FA delivered 
after 5 h at pH 7.5. Moreover, the loading/delivery performance of the solids was 
evaluated using the “relative loading efficiency” via the determination of the ratio 
between the amount of FA delivered (after 5 h at pH 7.5) per mg of loaded solid 
and the mg of FA used for loading 1 mg of MCM-41 (see Section 2 for details). 
 
The first block of bars of Figure 9 shows values of FA delivered per mg of A# 
solids, solids obtained by using a traditional immersion procedure. Among them, 
solid A1 was able to deliver 3.7 ± 0.2 μg of FA mg-1 of solid. By increasing the 
amount of FA present in the loading solution to 70 mg (0.016 mmol) (A3) the 
amount delivered increased to 21.2 ± 0.3 μg of FA mg-1 of solid. However, when 
the same amount of folic was loaded in the half of solvent, the release capacity 
decreased (A4) to 6.2 ± 0.2 μg of FA mg-1 of solid. To understand this behaviour 
the maximum FA amount able to be solubilized in PBS was determined, finding 
that above of 10 mg of FA mL-1 PBS, FA remains insolubilized, and thus, cannot 
participate in the loading process. 
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Figure 9. Maximum FA delivery (μg FA mg
-1
 solid) for different solids loaded by immersion in PBS and 
functionalized with N3 in acetonitrile (A# solids) or loaded by impregnation and functionalized with 
N3 in different solvents: water adjusted to pH 2 (BW), acetate buffer at pH 2 (BB) or acetonitrile 
(BA). Numbers 1-4 refers to different FA loading conditions described in Table 1. Values are 
Means ± SD, n = 3. 
 
The same figure shows values of FA delivered by solids loaded by impregnation 
and functionalized in water at pH 2 (BW#), acetate buffer at pH 2 (BB#) or 
acetonitrile (BA#). As it can be seen, BW# solids exhibited the lowest loading 
capacity. In fact the 4 solids prepared using these conditions were white, strongly 
suggesting the presence of a very low amount of FA (pale yellow) in the pores. To 
understand the cause of this behaviour, it was found that pH reached values of 10 
upon the addition of the amine N3 during the synthesis of the solid. At this pH FA 
is highly soluble and most likely leaked from the pore voids during the synthesis of 
the materials.  
 
In contrast, B solids functionalized with N3 in aqueous acetate buffer (BB# 
solids) or acetonitrile (BA# solids), showed a remarkable larger FA delivery in 
water. In this case, the poor solubility of FA in the acetate buffer or acetonitrile 
during the N3 functionalization avoided the FA leakage during this step of the 
synthesis. When both BA# and BB# solids are compared in terms of delivery, it can 
be stated the BB# series display larger delivery ability. In particular, BB# solids 
exhibited a remarkable delivery capacity (p<0.005), being solid BB4 able to release 
127 ± 5 μg of FA mg-1 of solid (Fig 9). As a conclusion, the choice of the solvent 
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employed for the surface functionalization step is as important as the loading 
procedure in terms of loading efficiency. Nevertheless, the maximum loading 
capacity calculated in Section 3.2 has not been achieved in any of the designed 
solids. 
 
From the release ability displayed by the different solids prepared and taking 
into account the amount of FA employed for the loading of each solid, the relative 
loading efficiency (RLE) was calculated. Figure 10 shows RLE values for the 16 
prepared solids. As expected, solids loaded by immersion (A#) were the less 
efficient in terms of delivery with RLE values of around 1-3%. Moreover RLE values 
of ca. 2.5-5%, 40-60% and 63-75% were observed for BW#, BA# and BB# supports. 
In addition, for solids BA# and BB# RLE increased significantly (p< 0.005) from 10 
mg in 1 cycle (#1 solids) to 15 mg in 3 cycles (#3 solids). However, the addition of 
1 extra cycle of addition (#4 solids) did not increase RLE values indicating that, in 
this case, not all the FA added was loaded inside the pore voids of the 
mesoporous materials. According to these results, the conditions employed for 
preparing solid BB3 should be considered as optimal, in terms of RLE values, for 
the preparation of MSP loaded with folic acid and gated with N3 moieties. 
 
Figure 10. Relative Loading Efficiency for different solids loaded by immersion in PBS and 
functionalized with N3 in acetonitrile (A# solids) or loaded by impregnation and functionalized with 
N3 in different solvents: water adjusted to pH 2 (BW# solids), acetate buffer at pH 2 (BB# solids) or 
acetonitrile (BA# solids). Numbers 1-4 refers to different FA loading conditions described in Table 1.            
Values are Means ± SD, n = 3. 
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All these prepared solids were characterized using standard techniques. In all 
cases XRD patterns and TEM images (data not shown) were equivalent to those 
obtained for solid S1 (Section 3.1), confirming that the mesoporous structure of 
the MCM-41 scaffold was maintained in spite of the different loading and 
functionalization process. 
 
3.5 In vitro folic acid bioaccessibility and nutritional implications 
 
After the loading optimization procedure described above, this section deals 
with the use of solid BB3, which exhibited the maximum RLE value, for delivery 
studies in a more realistic media. In particular, the aim of this part was to study FA 
release, and therefore FA bioaccessibility, during a simulated pass of the solid 
through the gastrointestinal tract. To evaluate this, a variation of the dynamic in 
vitro digestion protocol reported by Versantvoort et al. (2005) was performed. 
Briefly BB3 was suspended in simulated gastric juice and incubated for 2 h at 37 °C 
and then duodenal juice, bile and bicarbonate solution were added to obtain a 
simulated intestinal fluid (see Section 2 for details). Note that in this study the 
pass of the solid through large intestinal track was not taken into account since in 
vivo folic acid absorption occurs throughout the jejunum (Lucock, 2000). At 
certain times aliquots were taken, filtered and analysed by HPLC. Results of FA 
delivery from BB3 are shown in Figure 11. During the first two hours of simulated 
digestion, where BB3 solid was in contact with a simulated gastric fluid, only 10.2 
± 1.4 μg of FA mg-1 of solid were delivered. After the addition of the simulated 
intestinal fluid, FA delivered increased progressively to reach a maximum value of 
94 ± 9 μg of FA mg-1 of solid at 2 h. 
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Figure 11. Release profile of FA from solid BB3 along the simulated gastrointestinal digestion 
process. Time 0-2 h correspond to the simulation of stomach conditions and time from 2 to 4 h 
correspond with the simulation of intestinal conditions. Values are Means ± SD, n = 3. 
 
Thus, as it can be observed in Figure 9, BB3 solid is tightly capped in simulated 
gastric fluid yet opens and deliver the cargo when in contact with simulated 
intestinal fluid. Moreover, the most important thing is that 1 mg of solid BB3 is 
able to release ca. 95 μg of FA during the whole simulated digestion process. This 
implicates that the higher dietary reference intake in human nutrition, established 
for pregnant woman in 600 μg per day of folates or 360 μg of synthetic PGA (1 μg 
of dietary folate equivalent = 0.6 μg of folic acid) (Eichholzer et al., 2006), could be 
reached by an oral administration of only ca. 4 mg of BB3, which is a remarkable 
low amount. Moreover, based in the oral toxicological evaluation of other 
mesoporous silica particles carried out by Kupferschmidt et al. (2013) -that found 
that even high amounts of MSP up to 1200 mg of MSP kg-1 of rat administrated 
orally were not toxic- our less than 7 mg are very far of a toxicological effect, 
signifying that the optimized solid BB3 could be safe for oral administration. 
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4. Conclusions 
 
Mesoporous silica particles (MSP) have been recently proposed as smart 
delivery devices able to load large amounts of cargo and release the same using 
different triggering stimuli. In this study FA has been successfully encapsulated in 
mesoporous silica particles capped with N1-(3-
Trimethoxysilylpropyl)diethylenetriamine groups. A detailed study of the loading 
process allowed us to obtain solids with relative encapsulation efficiencies of the 
75%. The simulation of an in vitro digestion of selected optimized gated support 
allowed to conclude that the developed MSP capped with amines were not only 
able to hinder the release of the vitamin in the presence of a simulated gastric 
fluid, but also were able to deliver progressively the vitamin along the time in 
presence of a simulated intestinal fluid, offering a mechanism to modulate the 
bioaccessibility of the FA vitamin during the pass across the intestine. In this study 
it was found that 1 mg of the optimized solid was able to release ca. 95 μg of FA 
indicating that maximum levels of higher dietary reference intake in human 
nutrition could be reached using only 4 mg of the optimized solid. Bearing 
additionally into account that mesoporous silica particles are non-toxic at low 
levels for humans, it can be stated that pH-dependent capped MSP are suitable 
candidates for the design of orally applicable delivery systems designed to protect 
FA from the acidic conditions of the stomach (acid pH, gate closed) but release the 
vitamin at the intestine (basic pH, gate open). 
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4.1.2 Encapsulation of folic acid in different silica 
porous supports: a comparative study 
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Abstract 
 
Although folic acid (FA) is essential to numerous bodily functions, recent 
research indicates that a massive exposition to the vitamin could be a double-
edged sword. In this study, the capacity of different caped mesoporous silica 
particles (i.e. Hollow Silica Shells, MCM-41, SBA-15 and UVM-7) to dose FA during 
its passage through the gastrointestinal tract has been evaluated. Results 
confirmed that the four capped materials were capable to hinder the delivery of 
FA at low pH (i.e. stomach) as well as able to deliver great amounts of the vitamin 
at neutral pH (i.e. intestine). Nevertheless, the encapsulation efficiency and the 
deliver kinetics differed among supports. While supports with large pore entrance 
exhibited an initial fast release, MCM-41, showed a sustained release along the 
time. This correlation between textural properties and release kinetics for each of 
the supports reveals the importance of a proper support selection as a strategy to 
control the delivery of active molecules. 
 
Keywords: Folic acid, porous silica supports, smart delivery, nutrition, cell 
viability. 
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1. Introduction  
 
Folates have been, and remain, a subject of ongoing research due to their 
numerous bodily functions, including DNA synthesis and repair, cell division and 
cell growth. Folates exist in a large variety of foods including green leafy 
vegetables, fruits, meat products, beans, fermented dairy products, and cereals. 
However, folates are sensitive to physical factors such as temperature, pressure, 
and exposure to light and can be affected during food processing or digestion 
(Nasr Hage et al., 2012) so that folate deficiencies occur worldwide. Folate 
deficiency is of such importance to humans that it can cause neural tube defects 
in developing embryos, elevated plasma homocysteine, different types of cancer, 
Alzheimer, etc. (Nguyen & Hendrickx, 2003, Kotsopoulos et al., 2012, Hinterberger 
& Fischer, 2013 and Lubecka-Pietruszewska et al., 2013). To maintain an adequate 
folate status a diet supplementation with FA from fortified foods or nutritional 
supplements is generally recommended in many countries, especially during 
pregnancy. 
 
Although there are irrefutable evidences about the benefits of FA 
supplementation, recent studies suggest that a massive exposition to high 
bioavailable FA leads to the direct appearance of untransformed FA in the 
systemic circulation. The presence of unmetabolized FA in blood has been lately 
related to certain cancer development, cardiovascular disease, anaemias… 
(Kotsopoulos et al., 2012). In this context, encapsulation methods to prevent 
environmental degradation of folates as well as to control the release along the 
digestive tract (i.e. no delivery in the stomach -pH 2-, and a sustained release in 
the intestine -pH 7.5-) seems to be a convenient strategy to solve problems 
related to FA deficiency, while avoiding problems related with massive exposition 
to the vitamin. 
 
From another point of view, the development of nanotechnology is opening 
new areas for exploration in the design of smart delivery systems. In particular 
several nanodevices have been suggested to provide a benefit to the drug delivery 
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scene. Among potential drug-delivery supports, mesoporous silica particles 
(MSPs) have been widely proposed as delivery systems in various life science 
fields such as medicine, nutrition, and food technology in recent years (Wang et 
al., 2009 and Mondragón et al., 2014). 
 
Periodically ordered mesoporous silicas, created by combining surfactant 
micellar aggregates with reactive silica precursors, were discovered about 20 
years ago by researchers at Mobil (Beck et al., 1992). This first class of periodic 
mesoporous silicas was known as M41S phases. Since these seminal studies, fine 
tuning of the reaction parameters such as concentrations, pH value, chemical 
nature of the surfactants, temperature, and time has allowed a precise 
adjustment of size, morphology, and pore structure and the development of 
different MSPs such as MCM-41, SBA-15, UVM-7, etc. (Argyo et al., 2014 and 
Pérez-Esteve et al., 2014). MSPs are characterized by a high homogeneous 
porosity defined from tunable pores with size between 2 and 10 nm, which make 
these scaffolds ideal for hosting functional guest molecules. Moreover it has been 
reported that the surface of ordered silicas can be functionalised with 
molecular/supramolecular ensembles to develop gated-MSPs, which show “zero 
delivery” yet can release their cargo on-command in response to specially 
designed external stimuli (Aznar et al., 2009). This opens the possibility to design 
stimuli-responsive mechanisms with spatiotemporal control of cargo release 
(Argyo et al., 2014). In particular, polyamines are well-known pH-responsive 
molecules able to adopt different conformations as a consequence of changes in 
the pH, and this characteristic has been applied to the design of pH-responsive 
gated materials (Bernardos et al., 2008). 
 
In this work, encapsulation of large amounts of FA in the final delivery 
systems is very important to minimize the quantity of material needed to provide 
the dietary reference intake or a percentage of the same. Moreover, to control 
the FA release rate is very important to avoid absorption peaks. In this manner, 
the most suitable delivery system to modulate FA bioaccessibility along the 
gastrointestinal tract should be able to hinder FA release in the stomach, and 
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achieve a sustained release before arriving to the jejunum where FA is absorbed 
(i.e. first 2 h of the intestinal phase of the digestion) (Baker et al., 1969). It is well 
known that in mesoporous materials both, loading efficiency as well as release 
rate, depend on properties of the support such as surface area, pore size, pore 
geometry, total pore volume, surface chemistry as well as on the loading 
procedure. 
 
Based in these concepts, the aim of this work was the evaluation of different 
silica supports (MCM-41, SBA-15, UVM-7 and hollow silica microspheres) caped 
with pH-responsive molecular gates to encapsulate sufficient amount of FA and to 
achieve a controlled and sustained release of the vitamin under digestive 
conditions. To reach this goal studies on loading optimization, encapsulation 
capacity, release kinetics and biocompatibility of the delivery systems with 
different cell lines have been performed. 
 
2. Materials and methods  
 
2.1 Chemicals 
 
Tetraethylorthosilicate (TEOS), N-cetyltrimethylammonium bromide (CTABr), 
pluronic P123 (P123), triethanolamine (TEAH3), sodium hydroxide (NaOH), 
hydrochloric acid (HCl), acetic acid and N1-(3-
Trimethoxysilylpropyl)diethylenetriamine (N3), sodium phosphate monobasic 
(NaH2PO4), sodium phosphate dibasic (Na2HPO4), tetrabutylammonium hydrogen 
sulphate (TBAHS), deuterium oxide (D2O), sodium deuteroxide (NaOD) and all 
chemicals for the digestive fluids were provided by Sigma (Sigma-Aldrich Química 
S.L., Madrid, Spain). Folic acid was purchased from Schircks Laboratories (Jona, 
Switzerland). Acetonitrile HPLC grade was provided by Scharlau (Barcelona, 
Spain). Hollow Silica Shells were provided by Exilica Limited (Coventry, UK). 
Tetraethyl ammonium bromide (>99%) was provided by Merck (Darmstadt, 
Germany). 
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For cell culture experiments, trypan blue solution (0.4%) cell culture grade 
and DMSO, PBS and Dulbecco’s Modified Eagle’s medium (DMEM) with glucose, l-
glutamine and pyruvate for cell culture were provided by Sigma-Aldrich. Mc Coy’s 
5a Medium and Keratinocyte Serum Free Medium, Fetal Bovine Serum (FBS) and 
trypsin were purchased from Gibco (Life Technologies, Madrid, Spain). Cell 
proliferation reagent WST-1 was purchased from Roche Applied Science 
(Barcelona, Spain). 
 
2.2 Mesoporous silica particles synthesis 
 
Microparticulated MCM-41 particles (M) were synthesized following the so-
called “atrane route”, according to the method described by Bernardos et al. 
(2008). CTABr was used as the structure-directing agent. The molar ratio of the 
reagents was fixed to 7 TEAH3:2 TEOS:0.52 CTABr:0.5 NaOH:180 H2O. CTABr was 
added to a solution of TEAH3 containing NaOH and TEOS at 118 °C. After dissolving 
CTABr in the solution, water was slowly added with vigorous stirring at 70 °C. 
After a few minutes, a white suspension was formed. This mixture was aged in an 
autoclave at 100 °C for 24 h. 
 
SBA-15 microparticles (S) were synthesized following the method reported by 
Zhao et al. (1998). P123 was used as the structure-directing agent. The molar ratio 
of the reagents was fixed to: 0.017 P123:1.0 TEOS:6 HCl:196 H2O. The preparation 
was performed by mixing an aqueous solution of P123 with HCl solution, and 
stirring for 2 h, after which the silica source, TEOS, was added. This final mixture 
was stirred for a further 24 h. The mixture was aged in an autoclave at 100 °C for 
24 h. 
 
UVM-7 particles (U) were synthesised following the method presented by 
Comes et al. (2009), based also on the “atrane route”. The molar ratio of the 
reagents was fixed at 7 TEAH3:2 TEOS:0.52 CTABr:180 H2O. The TEOS/TEAH3 
mixture was heated to 120 °C in a Dean-Stark until no elimination of ethanol was 
observed. The mixture was cooled to 90 °C and CTABr was added gradually in 
small portions, followed by dilution with water. The mixture was aged for 24 h. 
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For all samples, the resulting powder was recovered by centrifugation, 
washed with deionised water, and air-dried at room temperature. To prepare the 
final mesoporous materials, the as-synthesized solids were calcined at 550 °C 
using an oxidant atmosphere for 5 h in order to remove the template phase. 
 
2.3 Folic acid loading and amine functionalization 
 
10 different FA loaded and functionalised solids were prepared for each 
support. In a typical synthesis, 0.5 mL of an aqueous solution of FA in phosphate 
buffer (PBS) (10 mg mL-1) was dropped to 100 mg of the corresponding support 
(i.e. MCM-41, SBA-15, UVM-7 and Hollow Silica Shells) and mixed. After the 
impregnation, solids were dried at 30 °C to eliminate water content. The 
procedure was repeated as many times as needed to obtain solids with a 
sequential number of impregnation cycles from 1 to 10. 
 
To obtain the final loaded and functionalised solids, 100 mg of each of the 
FA-loaded supports were suspended in 10 mL of an aqueous solution of acetic 
acid (5%) and an excess of N3 (0.43 mL, 0.015 mmol) was added. The final 
mixtures were stirred for 5.5 h at room temperature. The forty loaded and 
functionalized solids (H1-10, M1-10, S1-10 and U1-10) were isolated by vacuum 
filtration, washed with 300 mL of water adjusted to pH 2, and dried at room 
temperature for 24 h. 
 
To evaluate the efficiency of the different impregnation cycles, the “relative 
loading efficiency” was calculated (see Section 2.5). 
 
2.4 Characterization 
 
X-ray diffraction (XRD), transmission electron microscopy (TEM), field 
emission scanning electron microscopy (FESEM), N2 adsorption-desorption, 
thermogravimetric analysis (TGA), 1H NMR, laser diffraction and Z-potential 
measurements were employed to characterize the synthesized supports. 
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XRD were performed on a Bruker D8 Advance diffractometer (Bruker, 
Coventry, UK) using CuKα radiation. TEM images were obtained with a JEOL JEM-
1010 (JEOL Europe SAS, Croissy-sur-Seine, France). FESEM images were acquired 
with a Zeiss Ultra 55 (Carl Zeiss NTS GmbH, Oberkochen, Germany) and observed 
in the secondary electron mode. 
 
N2 adsorption-desorption isotherms were recorded with a Micromeritics 
ASAP 2010 automated sorption analyser (Micromeritics Instrument Corporation, 
Norcross, USA). The samples were degassed at 120 °C in vacuum overnight. The 
specific surface areas were calculated from the adsorption data in the low 
pressure range using the BET model. Pore size was determined following the BJH 
method. From the XRD and porosimetry studies, the a0 cell parameter and wall 
thickness of the different supports were calculated. 
 
The theoretical maximum loading capacity in the different supports was 
calculated by dividing the value of pore volume of each of the supports by the 
value of FA molecule volume (1.16 nm3) and assuming that in a highly efficient 
packaging FA could lead to a maximum occupancy of ca. 75% of the supports total 
pore volume (Pérez-Esteve et al., 2015). 
 
The composition of loaded and functionalised supports was determined by 
TGA and 1H NMR. Thermogravimetric analyses were carried out on a TGA/SDTA 
851e Mettler Toledo balance (Mettler Toledo Inc., Schwarzenbach, Switzerland), 
using an oxidant atmosphere (air, 80 mL min-1) with a heating program consisting 
of a heating ramp of 10 °C per minute from 393 to 1273 K and an isothermal 
heating step at this temperature for 30 min. 1H NMR spectra were recorded at RT 
using a Bruker AV400 spectrometer (Bruker Daltonik GmbH, Bremen, Germany) 
after dissolving the corresponding sample in NaOD/D2O in the presence of 
tetraethyl ammonium bromide as internal standard. 
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The particle size distribution of the different bare and functionalised MSPs 
was determined using a Malvern Mastersizer 2000 (Malvern Instruments, 
Malvern, UK). For the measurements, samples were dispersed in distilled water. 
Data analysis was based on the Mie theory using refractive indices of 1.33 and 
1.45 for the dispersant and MSPs, respectively. An adsorption value of 0.001 was 
used for all samples. Variation of this adsorption value did not significantly alter 
the obtained distributions. Measurements were performed in triplicate. 
 
To determine the zeta potential (ζ) of the bare and functionalised MSPs, a 
Zetasizer Nano ZS equipment (Malvern Instruments, Malvern, UK) was used. 
Samples were dispersed in distilled water at a concentration of 1 mg mL-1. Before 
each measurement, samples were sonicated for 2 min to preclude aggregation. 
The zeta potential was calculated from the particle mobility values by applying the 
Smoluchowski model. The average of five recordings was reported as zeta 
potential. The measurements were performed at 25 °C. Measurements were 
performed in triplicate. 
 
2.5 FA release kinetics and loading efficiency evaluation 
 
To obtain the FA release kinetics for each of the 40 solids at different pHs, 10 
mg of the corresponding solids were placed in 25 mL of water at pH 2 (simulating 
condition at the stomach) and pH 7.5 (simulating condition at the intestine). At a 
certain times aliquots were separated, the suspension filtered and the solution 
analysed by HPLC. 
 
The “relative loading efficiency” for each solid was calculated according to 
the following equation: 
 
Relative loading efficiency (%) = FAD/FAL x 100 
 
where FAD are the mg of FA delivered per 1mg of loaded solid at pH 7.5 after 
4 h and FAL are the mg of folic acid employed for the loading of 1 mg of the 
corresponding solid.  
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The FA release kinetics from pore voids of the porous silica supports were 
calculated using the Higuchi model where the amount of guest release, Qt, per 
unit of exposed area at time t can then be described by the following equation: 
 
Qt=kH√t 
 
where kH is the release rate constant for the Higuchi model. 
 
2.6 Folic acid quantification 
 
FA was quantified by reversed-phase gradient HPLC method according to the 
method described by Pérez-Esteve et al. (2015). The HPLC instrument consisted of 
a Hitachi LaChrom Elite liquid chromatograph (Hitachi Ltd., Tokyo, Japan) 
equipped with an auto-sampler and UV detector (model L-2400). A Kromaphase 
100 C18 (250 mm × 4.6 mm i.d., 5 μm particle size analytical column) (Scharlau, 
Barcelona, Spain) was used for the separations. The mobile phase consisted of (A) 
0.125 mM of NaH2PO4, 0.875 mM of Na2HPO4 and 0.4 mM of TBAHS in water and 
(B) acetonitrile-phase A 65:35 (v/v). The gradient program was as follows: 0-5 min, 
90% A and 10% B; thereafter, the proportion of B was increased linearly to reach 
36% at 15 min and 60% at 30 min. After that, decreased linearly to reach 10% at 
35 min and remained in the initial conditions for 5 min. 
 
2.7 Cell culture Conditions 
 
HeLa human cervix adenocarcinoma and HEPG2 human liver carcinoma were 
grown in DMEM supplemented with 10% FBS. HCT116 human colon carcinoma 
cells were grown in McCoy’s 5a Medium Modified supplemented with 10% FBS 
and HK2 homo sapiens kidney papilloma cells were grown in Keratinocyte Serum 
Free Medium supplemented with bovine pituitary extract (BPE) and human 
recombinant epidermal growth factor (EGF). All of these cells were purchased 
from the German Resource Centre for Biological Materials (DSMZ). Cells were 
maintained at 37 °C in an atmosphere of 5% carbon dioxide and 95% air and 
underwent passage twice a week. 
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2.8 WST-1 Cell viability Assay 
 
HeLa, HCT116, HEPG2 and HK2 cells were cultured in sterile 24-well plates at 
a density of 2·104 cells/well for HeLa and HK2 and 2·105 for HCT116 and HEPG2 in 
a 1000 μL of respectively grown medium and were incubated 24 h in a CO2 
incubator at 37 °C. Then, solids in DMSO were added to cells in quadruplicate at 
final concentrations of 50, 100, 150 and 200 μg mL-1. Control wells did not contain 
any solid. After 23 h, cells were washed with PBS and then 30 μL of WST-1 reagent 
were added to each well and were incubated during 1 h, a total of 24 h of 
incubation was therefore studied. Before reading the plate, cells shacked for 1 
min to ensure homogeneous distribution of colour. Then the absorbance was 
measured at a wavelength of 450 nm and 690 nm in VICTOR X5 PerkinElmer. 
Results are expressed as an average of the results of three independent 
experiments. 
 
2.9 Data analysis 
 
The results of the FA delivery from the different solids prepared were 
statistically processed using Statgraphics Centuriun XV (Manugistics Inc., Rockville, 
MD, USA). Statistical analysis on FA concentrations was made using an analysis of 
variance (One-Way ANOVA). The LSD (least significant difference) procedure was 
utilised to test for differences between averages at the 5% significance level.  
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3. Results and discussion 
 
3.1 Design, synthesis and characterization of the gated supports 
 
Incorporation of gate-like ensembles into porous silica particles is a suitable 
approach to design devices for controlled delivery applications. The development 
of responsive gated materials requires selecting two components: (i) a suitable 
gate-like ensemble that changes one or several properties (size, shape, bulkiness, 
charge, etc.) upon external stimuli and (ii) the selection of the nano-structured 
matrix in which the gate-like scaffold is grafted. In this wok we have selected a 
diethylenetriamine moiety as capping ensemble due to its proved properties to 
control the delivery of cargo molecules from the void of mesoporous silica 
particles as a response of pH changes (Bernardos et al., 2008, Casasús et al., 2008 
and Pérez-Esteve et al., 2015). Moreover as inorganic support, we have selected 
four different porous silica supports (MCM-41, UVM-7, SBA-15 and Hollow Silica) 
having different size, shape and pore system. In all cases, the particle size was in 
the microscale. The MCM-41 support (M), the most popular member of the M41S 
family, is characterized by a regular pore system which consists of a hexagonal 
array of unidimensional, hexagonally shaped pores (Grün et al., 1999). The UVM-7 
support (U) can be described as bimodal porous silica constructed by the 
aggregation of pseudo-spherical mesoporous primary nanoparticles. The intra-
nanoparticle pore system consists of regular-sized mesopores disposed in a 
pseudo-hexagonal disordered array, while the arrangement of the inter-particle 
meso/macropores exhibits xerogel-like characteristics (Pérez-Cabero et al., 2012). 
Microparticulated SBA-15 (S) presents uniform hexagonal pores with a narrow 
pore size distribution and a tunable pore diameter between 5 and 15 nm. The 
thickness of the framework walls is about 3.1-6.4 nm, which gives the material a 
higher hydrothermal and mechanical stability (Thielemann et al., 2011). Finally, 
Hollow Silica Shells (H) were employed due to their reported high storage capacity 
of its hollow core structure (Zhu et al., 2005). According to these reported textural 
features, FA (which measures 1 × 1.45 nm) might be easily encapsulated in the 
four selected supports (Pérez-Esteve et al., 2015). 
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Once synthesized (M, S, U) or acquired from the supplier (H), solids were 
characterized by using standard procedures. XRD patterns of each of the supports 
can be found in Figure 1.  
 
Figure 1H shows the diffractogram of the commercially available Hollow 
Silica Shells. As observed, at low angles there were no reflections suggesting the 
absence of any order in the pore structure. XRD at high angles revealed a broad 
peak around 22 (2θ) (data not shown), indicating that employed H support 
presents an amorphous structure. X-ray patterns of the MCM-41, SBA-15 and 
UVM-7 as synthesized, calcined and loaded with FA and functionalized with 
amines are shown in Figures 1M, 1S and 1U respectively.  
 
Figure 1M shows the four typical peaks of a hexagonal ordered array, 
indexed as (1 0 0), (1 1 0), (2 0 0) and (2 1 0) Bragg reflections, of the as-
synthesised MCM-41 material. An a0 cell parameter of 41.7 Å (d100 spacing = 36.1 
Å) was calculated. A significant shift of the (1 0 0) reflection in the XRD powder of 
the MCM-41 calcined sample was clearly appreciated, corresponding to a cell 
contraction (5.6 Å) related to condensation of silanols during the calcination step. 
The loaded and capped final material showed that reflections (1 1 0), (2 0 0) and 
(2 1 0) were lost, most likely due to a reduced contrast that can be attributed to 
the presence of FA in the pore voids and the anchored polyamine molecule. 
Nevertheless, the existence in all cases of the (1 0 0) peak in the XRD patterns 
indicated that the process of pore loading with FA, and the additional 
functionalization with the polyamine, did not modify the typical porosity of the 
mesoporous MCM-41 scaffold.  
 
Figure 1S shows a sharp peak at ca. 0.9, indexed as the (1 0 0) reflection, and 
two minor reflections in the 1.0-2.0 interval, indexed as (1 1 0) and (2 0 0) Bragg 
reflections, respectively. These peaks were indexed according to two-dimensional 
hexagonal p6mm symmetry, of a well-defined SBA-15 mesostructure. Hence, the 
obtained a0 cell parameter was 113.47 Å (d100 spacing = 98.27 Å). The calcination 
process displaced the (1 0 0) reflection due to condensation of silanol groups, 
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resulting a cell contraction of 10.5 Å. The preservation of (1 0 0) in the final solid 
indicated that the long-range hexagonal symmetry of SBA-15 was maintained 
after FA loading and amine functionalization.  
 
Finally, Figure 1U shows two broad low-angle reflections that could be 
related with a disordered hexagonal array of the mesopores in this UVM-7 
support. Assuming the first peak could be indexed as the (1 0 0) reflexion, an a0 
cell parameter of 47.54 Å (d100 spacing = 41.18 Å) was obtained. The XRD pattern 
of the calcined UVM-7 solid showed a displacement of the (1 0 0) peak. It 
indicated a cell contraction of approximately 3.1 Å. The X-ray diffraction patterns 
of the FA loaded and polyamine-functionalised solid was characterized by the 
presence of an intense peak at ca. 2 (1 0 0 reflection) typical of a surfactant-
assisted mesoporous material, indicating that neither the loading nor the 
functionalization induced any significant effect on the mesoporous structure of 
the silica matrix. 
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Figure 1. Powder X-ray patterns of the solids i) as synthesized, ii) after surfactant extraction and iii) 
after loading with folic acid and functionalisation with polyamines. Hollow Silica Shells (H), MCM-41 
(M), SBA-15 (S) and UVM-7 (U). 
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As a complement to XRD patterns to elucidate porous structure of different 
supports, Figure 2 shows FESEM and TEM images of the different silica support 
used in this study. By means of FESEM observation, a characterization of the 
shape of the particles was performed. All different supports showed sizes in the 
micro-scale. These pictures also confirmed that different particles exhibited 
diverse morphology, from completely spherical particles (H), to irregular shaped 
particles (M), elongated particles (S) or agglomeration of nanoparticles (U). The 
comparison of the pictures before and after loading with FA and functionalization 
with N3 for the same support allowed concluding that neither loading nor 
functionalization significantly modified the appearance of the external surface 
suggesting none deposition of FA on the surface, and thus a complete 
encapsulation of FA in the support. 
 
The presence of mesostructures on M, S and U after loading with FA and 
functionalization with polyamines was confirmed by TEM images. Figure 2 shows 
the typical channels of the mesoporous matrixes either as alternate black and 
white stripes or as pseudo hexagonal arrays of pore voids. These channels were 
visualised not only in the starting calcined materials but also in final FA-loaded 
and N3-functionalised supports, confirming the preservation of the mesopores 
during the preparation process. Moreover, TEM observations revealed the 
absence of any clear mesostructure in H particles. 
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Figure 2. Characterization of particle size, particle shape and pore system by means of FESEM and 
TEM. Hollow Silica Shells (H), MCM-41 (M), SBA-15 (S) and UVM-7 (U). 
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N2 adsorption-desorption isotherms of the starting and final silica supports 
are shown in Figure 3. Figure 3H shows the N2 adsorption-desorption isotherms of 
Hollow Silica Shells. No capillary condensation was detected in the isotherms, 
confirming the absence of mesopores suggested by XRD and microscopy 
observations. Nevertheless, the high loading capacity exhibited by this material 
(see Section 3.2) made us think that the sample might have accessible 
microcavities where FA can be clearly entrapped. 
 
Figures 3M and 3U show the isotherms of the MCM-41 and UVM-7 systems, 
respectively. In both cases the starting materials exhibited a sharp and well 
defined adsorption step at relative pressure values between 0.2 and 0.6, 
attributed to nitrogen condensation in the mesopore inlets. The absence of a 
hysteresis loop in this interval and the narrow BJH pore distribution suggested the 
existence of uniform cylindrical mesopores. The difference between M and U was 
that the curve of U showed two steps. The first, as commented, was originated 
from the capillarity condensation of N2 into the mesopores, whereas the second, 
at higher relative pressures, was related to the filling of textural interparticle 
pores typical of the U scaffolding. According to IUPAC definition, both isotherms 
are type IV, characteristic of mesoporous materials with narrow pore size 
distributions. Finally, Figure 3S shows a type IV isotherm with adsorption step at 
relative pressure around 0.6, typical of S particles with well-defined channel-like 
mesopores. Moreover, we have applied the Barrett-Joyner-Halenda (BJH) model 
on the adsorption curves of the isotherms to calculate pore diameter and pore 
volume of all solids. In addition, the application of the Brunauer, Emmett and 
Teller (BET) model allowed the calculation of total specific surface. Calculated 
values for different supports are shown in Table 1. M and U have a similar surface 
area of ca. 1000 m2 g-1 and a mesoporous size of ca. 2.6 nm. In contrast, S has 
lower surface area but a larger pore size of ca. 8 nm. Surface of Hollow Silica 
Shells was very low compared with the other supports due to the confirmed 
absence of mesoporosity. 
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For all supports, a change on the N2 adsorption-desorption isotherms for 
the corresponding FA-loaded and N3-functionalized supports was observed. In 
particular, isotherms showed no remarkable steps at low-intermediate relative 
pressure indicating a decrease of surface area and volume after FA loading and 
amine functionalization (Fig 3). 
 
Figure 3. Nitrogen adsorption(○)-desorption(●) isotherms for (a) Hollow Silica Shells, (b) MCM-41, (c) 
SBA-15 and (d) UVM-7.  
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Table 1. Textural properties of calcined silica matrixes: Hollow Silica Shells (H), MCM-41 (M), SBA-15 
(S) and UVM-7 (U). 
Silica 
Support 
Area
a
 
(m
2
 g
-1
) 
Mesopore 
(P/P0<0,6) 
Textural pore 
(P/P0>0,6) 
c
 (nm) 
dw
d
 
(nm) 
TMLC
e
            
(g mg
-1
) 
Pore 
volume
b
 
(c
3
 g
-1
) 
Pore size
b
 
(nm) 
Pore 
volume
b
 
(c
3
 g
-1
) 
Pore size
b
 
(nm) 
H 258 - - - - 
f f 
- 
M 1074 0.91 2.61 - - 4.54 1.93 431 
S 649 0.92 7.89 - - 10.54 2.64 436 
U 919 0.75 2.65 1.10 54.80 4.75 2.10 355 
a. BET specific surface values calculated from the N2 adsorption branch of the isotherms. 
b. Pore volumes and pore sizes (diameter) calculated from the N2 adsorption-desorption 
isotherms for selected materials. 
c. Cell parameter. 𝑎0=2𝑑100 · (√3)
−1 
d. Wall thickness. 𝑑𝑤 = 𝑎0 − 𝑑𝑝, where dp is the mesopore pore diameter 
e. Theoretical maximum loading capacity 
f. Without available data from XRD. 
 
 
Textural properties of different supports calculated from nitrogen 
adsorption-desorption isotherms and XRD are summarized in Table 1. Table 1 also 
shows the calculated theoretical maximum loading capacity for M, S and U. 
 
Particle size is important when designing devices for oral control release. It is 
well known that nanoparticles’ cellular uptake is size-dependant. In particular it 
has been reported that nanoparticles larger than 600-1000 nm exhibit a notable 
lower transport across the follicle-associated epithelium when compared with 
smaller particles (He et al., 2012). According to these data, all the final supports 
are suitable for oral delivery purposes and are not expected to be absorbed in the 
digestive tract. Size distribution of the four supports in all the stages of their 
preparation, from the bare particles to the particles loaded with FA and 
functionalised with the N3 polyamine is shown is Figure 4. Three of the supports 
(H, M and S) did not change significantly their grain size as a function of the 
loading and functionalization. However, U grains which are composed of an 
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agglomeration of porous nanoparticles changed dramatically its size after the 
functionalization with the polyamine. This change was attributed to the 
deflocculant effect of the functionalization process. During functionalization 
process the vigorous stirring provoked grain desegregation. The subsequent 
functionalization with amines increases the stability of desegregated grains by 
adding positive charges to the surface (Pérez-Esteve et al., 2014). This cooperative 
effect results in the reduction of U grain size, also detected in FESEM observations 
(Fig 1U). In this manner, after the loading and functionalization process, all the 
solids exhibited a particle size of ca. 0.6-1 μ. 
 
 
 
Figure 4. Size distribution of different bare particles (#), particles loaded with FA (#+F) and particles 
loaded with FA and functionalised with N3 (#+F+N3). 
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Finally, the efficiency of functionalization was tested by zeta potential 
determinations. It is generally accepted that mesoporous silica is negatively 
charged above the isoelectric point (pH 2-3). These values agree with those 
measured for all the four starting particles. As it can be seen in Figure 5, unloaded 
H, M, S, U exhibited negative zeta potential values in the -50 mV to -30 mV range. 
The loading of the supports with FA did not modify significantly zeta potential 
values. However, the functionalization of the loaded supports with the polyamine 
N3 transformed the zeta potential from negative to positive (ca. +30 mV), 
confirming that the functionalization successfully occurred in all cases. Moreover 
we also found that the number of loading cycles (vide infra) did not cause 
remarkable changes on final zeta potential values for the different particles. 
 
 
Figure 5. Zeta potential values (Mean ± SD) of unloaded supports (light grey), supports loaded with 
FA (dark grey) and supports loaded with FA and functionalised with N3 (black) dispersed in distilled 
water. Hollow Silica Shells (H), MCM-41 (M), SBA-15 (S) and UVM-7 (U). 
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3.2 Loading efficiency evaluation 
 
With the objective of evaluating the loading capacity of the silica supports 
with FA, different experiments were carried out. For each of the supports, 10 
solids impregnated from 1 to 10 times with 0.5 mL of an aqueous solution of FA in 
PBS (10 mg mL-1) were prepared. 
 
FA content in prepared solids was determined by TGA and 1H NMR. Table 2 
shows content of organic matter (α) in solids impregnated 10 times as well as in 
those with the highest (FA released): (FA employed in the loading of the support) 
ratio, called optimized solids (vide infra). For all the supports, the higher the 
impregnation cycles, the higher the content in FA. N3 content was larger for solids 
S and U, than for H and M. For the same support, content of N3 (expressed in mg 
N3 mg-1 SiO2) did not change as a function of the number of loading cycles. 
 
Table 2. Content () of FA and N3 in optimized solids and in solids loaded 10 times. Hollow Silica 
Shells (H), MCM-41 (M), SBA-15 (S) and UVM-7 (U) 
 
Support 
 Optimized  Loaded 10 times 
 FA (mg gsolid
-1
) N3(mg gsolid
-1
)  FA(mg gsolid
-1
) N3(mg gsolid
-1
) 
H  125 71  272 59 
M  99 75  249 63 
S  77 106  264 89 
U  95 142  257 118 
 
Comparing the calculated theoretical maximum loading capacity ( Table 1) 
with real FA content it was shown that M and S were able to reach after 10 
impregnation cycles ca. 60% of the maximum content, while U incorporated ca. 
70%. These results point that the loading procedure employed for FA loading (i.e. 
impregnation) is very efficient. 
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Release effectiveness of each solid was also evaluated by determining the 
maximum amount of FA delivered at pH 7.5. Figure 6 shows FA delivered (μg FA 
mg-1 solid) from each of the 40 solids prepared after reaching the equilibrium               
(2 h). As it can be seen, for each of the different supports, the more impregnation 
cycles employed, the more FA delivery was achieved. In no case a saturation of 
the loading capacity seems to be achieved, since the slope described by the bars 
for each of the impregnation cycles does not reach the horizon. These data 
confirm that the theoretical maximum loading capacity was not achieved in any of 
the supports. 
 
 
Figure 6. Maximum FA delivery (g FA mg
-1
 solid) for different solids impregnated from 1 to 10 times 
(ordered sequentially) and functionalized with N3. Hollow Silica Shells (H), MCM-41 (M), SBA-15 (S) 
and UVM-7 (U). Values are Means ± SD, n=3. 
 
Comparing the maximum amount of FA delivered for the different supports 
after 10 loadings, it can be seen how Hollow Silica Shells (H) was the support that 
exhibited the maximum FA delivery (262 μg FA mg-1 solid) followed by S (ca. 252 
μg FA mg-1 solid), M (227 μg FA mg-1 solid) and U (220 μg FA mg-1 solid). These 
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to a very low interaction among FA (charged negatively at pH 7.5) and the inner 
surface of the supports (also charged negatively at pH 7.5). 
 
Finally and with the objective of determine the relative loading/delivery 
performance of the solids from a technological efficiency point of view the 
“relative loading efficiency” (RLE) was calculated. This parameter was calculated 
by determining the ratio between the amount of FA delivered (after 4 h at pH 7.5) 
per mg of loaded solid and the mg of FA used for loading 1 mg of the support (see 
Section 2.5 for details). 
 
Figure 7 shows RLE values for different solids impregnated from 1 to 10 times 
with FA and functionalized with N3. As observed, each support exhibited a 
different behaviour according to the relative loading efficiency. S was the support 
with larger RLE, probably due to its higher pore size and pore volume. H also 
exhibited a high RLE, similar to M in the first impregnation cycles. Besides, U was 
the support with lower RLE values, most likely because FA tend to remain in the 
textural pore of the UVM-7 structure in the loading process and was removed 
during the washing process. 
 
Figure 7. Relative Loading Efficiency for different solids impregnated from 1 to 10 times (ordered 
sequentially) and functionalized with N3. Hollow Silica Shells (H), MCM-41 (M), SBA-15 (S) and UVM-
7 (U). Values are Means ± SD, n=3. 
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On the other hand, a comparison of RLE values among different impregnation 
cycles for each support indicated that H and M increased RLE until the third 
impregnation cycle and then decreased. S exhibited the highest RLE value in the 
second loading cycle. Finally, no significant statistical differences were found for U 
among different impregnation cycles. According to these results, we considered 
H3, M3, S2 and U2 as the optimised solids. Those solids were employed in 
subsequent release and toxicological experiments. 
 
3.3 FA pH-driven controlled release 
 
In order to evaluate the feasibility of different supports to control the 
bioaccessibility of FA in gastric and intestinal conditions, delivery studies of FA 
from optimised solids (i.e. H3, M3, S2 and U2) were carried out at pH 2 (gastric) 
and pH 7.5 (intestinal). FA concentrations in the solutions were monitored by 
HPLC. Figure 8 shows the release behaviour of the four supports loaded with FA 
and functionalised with N3. For all four supports, a nearly flat baseline was found 
at pH 2, indicating that FA remained in the voids of the particles without release. 
It confirmed the capability of the four proposed supports to hinder the release of 
the vitamin during pass through the stomach. As observed in previous works 
(Bernardos et al., 2008, Casasús et al., 2008 and Pérez-Esteve et al., 2015), there 
are three mechanisms that favour this zero release: solubility of FA, conformation 
of polyamines in the gate-like ensemble and the interaction of polyammonium 
groups with anionic species. At acid pH FA is in its acidic form, exhibiting a very 
low solubility that hampers FA delivery from the pores (Pérez-Esteve et al., 2015). 
On the other hand, at low pH values (i.e. pH 2) polyamines are transformed to 
polyammonium groups. This molecular change favours Coulombic repulsions 
between closely located chains. Tethered polyammonium moieties tend to adopt 
a rigid-like conformation that pushes them away towards pore openings, blocking 
the pores and inhibiting completely or partially the release of the vitamin. 
Moreover, polyammonium groups have the ability to coordinate anions. At pH 2, 
anions present in the sample (phosphates) interact with the protonated gate-like 
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ensemble creating a superstructure that collaborates to pore blocking. The last 
two mechanisms are closely interconnected and it is not easy to measure their 
individual contributions (Bernardos et al., 2008). 
 
  
 
Figure 8. Release profile for different solids in water adjusted at pH 2 (○) and 7.5 (●). Hollow Silica 
Shells (H), MCM-41 (M), SBA-15 (S) and UVM-7 (U). 
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solubility of FA and on the conformation of the polyamines. At pH 7.5 FA is in the 
form of salt, increasing its solubility, and enhancing the delivery from the pore 
voids to the solution (Zhou & García-Bennett, 2010). Meanwhile polyamines are, 
at neutral pH, less protonated and their interaction with anions is weaker, 
favouring pore unblockage. As a consequence, FA was able to be released. This 
overall behaviour (i.e. no FA delivery at acidic pH and FA delivery at neutral pH) 
pointed towards the suitability of the designed solids for a selective and 
controlled delivery of FA in the gastrointestinal tract. At acidic conditions 
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(stomach) the molecular gates would be closed, and therefore no release will be 
performed. In contrast, after passing to the duodenum the chime could be 
neutralized as a consequence of the bile and bicarbonate secretion from the 
pancreatic duct. This neutralization would favour the delivery of the vitamin from 
the voids, improving the bioaccessibility in the jejunum (pH 7.5), where folic acid 
is absorbed by a saturable, carrier-mediated, pH and energy-dependent transport 
mechanism (Wright et al., 2007). 
 
3.4 Release kinetics 
 
Besides achieving a remarkable pH-triggered release of FA, we also aimed to 
evaluate the capability of those systems to control the delivery of the vitamin 
along time. With this purpose, data from the release kinetics at pH 7.5 were fitted 
to the Higuchi model. This simple model has been widely, and satisfactorily, 
applied for describing drug release kinetics from insoluble porous carrier matrixes 
(Guo et al., 2014). It is based on Fickian diffusion processes taking into account 
the hypotheses that initial drug concentration in the matrix is much higher than 
drug solubility, that drug diffusion takes place in only one dimension and that 
drug diffusivity is constant (Dash et al., 2010). Figure 9 shows the good fitting of 
the model to data taken in the first minutes of the delivery, suggesting that in 
these conditions the delivery of the FA from the pores of different solids is 
basically a diffusive process. After these times a certain deviation from linearity 
was found (data not shown). 
 
To facilitate interpretation of the data, the release Higuchi rate constant 
(kH) of FA from the H3, M3, S2 and U2 supports was calculated. The highest kH 
constant was observed for H3 (kH = 19). S2 and U2 exhibited kH of 18 and 17 
respectively. The lowest kH value (13) was exhibited by M3, being the support 
that allows a more sustained delivery, and thus the most convenient for 
modulating FA bioaccessibility along the pass through the small intestine. 
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Figure 9. Higuchi release profile of FA delivered from solids H3, M3, S2 and U2 in aqueous media at 
pH 7.5 
 
Higuchi constant has been reported to depend, among other factors, on the 
diffusivity and solubility of the cargo in the solvent, the tortuosity of the system, 
the porosity of the matrix and the total amount of compound present in the 
matrix (Bernardos et al., 2008). In this work the cargo as well as the solvent were 
the same, and thus, different values were only due to the inorganic support. 
Having in mind that H is the support with the highest kH, coinciding with the 
larger cavity, and that S, U, and M are ordered according to its pore size, the 
effect of pore size seems to be important to modulate the release kinetics of FA 
from different supports. The bigger the pore diameter, the easier the entrance of 
the solution to voids (or main cavity in the case of H), and thus the lower the 
diffusional problems of FA to escape from the entrapping support. 
 
Figure 9 also allows observing that, with the exception of M3, three of the 
solids presented a y-interception very superior to 0 value. This phenomenon, 
called burst release, has been referred to an initial massive release occurring 
immediately upon placement the delivery system in the release medium. It has 
been observed in a number of capped mesoporous silica based delivery systems 
(Bhattacharyya et al., 2012 and Radhakrishnan et al., 2014). Burst release can be 
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favourable in some applications (i.e. encapsulation of aromas, targeted release). 
However, it is undesired when a sustained release is needed. Having this in mind, 
M is the support that allows controlling the release of FA during more time and 
avoids initial burst release. 
 
In previous works, some authors have tried to understand the underlying 
mechanisms of this effect. Potential reasons that may lead to this behaviour are 
surface characteristics of the host material, sample geometry, host-cargo 
interaction, morphology and porous structure of dry material among others 
(Huang & Brazel, 2001). Although the importance of this phenomenon, 
conclusions are still rare. Thus we have tried to elucidate why different supports 
with different textural properties exhibited different burst release. 
 
Intuitively, it is reasonable to assume that the amount of FA that is 
delivered during the initial burst release must be dependent on the FA surface 
directly exposed to the media once the molecular gate was opened at pH 7.5. The 
practically zero release at pH 2 and the relatively high density of N1-(3-
Trimethoxysilylpropyl)diethylenetriamine groups (preferentially anchored on the 
external surface of our solids) allows us to propose that the amount of FA on the 
external surfaces could be practically discarded. Then, under this last 
consideration, the FA species must be favourably located inside the pores or 
cavities present in our silicas. So, in the case of the M support, the initial exposed 
surface must correspond to the cross-section of the mesopore entrances. Taking 
into account that the morphology of this M sample is based on the existence of 
large micrometric particles, a relatively low number of mesopore entrances, and 
consequently a low initial FA/media interface is expected. In fact, the M support 
shows the smaller burst release. In a rough way, the U support could be viewed as 
a nano-version of the MCM-41, with respect to the particle size. This difference 
strongly affect the average length of the mesopores (although the mesopore sizes 
are similar, (i.e. their cross-sections). While micrometric mesopore lengths are 
expected for M supports, pores of nanometric length exist in the U sample. 
Hence, for a similar mass of support the number of mesopore entrances for the U 
Chapter 1 
  
128 
 
material must be higher than the entrances present in M support. So, as 
expected, a higher burst release is detected for U when compared to M support. 
 
Although the comparison between M and S supports could be 
straightforward (similar particle size for both solids, but larger mesopore size for 
the S), the fact that under the impregnation conditions we have used, the 
mesopores in the S support remain partially filled with FA (according to N2 
adsorption-desorption measurements), make complicated a direct comparison 
between both solids. In fact, a larger FA surface must be exposed for S support 
(associated not only to the mesopore entrances but also to the internal mesopore 
surfaces partially covered by FA). In consequence, as a larger FA/media surface is 
expected, a more pronounced burst release occurs. 
 
Among all supports, is precisely H the one that has a more singular 
morphology, which is markedly different from the rest of the mesoporous 
supports. In fact, there is not mesopores in the H support. Once the gate is 
opened, the invasion of the reaction media inside the internal microcavity must 
be a very quick process. Due to the fact that the FA should be considered as 
deposited on the internal cavity but not confined inside pores, a large contact 
surface is expected, with the subsequent large burst release. 
 
3.5 In vitro biocompatibiliy tests  
 
In addition to the FA loading and release properties of the different supports, 
it was also in our aim to assess the biocompatibility of the developed FA carriers. 
Therefore studies with solids H3, M3, S2 and U2 were performed using HeLa, 
HTC116, HEPG2 and HK2 cell lines to exclude any toxic effect of the 
microparticles. Cells were treated with the corresponding capped support for 24 h 
at final solid concentrations of 50, 100, 150 and 200 μg mL-1. After that time, a cell 
viability assay using WST-1 was performed. The WST-1 assay is based on the 
measurement of the absorbance of the stable tetrazolium salt WST-1. This salt is 
transformed to a soluble formazan derivative by a complex cellular mechanism 
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that occurs primarily at the cell surface. This bio-reduction is largely dependent on 
the glycolytic production of NAD(P)H in viable cells. Therefore, the amount of 
formazan dye formed directly correlates to the number of metabolically active 
cells in the culture. Tetrazolium salts are cleaved to formazan by the succinate-
tetrazolium reductase system which belongs to the respiratory chain of the 
mitochondria, and which is only active in metabolically intact cells. 
 
WST-1 cell viability assay indicated that all the cell lines exhibited a high level 
of cell viability (ca. 100% cell proliferation) after 24 h upon treatment with solids 
H3, M3, S2 and U2 up to a concentration of 200 μg mL-1 (Fig 10). The assay 
suggested that the developed supports loaded with folic and functionalized with 
N3 were well tolerated by the cells. 
 
Similar levels of biocompatibility of functionalised porous silicas have been 
reported by other authors (Yuan et al., 2011, Mas et al., 2013 and Feng et al., 
2013). This high biocompatibility is most likely related with both, the particle size 
employed and the surface functionalization. He et al. (2009) studied the cytotoxic 
effect of spherical mesoporous particles and observed that 190 nm and 420 nm 
particles showed significant cytotoxicity at concentrations above 25 mg mL-1, 
while micro-scale particles of 1220 nm showed only slight cytotoxicity due to 
decreased endocytosis. Moreover, the interaction of silanol groups (ca 6% of total 
surface) with biological molecules, such as cellular membrane lipids and proteins 
that may strongly interact and eventually modify the structure of these molecules 
was prevented in our case by the functionalization with organic molecules. In fact, 
it has been reported that the surface coating of porous silica with organic 
molecules can increase the biocompatibility and half-lives of cells by more than 10 
times compared to bare silica mesoporous supports (Tang et al., 2012). 
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Figure 10. WST-1 cell viability assay. HCT116 (light grey), HEPG2 (medium grey), HK2 (dark grey) and 
HeLa (black) cells treated with optimized solids  at concentrations of 25, 50, 100 and 200 μg mL
-1
 for 
24 h. Cells were incubated for 24h with optimized solids at the concentrations stated before and cell 
viability was quantified using the WST-1 reagent. 
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4. Conclusions 
 
We have reported herein the use of four different porous silica supports for 
the design of gated materials able to encapsulate FA, remaining closed at acidic 
pH (for instance the stomach) yet delivering efficiently the cargo in a neutral pH 
(for instance in the intestine). Despite the fact that all the designed supports 
presented a high loading capacity, that all were capable to control the FA release 
as a function of the pH and that none of them exhibited unspecific toxicity for four 
different cell lines, one of the supports stands out for showing remarkable 
advantages in controlling FA bioaccessibility. Concretely, results reported herein 
confirm that microparticulated MCM-41 capped with a simple pH-responsive gate 
based on polyamines was the only support able to sustain the cargo release for at 
least one hour. This sustained release is essential to modulate the bioaccessibility 
of the vitamin before absorption in the jejunum and thus to avoid problems 
related to FA absorption peaks that lead into the appearance of untransformed FA 
in blood. Thus, election of a proper support seems to be essential when planning 
the design of a smart delivery system. 
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Abstract 
 
Mesoporous silica materials have the ability to entrap drugs, nutrients and 
functional biomolecules creating smart delivery systems capable to control and 
target the release of their cargo in a particular part of the gastrointestinal tract 
when administrated orally. The aptness of these encapsulation supports in in vivo 
oral controlled release relies on their chemical stability through the whole 
digestive tube. In this study, we evaluate the stability of four different 
mesoporous silica particles frequently used as encapsulating support during an in 
vitro digestion process comprising buccal, stomach and intestinal phases. Results 
showed that after 4 h of digestion, the textural properties of silica supports based 
on nanoparticles (MCM-41 nanoparticles and UVM-7) were lost in varying 
degrees. Porous structure of silica supports based in microparticles (MCM-41 
microparticles and SBA-15) endure better the digestion process. Moreover, the 
protective effect of surface functionalization with N1-(3-
trimethoxysilylpropyl)diethylenetriamine, an organic moiety commonly used in 
the preparation of pH-responsive mesoporous silica particles, improved the 
stability of the supports. In this manner, the same process that allows obtaining 
gated silica particles for controlled release purposes improves the stability of the 
inorganic supports during a human digestion process. 
 
 
 
Keywords: mesoporous silica particles, in vitro digestion, stability, amine-
functionalization  
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1. Introduction 
 
Mesoporous Silica Particles (MSPs) are receiving great attention in the field 
of oral controlled release due to their capability for improving drug solubility and 
stability in the gastrointestinal tract, as well as to release the cargo along the time 
(sustained controlled release) specific places of the gastrointestinal tract (GIT) 
(targeted controlled release) (Agostini et al., 2012; Popat et al., 2012). These 
reported features that render MSPs unique smart delivery systems are due to 
their large loading capacity (Coll et al., 2011), low toxicity (Suh et al., 2009) and 
the fact that their surface can be functionalized with molecular/supramolecular 
ensembles. This last feature allows the development of gated-MSPs showing “zero 
delivery”, and capability of releasing their cargo on-command in response to 
specifically designated external stimuli (Mondragón et al., 2014). 
 
Drug delivery/formulation technologies that can improve bioavailability, drug 
stability and subsequently increase drug effectiveness are much desired in the 
pharmaceutical sciences. In food technology, encapsulation of bioactive 
molecules (e.g. vitamins, antioxidants, phytochemicals, etc.) may improve their 
biological stability, facilitate components handling, mask unpleasant sensorial 
properties and modulate the bioaccessibility of the molecule of interest along the 
GIT (Pérez-Esteve et al., 2015). 
 
Besides a high loading capacity, controlled release and biocompatibility, the 
suitability of these MSPs in oral controlled release in in vivo applications depend 
on the chemical stability of the supports though the whole digestive tube. 
However, it is known that, due to the metastability of MSPs, silica can be 
biodegraded into silicic acids, including monomeric silicic acid and various 
polysilicic acids with different polymerization degrees, under harsh environments 
provoking a collapse of the porous structures (He et al., 2009). In this line, Cauda, 
Schlossbauer & Bein (2010) studied the biodegradation of colloidal mesoporous 
silica nanoparticles (50 nm) in simulated body fluid of bare, globally 
functionalized, and surface poly(ethylene glycol)-coated colloidal mesoporous 
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silica nanoparticles in simulated body fluid (pH 7.4) for a period of 1 month at 37 
°C. After this month, the textural properties of the mesoporous system were lost 
and pores were blocked because the precipitation of inorganic components from 
the simulated body solution. Particles stability increased by surface 
functionalization with poly(ethylene glycol). The degradation behaviour of 
surfactant-extracted mesoporous silica in simulated body fluid was also evaluated 
by He and co-workers (He et al., 2010), who proposed a three-stage degradation 
process comprising a fast bulk degradation on an hour-scale, a silicon 
concentration decrease stage due to the deposition of calcium/magnesium 
silicate layer, and a later continuous sustained diffusion over a period of days. The 
same year, Lin, Abadeer & Haynes (2011), evaluated the stability of small 
mesoporous silica nanoparticles (<50 nm) functionalised with poly(ethylene 
glycol) in H2O, phosphate buffer solution (PBS) (pH 7.5), and Dulbecco’s modified 
Eagle’s medium (DMEM) with 10% fetal bovine serum (FBS) (pH ca. 7.5). These 
particles exhibited long term stability in all these media at both, room and 
physiological temperature. In a different attempt, El Mourabit et al. (2012) 
studied the stability of mesoporous silica under acidic conditions. In their work, 
the loss of textural properties of silicas under acid solutions was observed. 
However, it was stated that the degradation rate depends of the nature of the 
acidic media (phosphoric acid have stronger impact than hydrochloric or 
sulphuric) and also the type of silica.  
 
Most of these studies evaluated the stability of mesoporous silica 
nanoparticles. However, MSPs can be fabricated with a controlled size from 50 nm 
to a few microns. When preparing smart delivery systems based on MSPs, particle 
size is very important since it conditions the distribution and behaviour of 
particles in living systems. In general, small MSPs can cross epitheliums and can be 
distributed in the body to be non-specifically internalized by certain cells (Arcos & 
Vallet-Regí, 2013). In contrary, oversized particles (microparticles) cannot easily 
cross physical membranes in the body, and thus large particle sizes are preferred 
for developing orally administrated controlled release devices (Pérez-Esteve et al., 
2016). Having in mind the importance of particle size in oral administration, 
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studies of stability of mesoporous silica particles should also be done with 
particles in the micro size. However, as far as we know, the stability of large MSPs 
has not yet been studied. Moreover, there are no available studies about the 
effect of saliva (pH 7.5), gastric (pH 1.2-2), or intestinal fluids (pH 7.8-8) on the 
stability of the small and large MSPs. Thus, notwithstanding these works a lack of 
information about the degradability/stability of MSPs with different sizes during a 
whole digestion is still unavailable.  
The aim of this study was to evaluate the stability of different bare and 
functionalised mesoporous silica particles differing in particle size, particle shape 
and pore structure (pore size and wall thickness) during a simulated in vitro 
digestion. With this purpose, a detailed evaluation of the stability of textural 
properties of MSPs during the in vitro digestion has been performed. Descriptive 
studies were completed with the assessment of potential cytotoxicity of digested 
particles or their degradation products. 
 
2. Materials and methods 
 
2.1 Chemicals 
 
Tetraethylorthosilicate (TEOS), N-cetyltrimethylammonium bromide (CTABr), 
Pluronic P123 (P123), triethanolamine (TEAH3), sodium hydroxide (NaOH), 
hydrochloric acid (HCl), N1-(3-trimethoxysilylpropyl)diethylenetriamine (N3), and 
all chemicals for the digestive fluids were provided by Sigma-Aldrich (Poole, 
Dorset, UK). HPLC grade acetonitrile was provided by Scharlau (Barcelona, Spain). 
Rhodamine B was acquired from Fluka (Missouri, USA).  
 
For cell culture experiments, trypan blue solution (0.4%) cell culture grade 
and dimethyl sulfoxide (DMSO), phosphate buffered saline (PBS) and Dulbecco's 
Modified Eagle's medium (DMEM) with glucose, L-glutamine and pyruvate for cell 
culture were provided by Sigma-Aldrich (Poole, Dorset, UK). Mc Coy’s 5a Medium 
and Keratinocyte Serum Free Medium, Fetal Bovine Serum (FBS) and trypsin were 
purchased from Gibco (Life Technologies, Madrid, Spain). Cell proliferation 
reagent WST-1 was purchased from Roche Applied Science (Barcelona, Spain).  
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2.2 Mesoporous silica particles synthesis 
 
Synthesis of microparticulated MCM-41 (M) was carried out following the so-
called “atrane route”, using CTABr as the structure-directing agent and a molar 
ratio fixed to 7TEAH3:2TEOS:0.52CTABr:0.5NaOH:180H2O. The procedure 
consisted in adding CTABr to a solution of TEAH3 and NaOH containing TEOS at 
118 °C. After dissolving CTABr in the liquor, water was slowly added with vigorous 
stirring at 70 °C to form a white suspension. This mixture was aged at room 
temperature overnight (Bernardos et al., 2008). 
 
Nanoparticulate MCM-41 (N) was synthesized using the following procedure: 
NaOH was added to the CTABr solution, followed by adjusting the solution 
temperature to 95 °C. TEOS was then added dropwise to the surfactant solution. 
The mixture was allowed to stir for 3 h to give a white precipitate (Bernardos et 
al., 2010). 
 
UVM-7 (U) was synthesised using, once again, the “atrane route”. The molar 
ratio of the reagents in the mother liquor was fixed at 
7TEAH3:2TEOS:0.52CTABr:180H2O. The TEOS/TEAH3 mixture was heated to 120 °C 
until no elimination of ethanol was observed. The mixture was cooled to 90 °C and 
the CTABr was added gradually in small portions, followed by water. The mixture 
was aged for 24 h (Comes et al., 2009). 
 
The SBA-15 (S) sample was synthesized using P123 as the structure-directing 
agent with the reactant molar ratios: 0.017P123:1.0TEOS:6HCl:196H2O. The 
preparation was carried mixing an aqueous solution of P123 with HCl solution, 
and stirring for 2 h, after which the silica source, TEOS, was added. This final 
mixture was stirred for a further 20 h (Zhao et al., 1998). 
 
After the synthesis, the different solids were recovered, washed with 
deionised water, and air-dried at room temperature. The as-synthesized solids 
were calcined at 550 °C using an oxidant atmosphere for 5 h in order to remove 
the template phase. 
Chapter 1 
  
144 
 
The surface of the four types of particles was functionalised with N1-(3-
trimethoxysilylpropyl)diethylenetriamine (N3) according to the procedure 
described by Pérez-Esteve et al. (2014). Concretely, 1 g of the different MSPs were 
suspended in 40 mL of acetonitrile and an excess of N3 (4.3 mL, 15.0 mol g-1) was 
then added. Final mixtures were stirred for 5.5 h at room temperature. Finally, the 
solids were filtered off, washed with 30 mL of deionised water, and dried at room 
temperature.  
 
2.3 Simulated digestion procedure 
 
An in vitro digestion model consisting of mouth, gastric and intestinal phases 
described by Versantvoort et al. (2005) was used to simulate the typical chemical 
composition, pH and residence time periods of each of the three main 
compartments of the GIT. A schematic representation of the in vitro digestion 
model is presented in Figure 1. The pH values of the digestive juices were checked 
and, if necessary, adjusted to the appropriate interval with NaOH (1 M) or HCl 
(37% w/w). 
 
Figure 1. Schematic representation of the in vitro digestion process. The in vitro digestion model 
describes a three-step procedure simulating the digestive processes in mouth, stomach and small 
intestine. In each compartment, the matrix is incubated at 37 °C for a time relevant for the 
compartment. The digestion is initiated by addition of artificial saliva to the material. Subsequently, 
gastric juices and intestinal fluids are added to simulate the digestive processes in stomach and 
small intestine, respectively. See composition of the fluids in appendix 3 (page 257). 
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2.4 Mesoporous silica particles characterization 
 
All materials, as synthetized and after suffering a simulated digestion 
process, were characterized by standard procedures: X-ray diffraction (XRD), N2 
adsorption-desorption isotherms, transmission electron microscopy (TEM), field 
emission scanning electron microscopy (FESEM), confocal laser scanning 
microscopy (CLSM), particle size distribution and zeta potential measurements. 
 
XRD were performed on a Bruker D8 Advance diffractometer (Bruker, 
Coventry, UK) using CuKα radiation. N2 adsorption-desorption isotherms were 
recorded with a Micromeritics ASAP 2010 automated sorption analyser 
(Micromeritics Instrument Corporation, Norcross, USA). The samples were 
degassed at 120 °C in vacuum overnight. The specific surface areas were 
calculated from the adsorption data in the low pressure range using the BET 
model. Pore size was determined following the BJH method.  
 
The effect of digestion on single particle surface and morphology was 
evaluated through electron microscopy observations. TEM images were obtained 
with a JEOL JEM-1010 (JEOL Europe SAS, Croissy-sur-Seine, France). FESEM images 
were acquired with a Zeiss Ultra 55 (Carl Zeiss NTS GmbH, Oberkochen, Germany) 
and observed in the secondary electron mode. 
 
To determine the changes of MSPs structures and aggregation state along 
the whole in vitro digestion procedure, confocal laser scanning microscopy (CLSM) 
micrographs were taken. Three aliquots were taken from the digestion solution at 
5 min, 2 and 4 h, just after finishing the mouth, stomach and intestine steps 
respectively. Samples were stained with 20 µL of rhodamine B solution (2 g L-1). 
The observations were made 10 min after the dyes were added. Pictures were 
acquired using a Nikon Eclipse E800 microscope (Nikon, Tokyo, Japan). An Ar laser 
line (488 nm) was used to excite the rhodamine B. The images were obtained and 
stored at a 1,024 × 1,024-pixel resolution using the microscope software (EZ-C1 
v.3.40, Nikon, Tokyo, Japan). 
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Microscopic studies were completed by determining the particle size 
distribution, and surface charge at the interface of different MSPs during the in 
vitro digestion process. To avoid interference of organic components (sugars, 
enzymes, etc.) in measured values, digestive fluids addressed for determination of 
size distribution and zeta potential were prepared with only the inorganic 
components (Peters et al., 2012). The size distribution of MSPs in each of the 
digestion steps (mouth, stomach and intestine) was measured with a Malvern 
Mastersizer 2000 (Malvern Instruments, Malvern, UK). For data evaluation, an 
optical model based on the Mie theory was created using the instrumental 
software assuming 1.45 as the real and 0 as the imaginary part of the refractive 
index of the particles. The surface charge at the interface of the MSPs or zeta 
potential () after each of the in vitro digestion steps, was measured at 25 °C in a 
Zetasizer Nano ZS equipment (Malvern Instruments, Malvern, UK). The zeta 
potential was calculated from the particle mobility values by applying the 
Smoluchowski model. The average of five recordings was reported as zeta 
potential. The measurements were performed at 25 °C. Zeta potential 
distributions were obtained by averaging 3 measurements.   
2.5 Quantification of silicon content in digestion fluids 
 
For determination of the free silicon generated during the digestion process 
samples, digestion juices were centrifuged (9500 rpm; 10 min) to separate 
digested MSPs from the aqueous solution. The degraded silicon concentration in 
the supernatant was determined by inductively coupled plasma optical emission 
spectrometry (ICP-OES) using a Horiba Jobin Yvon ULTIMA 2 spectrometer 
(Longjumeau, France). Before the analysis the recovered supernatants were 
chemically digested with nitric acid under reflux. 
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2.6 WST-1 Cell viability Assays 
 
HeLa human cervix adenocarcinoma and HEPG2 human liver carcinoma were 
grown in DMEM supplemented with 10% FBS. HCT116 human colon carcinoma 
cells were grown in McCoy's 5a Medium Modified supplemented with 10% FBS 
and HK2 homo sapiens kidney papilloma cells were grown in Keratinocyte Serum 
Free Medium supplemented with bovine pituitary extract (BPE) and human 
recombinant epidermal growth factor (EGF). All of these cells were purchased 
from the German Resource Centre for Biological Materials (DSMZ). Cells were 
maintained at 37 °C in an atmosphere of 5% carbon dioxide and 95% air and 
underwent passage twice a week.  
 
Cells were placed in 96-well plates at a density of 1000 cells per well. After 24 
h, plates were incubated with the digestion fluids containing MSPs at different 
concentrations at 37 °C for 24 h. After removing the digestive medium containing 
the MSPs, MTT solution (200 mL, 1 mg mL-1) was added and the cells were 
incubated for another 3 h. Upon removal of the MTT solution, the purple 
formazan crystals were solubilized with DMSO (200 mL) and measured at 560 nm 
on a microplate reader (SPECTRAmax plus, Molecular Devices, Sunnyvale, CA). The 
cytotoxicity was expressed as the percentage of cell viability. 
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3. Results and discussion 
 
3.1 Preparation and characterization of the mesoporous silica supports  
 
Four different mesoporous silica particles differing in size, shape, and pore 
structure were prepared following the procedures described by previous reports. 
M are porous irregular-shaped particles of ca. 1 m with 2D-hexagonal 
arrangement whose pore size is in the range of 2-3 nm. With the same porous 
structure, N are spherical particles of ca. 100 nm. U supports are porous 
nanoparticles organized in the form of clusters creating a bimodal system of pores 
(mesopores and structural micropores). Finally, S are elongated particles of ca. 1 
m with a well-defined hexagonal distribution of mesopores ranging from 5-15 
nm (Pérez-Esteve et al., 2014). These particles were used as models to evaluate 
the effect of human digestion on the stability of MSPs as well as to assess the 
cytotoxicity of digested MSPs in four different cell lines. 
 
After the synthesis, different MSPs were characterised using standard 
procedures. The mesostructure of different supports was characterised by X-Ray 
diffraction. As expected, the four mesoporous supports exhibited the typical 
properties of their family of material. Figure 2a and 2b show the diffractogram of 
micro (a) and nanoparticles (b) of MCM-41. Curves (i) for both particles display the 
hexagonal ordered array of the MCM-41 family characterized by the presence of 
four typical peaks, indexed as (1 0 0), (1 1 0), (2 0 0) and (2 1 0) Bragg reflections 
(Bernardos et al., 2008; Bernardos et al., 2010). Similarities between the two 
curves confirm that the change in the particle size (nano or micro) does not have 
any influence in the porous structure of the particles. Moreover, the 
functionalization of particles’ surface with N3 does not modify the typical porosity 
of the mesoporous MCM-41 scaffold (iii), since the (1 0 0) peak is present in both 
cases.  
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Likewise, Figures 2c and 2d show typical diffractograms of bare (i) and 
functionalized (iii) S and U (Pérez-Esteve et al., 2016). On the one hand, Figure 2c 
shows a different reflection pattern characterised by a sharp peak at 1.0 2q, 
indexed as the (1 0 0) reflection, and two minor reflections in the 1.0-2.0 interval, 
indexed as (1 1 0) and (2 0 0) Bragg reflections, respectively. These peaks were 
indexed according to two-dimensional hexagonal p6mm symmetry, of a well-
defined S mesostructure. On the other hand, Figure 2d presents two broad low-
angle reflections that could be related with a disordered hexagonal array of the 
mesopores in this U support. Again, the presence of at least the (1 0 0) reflection 
peak in (iii) curves confirm that the functionalization process does not have any 
influence in the porous structure. 
 
Characterization of textural properties was complemented by performing N2 
adsorption-desorption isotherms. Table 1 list BET specific surface values, pore 
volumes, and pore sizes of the particles object of study. As observed, before the 
digestion process, all the synthetized bare particles exhibited large pore volumes 
and large surface area provided by the channels that cross the particles. 
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Figure 2. Powder X-ray patterns of as-synthesised MSPs before (i) and after the in vitro digestion (ii) 
as well as amine-functionalised MSPs before (iii) and after (iv) the in vitro digestion. MCM-41 
microparticles (a), MCM-41 nanoparticles (b), SBA-15 (c) y UVM-7 (d) supports.  
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Table 1. BET specific surface values, pore volumes and pore sizes calculated from 
the N2 adsorption-desorption isotherms for selected materials. MCM-41 micro 
(M), MCM-41 nano (N), SBA-15 (S) and UVM-7 (U). 
 
 Particle size SBET (m
2
 g
-1
) Pore volume
a
 
(cm
3
 g
-1
) 
Pore size
a,b
 
(nm) 
Wall thickness
c
 
(nm) 
M 1.1 ± 0.2 1063 0.95 2.65 2.05 
N 0.09 ± 0.02 1070 0.92 2.53 1.91 
S 1.2 ± 0.2 642 0.93 7.82 2.56 
U 1.2 ± 0.3 981 0.72 2.62 2.22 
a. Pore volumes and pore sizes are only associated with intraparticle mesopores. 
b.  Pore size estimated by using the BJH model applied on the adsorption branch of the 
isotherm. 
c. Wall thickness was estimated as cell parameter taken from the XRD minus pore size.  
 
3.2 Effect of in vitro digestion in microstructure of bare particles 
 
To test the effect of human digestion on bare MSPs stability, different as-
synthesised particles followed a typical in vitro digestion procedure (Figure 1). 
After the digestion process, particles were washed with water, recovered by 
centrifugation and characterized by XRD, TEM, FESEM, and N2 adsorption-
desorption isotherms.  
 
The XRD diffractogram (Fig 2) revealed a loss of the order in all bare digested 
particles (ii) characterized by a decreased intensity of (1 0 0) Bragg reflexion and a 
loss of almost the rest of reflexions when compared with undigested ones (i). 
According to the loss of intensity, the particle that exhibited a more pronounced 
one was N (wall thickness = 1.91), closely followed by M (wall thickness = 2.05) 
and U (wall thickness = 2.22). The differences in wall thickness among N (less than 
2 nm) and M and U (more than 2 nm) might be due to the synthesis route. N and 
U follow the atrane route of synthesis, a procedure that provides wide framework 
walls.  
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For its part, S with a wall thickness of 2.56 nm seemed to be the particle that 
better conserve the hexagonal structure of the particle. In fact, diffractogram of 
digested S was very similar than that of the undigested particle meaning that 
mesoporous arrangement is preserved during the whole in vitro digestion 
procedure.  
 
Nitrogen sorption data (Fig 3) show a reduction of the adsorbed N2 volume in 
all the solids, what means that the digestion procedure provokes a loss of specific 
surface area and porous volume. This reduction is more marked in the case of N 
and U that in M and S in consonance with XRD patterns. This loss of total surface 
area and pore volume as a consequence of the contact with biological media has 
also been observed by other authors (Cauda et al., 2010; El Mourabit et al., 2012). 
In these works, the loss of textural properties of silicas is associated with a 
progressive elimination of the porosity by dissolution of the silica, with a pore 
blockage by precipitation of inorganic compounds onto the surface of the porous 
silica or with their combination.  
 
 
Figure 3. Nitrogen adsorption-desorption isotherms for microparticulate MCM-41 (a), 
nanoparticulate MCM-41 (b), SBA-15 (c) and UVM-7 (d) before (i) and after (ii) the in vitro digestion 
procedure. 
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To further understand which of these mechanisms are involved in the 
digestion-induced silica degradation, in parallel with XRD and N2 absorption-
desorption isotherms experiments, TEM and FESEM observations of the four silica 
supports were carried out. Figure 4 shows FESEM and TEM pictures of different 
bare particles before and after the in vitro digestion process. This figure allows 
observation of not only the particle size and shape of the single particle, but also 
particle porosity.  
 
After the digestion, two particles did not change their appearance (FESEM) 
and pore integrity (TEM). These particles are M and S, those with single particle 
size in the microscale. This implies that for these particles the loss of order 
observed in XRD was not provoked by a collapse of the mesostructure, but 
probably by the formation of a small volume fraction of “gel” consisting mostly of 
(SiOH2)n (El Mourabit et al., 2012) or the adsorption of calcium and phosphate 
ions present in the digestion fluids on the silica surface forming a hydroxyapatite 
phase (Ohtsuki, Kokubo & Yamamuro, 1992; Cho et al., 1998; Radim, Falaize, Lee 
& Ducheyne, 2002; Cauda et al., 2010). 
 
In contrast, supports based on nanoparticulated materials, N and U 
biodegraded with a modification of the appearance of both, surface and pore 
structure, as a consequence of the digestion procedure. The most affected 
supports were N. After the whole digestion process, these particles lost the 
uniformity of pore structure (TEM) and despite keeping their particle size and 
shape, altered the structure of its surface (FESEM). In those cases, besides the 
pore closure provoked by the apparition of new phases, the decrease of the 
mesostructure observed by XRD and N2 adsorption-desorption isotherms was 
originated by pore collapse. 
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Figure 4. Characterization of particle size, particle shape and pore system of bare MSPs before and 
after the in vitro digestion procedure (IDP). MCM-41 (M), MCM-41 nano (N) SBA-15 (S) and UVM-7 
(U). 
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Having in mind these results, it is stated that all the studied MSPs are altered 
as a consequence of the in vitro digestion process. However, the degradation 
degree depends on the type and size of the particles. In this context, El Mourabit 
et al. (2012) studied the structure alteration of several porous silica differing in 
particle size, particle shape, pore-size distribution, specific surface area, pore 
volume and average of pore diameter caused by immersion in acid solutions and 
found that the degradation of the supports was not obviously influenced by 
textural properties of the particles. Nevertheless, in our study, it seems to be clear 
that particle size and wall thickness seem to be the characteristics that condition 
the degradation. 
 
In order to correlate the impact of each of the phases of the digestion with 
the steps of the particle’s degradation, a further experiment was done. For this 
detailed experiment MCM-41 nanoparticles were selected given that it was the 
most affected support by the whole digestion process. For this purpose, N was put 
in contact with water over 4 h. In parallel, a typical in vitro digestion process (4 h) 
was performed. After each of these steps, samples were washed and observed 
with TEM. Figure 5 shows TEM micrographs of N after 4 h in contact with water 
(a) and after each of the phases of the in vitro digestion process: buccal (b), gastric 
(c) and intestinal (d). As observed, particle size (ca. 100 nm) did not vary during 
the digestion suggesting that particle structure remains unaltered after the whole 
digestion process. Moreover, surface and porosity of MCM-41 remained 
unchanged after 4 h in water, meaning that particles do not collapse easily in 
water solution. Particles are also intact after the 5 min of contact with simulated 
saliva. However, particles change dramatically their conformation after the 2 h of 
gastric phase. Concretely, after this digestion step, particles lose their clearly 
spherical shape and ordered porous conformation and become irregular shaped 
spheres with disordered porosity. Little differences among particles observed 
after gastric and after both, gastric and intestinal phases are shown. Therefore, it 
is thought that once the digestive solution is neutralized by the addition of 
intestinal juices, the degradation process is stopped. 
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Figure 5. TEM images showing particle size, particle shape and pore system of bare MCM-41 
nanopaticles after 4 h in water, and buccal, gastric and intestinal phases of the in vitro digestion 
procedure.   
 
These findings confirm that gastric phase (pH 2) is the responsible for 
particle’s degradation. The role of acids in porous silica degradation has previously 
been described (El Mourabit et al., 2012). These authors realised that protons play 
a role in the acidic alteration process of the silica. Moreover, they pointed out 
that in acidic conditions, anions (i.e. SO4
2-, Cl-, PO4
3-) present in the media can act 
as nucleophilic catalyst accelerating the degradation reactions. Having in mind the 
composition of the two fluids comprising gastric phase of the digestion (i.e. saliva 
and gastric juice) it can be stated that all these degradative species (i.e. NaSO4, 
NaH2PO4, HCl, NaCl, KCl, CaCl2 and NH4Cl) are present.  
3.3 Effect of in vitro digestion in microstructure of amine-functionalised particles 
 
To investigate if functionalization of particles surface with organic molecules 
acting as molecular gates has any influence on the preservation of the structure 
during the in vitro digestion, the four particles of study were functionalised with 
N1-(3-trimethoxysilylpropyl)diethylenetriamine. This polyamine is one of the most 
common organic molecules used to fabricate capped mesoporous silica particles 
able to modulate the release of payload molecules in response to pH changes 
(Casasús et al., 2004). After functionalization, particles were subjected to 
digestion process described in Figure 1. Digested particles were washed with 
water, dried and characterized by XRD, TEM and FESEM. 
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Figure 2 shows XRD patterns of amine-functionalized particles before (ii) and 
after (iv) the in vitro digestion process. In contrast to bare particles, functionalised 
particles showed the same diffraction peacks before and after the digestion, 
which indicate a preservation of the porous structure after the digestion 
procedure. The structure preservation was confirmed by microscopic analysis. As 
can be observed in Figure 6, morphology, particle size and porous structure of 
different amine-functionalized supports is the same before and after the in vitro 
digestion procedure. These determinations point out the role of amines in the 
protection of porous silica, especially those with nanosize (N and U), during the 
attack by the acids and chemical species present in the digestive juices. The 
prevention of silica degradation after organic functionalization has also been 
observed by other authors. Lin et al. (2011) observed that degraded Si amounts 
from 42 nm diameter silica nanoparticles were greater than that from the 
equivalent pegylated nanoparticles after both 10 days in deionized water and PBS 
at room temperature and 37 °C. Cauda et al. (2010) also observed that the 
attachment of a poly(ethylene glycol)-layer on the outer surface of colloidal 
mesoporous silica stabilizes the particles by reducing the rate of degradation in 
simulated body fluid at 37 °C for 1 month. The preventive effect of functional 
groups attached to the surface of the silica supports on the degradation of porous 
silica could be attributed to the capability of these molecules to interfere with the 
corrosion caused by acids and catalytic anions as well as to prevent the adsorption 
of calcium/phosphate cations and the reordenation of silicon species on a new 
“gel” fraction on the walls of the mesoporous silica particles.  In our case, amine 
groups attached to particle’s surface are also able to locally neutralize the acidic 
environment created by HCl, counteracting the corrosive effect of the acid. 
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Figure 6. Characterization of particle size, particle shape and pore system of amine-functionalised 
MSPs before and after the in vitro digestion procedure. MCM-41 (M), MCM-41 nano (N) SBA-15 (S) 
and UVM-7 (U). 
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3.4 Effect of in vitro digestion in macroscopic structure 
 
To understand the effect of each of the digestion steps on the particle size 
and aggregation tendency, particles were observed by CLSM in each of the 
artificial digestion mixtures (Fig 7). This analysis revealed that in water solution, all 
the particles tended to form aggregates. This trend to form large aggregates, 
especially observed in N and U, in accordance with results previously reported 
(Pérez-Esteve et al., 2014). Figure 7 also allows observing that for each of the 
particles the gastric phase provokes an enlargement of particles aggregates, and 
that in none of the cases digestion triggered the loss of macroscopic particle 
structure.  
 
Figure 7. Characterization of particle size and particle shape of bare MSPs before and after the in 
vitro digestion procedure. MCM-41 micro (M), MCM-41 nano (N), SBA-15 (S) and UVM-7 (U). 
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Aggregation tendency observed in gastric phase for all the particles was 
confirmed by particle size distribution measurements. As shown in Figure 8, 
according to particles’ grain size in different digestive media, two different groups 
of particles can be distinguished. On the one hand, S and M microparticles, 
exhibited a size distribution in the range 0.5-2 m, while size distribution of N and 
U ranged from 5 up to 40 m. Differences between single particle size and size 
exhibited when suspended in aqueous media suggest the formation of particle 
clusters.  
 
 
 
Figure 8. Hydrodynamic size distribution of MCM-41 micro (a), MCM-41 nano (b), SBA-15 (c) and 
UVM-7 (d) expressed as number percentage. Discontinuous gray line (buccal), continuous black line 
(gastric) and discontinuous black line (intestinal).  
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Zeta Potential analysis of particles was performed at the end of each of the 
three steps of the digestive process (saliva, grastric and intestinal media) to assess 
the influence of the digestion phase on the surface charge of the particles. As 
observed in Figure 9, particles exhibited a negative zeta potential (ca. -30 mV) in 
the presence of saliva (neutral pH and changed dramatically during gastric phase 
(ca. +10 mV) due to the protonation of silanolates at the pH of the stomach (pH 
2), where silica has the isoelectric point (Kosmulski, 1998). However, after 
neutralization of pH in the intestinal phase, zeta potential reached negative values 
of ca -20 or -30 mV. Generally it is considered that particles exhibiting a zeta 
potential in the range from +30 to -30 mV tend to aggregate (Duman & Tunç, 
2009). As expected, changes in zeta potential could be the reason for aggregation 
tendency in the gastric environment.  
 
 
 
Figure 9. Zeta potential values (mean ± SD) of MSPs after oral phase (light gray), gastric phase (dark 
gray) and intestinal phase (black). MCM-41 micro (M), MCM-41 nano (N), SBA-15 (S) and UVM-7 (U). 
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3.5 Quantification of silica degradation and degree of silica network 
condensation  
 
In previous sections it has been concluded that bare particles, especially N 
and U, lose part of their textural properties as a consequence of the in vitro 
digestion process. It was also stated by TEM and FESEM pictures that stomach 
phase was the responsive of the structural changes of the porous systems and the 
surface appearance. To better understand the degradation process it was our aim 
to quantify the amount of free silicic acid formed during the digestion quantified 
as free silicon by ICP-OES, since it is a clear indicator of silica degradation (Lin et 
al., 2011). As observed in Table 2, amounts of silicon species in the digestive juice 
after the 4 h of digestion process was very similar for all the particles (20-25 mg Si 
L-1 of digestive fluid) and surface functionalization with polyamines did not 
influence this value. These amounts of free silicon are equivalent to 4-5% of the 
silicon present in the MSPs, depending on the support. Thus, as previously 
suggested, the degradation of porous structure of bare porous silica is not due to 
a simple dissolution of the silica provoking a collapse of the particle, but by a 
transformation of the silica in a new disordered phase. In addition, determination 
of free silicon formed in the three phases of the digestion of bare MCM-41 
nanoparticles revealed that only 0.4% of the silicon was dissolved during the 
buccal phase of digestion. Percentage of dissolved silicon reached values of 2% in 
the stomach phase and continued increasing until 4% at the end of the intestinal 
phase.   
 
 
Table 2. Free silicon formed during the in vitro digestion procedure (4 h) of MCM-41 microparticles 
(M), MCM-41 nanoparticles (N), SBA-15 (S) and UVM-7 (U). 
 
Free silicon (mg L
-1
) M N S U 
Bare 20 ± 2 19 ± 2 21 ± 2 25 ± 3 
N3-functionalised 19 ± 1 22 ± 1 21 ± 1 23 ± 2 
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3.6 Biocompatibility of particles after the in vitro digestion 
 
Finally, the biocompatibility of bare and functionalized particles subjected to 
the digestion process was tested through WST-1 test. In previous works, we have 
studied the cytotoxicity of the four particles object of study loaded with folic acid 
and functionalized with N1-(3-trimethoxysilylpropyl)diethylenetriamine (Pérez-
Esteve et al., 2016).  The study concluded that functionalised M, N, S and U 
particles did not induce significant cell death upon 200 mg mL-1 for 24 h. However, 
it has been recently reported  that biodegradation of silica into silicic acids 
including monomeric silicic acid and various polysilicic acids with different 
polymerization degrees could cause cytotoxicity via adsorbing and binding 
enzymes and substrate proteins (He et al., 2009).  
 
In previous sections, it has been demonstrated that MSPs were attacked 
during the digestion procedure, and that during the attack free silicon is formed.  
Thus, with the purpose of evaluating potential side effects of digested supports 
and their degradation products on human cells we aimed in this section the 
evaluation of the cytotoxicity of digestive fluids containing different 
concentrations of MSPs. To test the cytotoxicity, human colon carcinoma cells 
(HCT116), human liver carcinoma cells (HEPG2), human kidney epithelial cells 
(HK2), and human cervix carcinoma cells (HeLa) cells were chosen to test the 
toxicity of the products of bare and amine-functionalised M, N, S and U particles 
after the in vitro digestion procedure described above.   
 
The results in Figure 9 and Figure 10 show that the viability of none of the 
cell lines was compromised even exposure at a relatively high particle 
concentration (200 mg mL-1). It is considered that polysilicic acids developed 
during silica degradation could cause cytotoxicity via adsorbing and binding 
enzymes and substrate proteins. In contrast, monomeric silicic acid would not 
bind proteins and therefore had no cytotoxicity (He et al., 2009). Having this in 
mind, results of this study implies that a) the formation of silicic species is very 
low or b) the biodegradation products of the different MSPs are mainly 
monomeric and oligomeric silicic acids rather than cytotoxic polysilicic acids with 
high polymerization degree. 
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Figure 9. WST-1 cell viability assay. HCT116 (light grey), HEPG2 (medium grey), HK2 (dark grey) and 
HeLa (black) cells treated with digestion fluids containing bare MSPs  at concentrations of 50, 100, 
150 and 200 μg mL
-1
 for 24 h. Cells were incubated for 24h with optimized solids at the 
concentrations stated before and cell viability was quantified using the WST-1 reagent. MCM-41 
microparticles (a), MCM-41 nanoparticles (b), SBA-15 (c) and UVM-7 (d). 
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Figure 10. WST-1 cell viability assay. HCT116 (light grey), HEPG2 (medium grey), HK2 (dark grey) and 
HeLa (black) cells treated with digestion fluids containing amine-functionalized MSPs  at 
concentrations of 50, 100, 150 and 200 μg mL
-1
 for 24 h. Cells were incubated for 24h with optimized 
solids at the concentrations stated before and cell viability was quantified using the WST-1 reagent. 
MCM-41 microparticles (a), MCM-41 nanoparticles (b), SBA-15 (c) and UVM-7 (d). 
4. Conclusions 
The present work demonstrates the effect of an in vitro digestion process on 
the stability of bare and amine-functionalized mesoporous silica particles.  Results 
showed that bare SBA-15 and MCM-41 microparticles were very stable against 
degradation. However, supports based on nanoparticles (i.e. MCM-41 
nanoparticulated and UVM-7) exhibited an evident degradation of its structure 
characterized by a loss of pore order and surface attack. In the degradation 
process, only ca. 5% of the silicon present in the sample was dissolved in the 
digestion fluids, confirming that the degradation process is not caused by the loss 
of matter, but in the chemical transformation of the SiO2 in other silicic phases. 
This degradation was avoided by the functionalization of the external surface of 
the particles with N1-(3-trimethoxysilylpropyl)diethylenetriamine. These findings 
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evidence the importance of particle size and surface modification on the 
degradation behaviour during an in vitro digestion process. In addition, despite 
the formation of free silicon during the different phases of the digestion, neither 
the digested particles nor the biodegradation products show any toxicity to 
HCT116, HEPG2 HK2 and HeLa cells. In accordance to these results, the utilization 
of mesoporous silica microparticles, and over all, amine-functionalized 
mesoporous silica microparticles in the design of oral delivery systems guarantees 
the chemical stability of the supports through the whole digestive tube. 
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F., Soto, J., Barat, J. M., Perez-Paya, E., Guillem, C.,  & Amorós, P. (2010). Enzyme-
responsive intracellular controlled release using nanometric silica mesoporous supports 
capped with “saccharides”. Acs Nano, 4(11), 6353-6368. 
Article 3 
 
167 
 
Casasús, R., Marcos, M. D., Martínez-Máñez, R., Ros-Lis, J. V., Soto, J., Villaescusa, L. A., 
Amorós, P., Beltrán, D., Guillem, C., & Latorre, J. (2004). Toward the development of 
ionically controlled nanoscopic molecular gates. Journal of the American Chemical 
Society, 126(28), 8612-8613. 
Cauda, V., Schlossbauer, A., & Bein, T. (2010). Bio-degradation study of colloidal 
mesoporous silica nanoparticles: effect of surface functionalization with organo-silanes 
and poly (ethylene glycol). Microporous and Mesoporous Materials, 132(1), 60-71. 
Cho, S. B., Miyaji, F., Kokubo, T., Nakanishi, K., Soga, N., & Nakamura, T. (1998). 
Apatite formation on silica gel in simulated body fluid: effects of structural modification 
with solvent-exchange. Journal of Materials Science: Materials in Medicine, 9(5), 279-284. 
Comes, M., Aznar, E., Moragues, M., Marcos, M. D., Martínez‐Máñez, R., Sancenón, F., 
Soto, J., Villaescusa, L. A., Gil, L., & Amorós, P. (2009). Mesoporous hybrid materials 
containing nanoscopic “binding pockets” for colorimetric anion signaling in water by using 
displacement assays. Chemistry-A European Journal, 15(36), 9024-9033. 
Coll, C., Mondragón, L., Martínez‐Máñez, R., Sancenón, F., Marcos, M. D., Soto, J., 
Amorós, P.,  & Pérez‐Payá, E. (2011). Enzyme‐Mediated Controlled Release Systems by 
Anchoring Peptide Sequences on Mesoporous Silica Supports. Angewandte Chemie 
International Edition, 50(9), 2138-2140. 
Duman, O., & Tunç, S. (2009). Electrokinetic and rheological properties of Na-
bentonite in some electrolyte solutions. Microporous and Mesoporous Materials, 117(1), 
331-338. 
He, Q., Shi, J., Zhu, M., Chen, Y., & Chen, F. (2010). The three-stage in vitro 
degradation behavior of mesoporous silica in simulated body fluid. Microporous and 
Mesoporous Materials, 131(1), 314-320. 
He, Q., Zhang, Z., Gao, Y., Shi, J., & Li, Y. (2009). Intracellular Localization and 
Cytotoxicity of Spherical Mesoporous Silica Nano‐and Microparticles. Small, 5(23), 2722-
2729. 
El Mourabit, S., Toquer, G., Cambedouzou, J., Goettmann, F., & Grandjean, A. (2012). 
Stability of mesoporous silica under acidic conditions. RSC Advances, 2, 10916-10924. 
Kosmulski, M. (1998). Positive electrokinetic charge of silica in the presence of 
chlorides. Journal of colloid and interface science, 208(2), 543-545. 
Lin, Y. S., Abadeer, N., & Haynes, C. L. (2011). Stability of small mesoporous silica 
nanoparticles in biological media. Chemical Communications, 47(1), 532-534. 
Mondragón, L., Mas, N., Ferragud, V., de la Torre, C., Agostini, A., Martínez‐Máñez, 
R., & Orzáez, M. (2014). Enzyme‐Responsive Intracellular‐Controlled Release Using Silica 
Mesoporous Nanoparticles Capped with ε‐Poly‐L‐lysine. Chemistry-A European Journal, 
20(18), 5271-5281. 
Chapter 1 
  
168 
 
Ohtsuki, C., Kokubo, T., & Yamamuro, T. (1992). Mechanism of apatite formation on 
CaO SiO 2 P 2 O 5 glasses in a simulated body fluid. Journal of Non-Crystalline Solids, 143, 
84-92. 
Pérez-Esteve, É., Fuentes, A., Coll, C., Acosta, C., Bernardos, A., Amorós, P., Marcos, M. 
D., Sancenón, F., Martínez-Máñez, R.,  & Barat, J. M. (2015). Modulation of folic acid 
bioaccessibility by encapsulation in pH-responsive gated mesoporous silica 
particles. Microporous and Mesoporous Materials, 202, 124-132. 
Pérez-Esteve, E., Oliver, L., García, L., Nieuwland, M., de Jongh, H. H., Martínez-Máñez, 
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Abstract 
 
The aim of this work was to investigate the impact of mesoporous silica 
particles (MSPs) on the physicochemical properties of filled protein gels. We have 
studied the effect of the addition of different mesoporous silica particles, either 
bare or functionalised with amines or carboxylates, on the physical properties of 
gelatine gels (5% w/v). Texture properties of the filled gels were investigated by 
uniaxial compression, while optical properties were investigated by turbidity. The 
MSPs were characterised with the objective of correlate particle features with its 
impact on the corresponding filled gel properties. The addition of MSPs (both with 
and without functionalization) increased the stiffness of the gelatine gels. 
Furthermore, functionalised MSPs showed a remarkable increase in the strength 
of the gels and a slight reduction of the brittleness of the gels, in contrast with 
non-functionalised MSPs which showed no effect on these two properties. 
Turbidity of the gels was also affected by the addition of all tested MSPs, showing 
that the particles that formed smaller aggregates resulted in a higher contribution 
to turbidity.  MSPs are promising candidates for the development of functional 
food containing smart delivery systems, being also able of modulating the 
functionality of protein gels. 
 
Keywords: Mesoporous silica particles, smart delivery systems, gelatine, texture 
properties, turbidity. 
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1. Introduction  
The design of new functional food with nutritional and/or health declarations 
often requires the encapsulation, controlled release, or protection of suitable 
bioactive agents (Weiss et al., 2006). To achieve this goal, novel smart delivery 
systems based on emulsions (Anton et al., 2010), liposomes (An et al., 2013), 
polymeric hydrogels (Chaturvedi et al.,, 2013) and various inorganic particles 
(Bernardos et al., 2008; Barat et al.,2011) have been reported recently. 
 
Among them, mesoporous silica particles (MSPs) have been studied as smart 
delivery systems in various life science fields such as medicine, nutrition, and food 
technology (Pérez-Esteve et al.,2013). Their unique properties (e.g., an ordered 
and uniform pore network, an adjustable pore size (from 2.0 to 50 nm), a high 
surface area (>700 m2 g-1) (Vallet-Regí et al., 2007) and the possibility of modify 
their surface with organic molecules that act as bioresponsive molecular gates 
(Aznar et al., 2009) favor the development of promising biomedical applications 
related to encapsulation, protection, and the controlled delivery of bioactive 
agents. 
 
Different MSPs have in common that their composition is based on a SiO2 
network, a mesostructure, and the presence of silanol groups on the surface. 
Some differ from each other in size, shape, porous size and volume, specific 
surface area, and density of silanol groups on the surface providing different 
surface charge. Despite the fact that the most studied mesoporous silica-based 
material is MCM-41, (Aznar et al., 2009; Zhao et al., 1996) both as nanoparticles 
(Salonen et al., 2005) and microparticles, (Trewyn et al., 2007) other MSPs with 
different shapes and porous systems (e.g., SBA-15 (Rahmat et al., 2010; Song et 
al., 2005) and UVM-7 (El Haskouri et al., 2002, Comes et al., 2009)) have also been 
employed as molecular carriers. 
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MSPs possess most of the desired features for a smart delivery system 
designed to be incorporated into a food product, such as the capability to 
encapsulate a large amount of bioactive molecules, the possibility to control 
release within the gastrointestinal tract, (Bernardos et al., 2008; Song et al., 2005) 
and the ability to be highly stable and biocompatible (Asefa & Tao, 2012; 
Mamaeva et al., 2013; Moon & Lee, 2009). However, to the best of our 
knowledge, there is no information in the literature about the effect of the 
incorporation of MSP on product appearance, texture, mouth feel, flavor, and 
shelf life of the final food or beverage matrixes in which they potentially could be 
incorporated. 
 
One way to integrate the MSPs in food systems is to incorporate them as 
fillers in protein gel matrixes. The mechanical properties of emulsion filled gels or 
composite gels for food applications have been studied (Lorenzo & Zaritzky, 2013; 
Sala et al., 2009a; Sala et al., 2009b). These studies show that the mechanical 
properties of filled gels depend not only on the physicochemical characteristics of 
the gel matrix or the size, shape, spatial distribution, and volume fraction of the 
filler but also on the strength of the interaction between the filler and the gel 
matrix (van Vliet, 1988). Depending on the nature of this interaction, the fillers 
are, at the extremes, mechanically connected to the gel network and then 
increase the gel elastic modulus (“active”) or remain inert from the gel matrix and 
thereby weaken the gel by acting as a hindering steric contribution during gel 
formation (“inactive”) (Ring & Stainsby, 1982).  
 
Bearing in mind the lack of information on studies on the interaction of silica 
mesoporous particles on (protein) gels, this article evaluates the effect of the 
incorporation of MSPs differing in particle size and shape and bearing different 
surface functionalization on the physical properties of gelatine gels, one of the 
most common model food systems. 
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2. Materials and methods 
 
2.1 Chemicals 
 
Porcine skin gelatine (type A, 300 bloom, average molecular weight 50-100 
kDa, and isoelectric point pI = 7.0-9.0) was purchased from Sigma. For the 
synthesis of the mesoporous silica particles, tetraethylorthosilicate (TEOS), N-
cetyltrimethylammonium bromide (CTABr), pluronic P123 (P123), triethanolamine 
(TEAH3), sodium hydroxide (NaOH), chloride acid (HCl), acetic acid, and N1-(3-
Trimethoxysilylpropyl)diethylenetriamine (N3) were provided by Sigma (Sigma-
Aldrich Química S.L., Madrid, Spain), while N-3-(trimethoxysilyl)propyl 
ethylenediamine triacetic acid trisodium salt (C3) was provided by Fluorochem 
(Hadfield, UK). 
 
2.2 Sample preparation 
 
2.2.1 Mesoporous silica particles synthesis 
Microparticulated MCM-41 particles (M) were synthesized following the so-
called atrane route (Cabrera et al., 2000) according to the method described by 
Barat et al. (2011). N-Cetyltrimethylammonium bromide (CTABr) was used as the 
structure-directing agent. The molar ratio of the reagents was fixed to 7 TEAH3:2 
TEOS:0.52 CTABr:0.5 NaOH:180 H2O. CTABr was added to a solution of 
triethanolamine (TEAH3) containing sodium hydroxide (NaOH) and 
tetraethylorthosilicate (TEOS) at 118 °C. After CTABr was dissolved in the solution, 
water was slowly added with vigorous stirring at 70 °C. After a few minutes, a 
white suspension was formed. This mixture was aged at room temperature 
overnight. 
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Nanoparticulated MCM-41 particles (N) were synthesized using the 
procedure described by Bernardos et al. (2011) The molar ratio of the reagents 
was fixed at 1 TEOS:0.1 CTABr:0.27 NaOH:1000 H2O. NaOH was added to the 
CTABr solution, followed by adjusting the solution temperature to 95 °C. TEOS 
was then added dropwise to the CTABr solution. The mixture was allowed to stir 
for 2 h, yielding a white precipitate. 
 
SBA-15 particles (S) were synthesized following the method reported by Zhao 
et al. (1998). P123 was used as the structure-directing agent. The molar ratio of 
the reagents was fixed at 0.017 P123:1.0 TEOS:6 HCl:196 H2O. The preparation 
was performed by mixing an aqueous solution of P123 with HCl solution and 
stirring for 2 h, after which the silica source, TEOS, was added. This final mixture 
was stirred for another 20 h. 
 
UVM-7 particles (U) were synthesized following the method presented by 
Comes et al. (2009) which was also based on the atrane route. The molar ratio of 
the reagents was fixed at 7 TEAH3:2 TEOS:0.52 CTABr:180 H2O. The TEOS/TEAH3 
mixture was heated to 120 °C until no elimination of ethanol was observed. The 
mixture was cooled to 90 °C, and CTABr was added gradually in small portions, 
followed by dilution with water. The mixture was aged for 24 h. 
 
For all samples, after the synthesis, the resulting powder was recovered by 
centrifugation, washed with deionized water, and air dried at room temperature. 
To prepare the final mesoporous materials, the as-synthesized solids were 
calcined at 550 °C using an oxidant atmosphere for 5 h in order to remove the 
template phase. 
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2.2.2 Mesoporous silica particles functionalization 
The surfaces of the four types of particles (#) were functionalized with N-(3-
trimethoxysilylpropyl) diethylenetriamine (N3) or with N-[3-
(trimethoxysilyl)propyl]ethylenediamine triacetic acid trisodium salt (C3) to add 
positive and negative charges, respectively. To obtain #-N3 particles, 1 g of MSPs 
was suspended in 40 mL of acetonitrile, and an excess of N3 (4.3 mL, 15.0 mmol  
g-1) was then added. To obtain #-C3 particles, 1 g of MSPs was suspended in 30 mL 
of water, and an excess of C3 (5.5 mL, 15.0 mmol g-1) was then added. Final 
mixtures were stirred for 5.5 h at room temperature. Finally, the solids were 
filtered off, washed with 30 mL of deionized water, and dried at room 
temperature. 
 
2.2.3 Filled gelatine gels preparation 
Gelatine gels containing 5% (w/w) gelatine in the aqueous phases were 
prepared with the four types of particles (M, N, U, and S) both bare (#) and 
functionalized with carboxylates (#-C3) and amines (#-N3) at different 
concentrations (0, 0.1, 0.25, 0.5, 0.75, and 1% w/w). 
 
A stock solution of gelatine in 0.2 M acetate buffer (pH 5.5) (10% w/v) was 
prepared by allowing the gelatine to hydrate for 2 h under gentle stirring at room 
temperature. The gelatine was subsequently dissolved by holding at 60 °C for 30 
min. 
 
MSPs were dispersed, at a known volume fraction, in acetate buffer (pH 5.5) 
and sonicated gently to reduce particle aggregates. The required amount of the 
selected MSP dispersion was then mixed with the gelatine solution. For large 
deformation analysis, the mixture was transferred into 20 mL plastic syringes 
(internal diameter 20 mm) coated with a thin film of paraffin oil. For turbidity 
measurements, the gels were prepared in 1 cm plastic cuvettes. In both cases, the 
samples were left to gel and age for 22 ± 2 h at 20 °C. 
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2.3 Determination of particle size distribution and zeta-potential 
 
The particle size distribution of the different bare and functionalized MSPs 
was determined using a Malvern Mastersizer 2000 (Malvern, UK). For the 
measurements, samples were dispersed in acetate buffer. Data analysis was 
based on the Mie theory using refractive indices of 1.33 and 1.45 for the 
dispersant and MSP, respectively. An adsorption value of 0.001 was used for all 
samples. The variation of this adsorption value did not significantly alter the 
obtained distributions. Measurements were performed in triplicate. 
 
To determine the zeta potential () of the bare and functionalized MSPs, a 
Zetasizer Nano ZS (Malvern Instruments, UK) was used. Samples were dispersed in 
acetate buffer at concentration of 1 mg mL-1. Before each measurement, samples 
were sonicated for 2 min to preclude aggregation. The zeta potential was 
calculated from the particle mobility values by applying the Smoluchowski model. 
The average of five recordings is reported as the zeta potential. Measurements 
were performed at 25 °C in triplicate. 
 
2.4 Determination of functionalization degree 
 
The degree of functionalization of different particles was determined by 
thermogravimetric analyses. Determinations were carried out on a TGA/SDTA 
851e Mettler Toledo balance, with a heating program consisting of a heating ramp 
of 10° per minute from 273 to 373 °C followed by an isothermal heating step at 
this temperature for 60 min under a nitrogen atmosphere (80 mL min-1). Then, the 
program continued with a dynamic heating segment from 373 to 1273 °C  using an 
oxidant atmosphere (air, 80 mL min-1) and an isothermal heating step at this 
temperature for 30 min. 
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2.5 Transmission electron microscopy (TEM) 
 
For transmission electron microscopy (TEM) analysis, MSPs were dispersed in 
dichloromethane and sonicated for 2 min to preclude aggregates, and the 
suspension was deposited onto copper grids coated with a carbon film (Aname SL, 
Madrid, Spain). Imaging of the MSP samples was performed using a JEOL JEM-
1010 (JEOL Europe SAS, France) operating at an acceleration voltage of 80 kV. The 
single-particle size was estimated by averaging the measured size values of 50 
particles. 
 
2.6 Confocal laser scanning microscopy (CLSM 
 
The morphologic analysis of bare and functionalized MSP particles dispersed 
in acetate buffer and also incorporated into gelatine was performed by confocal 
laser scanning microscopy after staining the samples with rhodamine B (0.2%). 
CSLM images were recorded on a Leica TCS SP confocal laser scanning microscope 
(Leica Microsystems CMS GmbH., Manheim, Germany) equipped with an inverted 
microscope (model Leica DM IRBE) used in single-photon mode with an Ar/Kr 
visible light laser. The excitation wavelength was set at 540 nm. Digital image files 
were acquired in the format of 1024 pixel × 1024 pixel resolution. 
 
2.7 Large deformation experiments 
 
Uniaxial compression tests were performed using a texture analyzer 
(TA.XT.plus Texture Analyser, Stable Micro Systems, Godalming, Surrey, United 
Kingdom), employing a plate probe (diameter: 75 mm). The plates were lubricated 
with a thin layer of paraffin oil. The gels were removed from the syringe and cut 
to obtain cylinders of 20 mm of diameter and 20 mm of height. The 
measurements were performed at a constant deformation speed of 1 mm s-1 and 
up to a compression strain of 90%.  
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The relative deformation at a certain stage is expressed as a true or Hencky strain, 
(H ), which is defined as: 
 
                                  𝜀𝐻 = ∫
1
𝐻
𝐻𝑡
𝐻0
𝑑𝐻 = 𝑙𝑛 (
𝐻𝑡
𝐻0
),       (1) 
 
where H0 is the initial specimen height (m), and H is the actual height after certain 
deformation time t (m). For compression, the Hencky strain is negative, but it will 
be expressed as a positive figure. The average true or Hencky stress, t (Pa) in 
the test piece at a certain deformation at time t is given by: 
 
                                              𝜎(𝑡) =
𝐹(𝑡)
𝐴(𝑡)
,    (2) 
 
 where F(t) is the measured force  after a deformation time t (N), and A(t) is the 
cross-sectional area of the sample (m2). The true stress accounts for the 
continuous change in the cross-sectional area assuming no change in cylindrical 
shape and constant volume during the compression. The apparent Young’s 
modulus, E (Pa), of the sample was defined as the initial slope within the linear 
region of the true stress versus true strain curve. The Young’s modulus is 
representative of the stiffness of the gel. Fracture stress and strain are defined as 
strength and brittleness of the gel, respectively. 
 
2.7 Turbidity measurement 
 
The turbidity () of the gels was measured using a JASCO V-630 
Spectrophotometer (JASCO Analitica Spain S.L, Madrid, Spain) at 550 nm against 
acetate buffer and expressed as % of transmittance.  Measurements were 
performed in duplicate. 
 
2.8 Statistical analysis 
 
All tests were carried out for at least three times and data were subjected to 
multifactorial analysis of variance (ANOVA) using Statgraphics Centuriun XV 
(Manugistics Inc., Rockville, MD, USA). Results followed by the same letter in the 
same column are not significantly different between means (p<0.005). 
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3. Results and discussion  
 
3.1 MSPs characterization 
 
A morphologic analysis of different synthesized MSPs was performed by 
transmission electron microscopy (TEM). The first column of Figure 1 shows the 
evident differences in particle size, shape, and porosity. Nanoparticulate MCM-41 
particles (N) are spherical nanoparticles with an apparent pore size in the range of 
2 to 3 nm. UVM-7 particles (U) are organized in the form of clusters of 
pseudospherical mesoporous nanoparticles. Microparticulate MCM-41 particles 
(M) look like porous irregularly shaped particles whose pore size is in the range of 
2 to 3 nm. Finally, SBA-15 (S) particles are elongated with a well-defined 
hexagonal mesoporous distribution. 
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Figure 1. TEM (left) and CLSM images of different MSPs stained with Rhodamine B dispersed in 
acetate buffer (middle) or incorporated in gelatine gels (right). N: Nanoparticulated MCM-41; U: 
UVM-7; M: Microparticulated MCM-41; S: SBA-15 
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Besides the shape, this morphological analysis allowed the determination of 
the single-particle size of different MSPs. Size oscillated from ca. 100 nm of N to 
ca. 1-1.5 μm of M or S. U clusters had different sizes, being the average next to 
the microscale. Size values are summarized in Table 1. 
 
Table 1. Size (Mean±SD) of different bare and functionalised MSP determined by TEM (dry) or Light 
Diffraction (dispersed in acetate buffer). N: Nanoparticulated MCM-41; U: UVM-7; M: 
Microparticulated MCM-41; S: SBA-15 
MSP Bare (Dry) 
Single particle 
size (µm) 
Bare (Acetate) 
d(0.5)
* 
(µm) 
COO
- 
(Acetate) 
d(0.5)
* 
(µm) 
NH3
+ 
(Acetate) 
d(0.5)
* 
(µm) 
N 0.09 ± 0.02
c
 4.79 ± 0.04
c
 2.36 ± 0.06
b
 0.86±0.01
b
 
U 0.87 ± 0.25
b
 6.19 ± 0.04
b
 3.38 ± 0.03
c
 2.62±0.08
c
 
M 1.2 ± 0.3
a
 0.82 ± 0.01
a
 0.74 ± 0.01
a
 0.55±0.00
a
 
S 1.3 ± 0.2
a
 0.78 ± 0.00
a
 0.78 ± 0.02
a
 0.63±0.01
a
 
*Maximum particle diameter below which 50% of the sample exists.  Values with different letters in 
the same column are significantly different at p-value p<0.001.  N, nanoparticulate MCM-41; U, 
UVM-7; M, microparticulate MCM-41; S, SBA-15. 
 
As the particles were incorporated into gelatine gels in a buffered aqueous 
dispersion, the size distribution and zeta potential of the particles were also 
determined in acetate buffer (pH 5.5). Figure 2a shows the size distribution of the 
four bare particles. A direct visual inspection allows us to distinguish two different 
groups of particles according to their size in water. On one hand, S and M 
exhibited a size distribution in the range 0.5-10 μm, while the size distribution of 
N and U ranged from 5 to 20 μm. When the single-particle size obtained by TEM 
and the size distribution obtained by the Mastersizer were compared (Table 2), it 
was stated that the particle size remained in the same range for S and M. 
However, the size increased dramatically in the case of N and U, passing from the 
nanoscale to the microscale. The size of different MSPs was also checked by 
CLSM, confirming that the particle size in a water suspension was in accordance 
with the size distribution measured by light diffraction (Fig 1, middle). 
  
Article 4 
 
185 
 
 
The size distribution of functionalized MSPs was also determined. Figure 2b,c 
shows the size distributions of #-C3 and #-N3 particles, respectively. For all MSPs, 
both types of functionalization resulted in a decrease in the particle size. This 
difference was more significant for N and U and more pronounced in the case of 
the functionalization with amines 
 
Figure 2. Size distribution of different MSPs dispersed in acetate buffer at pH 5.5. a) 
Microparticulated MCM-41. b) SBA-15. c) Nanoparticulated MCM-41. d) UVM-7. #: Bare particle. #-
C3: Carboxylate functionalised particle. #-N3: Amine functionalised particle. 
 
Finally, the morphology of bare and functionalized particles after being 
incorporated in gelatine gels was also characterized by CLSM. The third column of 
Figure 1 shows how the interaction of MSP with gelatine did not modify the size 
or shape of the particles, in comparison to the same particle in a buffer dispersion 
(Fig 1, middle). 
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3.2 Functionalization characterization 
 
The degree of functionalization of solids #-C3 and #-N3 was determined by 
thermogravimetric analysis (Table 2). As can be seen, similar functionalization was 
observed for the different materials when functionalized with N3 or C3. However, 
for a given material if C3 and N3 functionalization are compared, it is apparent 
from the data that the amount of N3 anchored to the particles (ca. 400 mg g-1 
SiO2) is greater than the amount of C3 (ca. 300 mg g
-1 SiO2). This was somehow 
expected and can be explained by taking into account that C3 is a bulkier molecule 
than N3. 
 
Table 2. Content of organic molecules anchored to the particles after functionalization. 
MSP Carboxylate functionalised  
(mg C3 g
-1
 SiO2) 
Amine functionalised  
(mg N3 g
-1
 SiO2) 
N 322 403 
U 347 442 
M 354 432 
S 332 425 
 
 
The efficiency of functionalization was also tested by zeta potential 
determinations. Figure 3 shows the zeta potential values of different MSPs 
suspended in acetate buffer. For bare particles, two groups could be 
distinguished. On one hand, S and M particles exhibited a zeta potential close to -
30 mV. On the other hand, U and N showed zeta potential values next to -10 mV. 
After functionalization with carboxylates, zeta potential values became more 
negative for all types of particles. In contrast, the zeta potential changed from 
negative to positive values after functionalization with amines, confirming the 
effect of the functionalization on the surface charge. For both kinds of 
functionalization, the zeta potential achieved a value of -30 or +30 mV. 
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Figure 3. Zeta potential values (Mean ± SD) of different bare (black), carboxylate functionalised (dark 
grey) and amine functionalised (light grey) MSP dispersed in acetate buffer (pH 5.5). N: 
Nanoparticulated MCM-41; U: UVM-7; M: Microparticulated MCM-41; S: SBA-15.  
 
Zeta potential measurements also explain the changes or preservation of 
particle size after functionalization. The general dividing line between stable and 
unstable suspensions is taken at either +30 or -30 mV. Particles with zeta 
potentials more positive than +30 mV or more negative than -30 mV are normally 
considered to be stable (Duman & Tunç, 2009). This fact explain why bare N and U 
(particles that exhibited a zeta potential of ca. -10 mV) increased its size 
dramatically from the nanoscale to the microscale in an aqueous suspension as a 
consequence of particle aggregation, while the particle distributions of S and M 
(zeta potential value of ca. -30 mV) remained in the same order. Values of the 
zeta potential also allowed us to explain why N and U decreased its size after 
functionalization with amines or carboxylates due to stability improvement. 
 
3.3 Effect of MSP on large deformation properties of the gelatine gel matrix  
 
The effect of the incorporation of different MSPs on the texture properties of 
gelatine gels was studied by a comparison of the modulus and fracture properties 
of gelatine gels containing different percentages of MSPs with those gels without 
particles.  
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3.3.1 Effect on the Young’s Modulus 
 
Figure 4 shows the Young’s modulus of gels containing different 
concentrations of bare and functionalized MSPs. The addition of the four types of 
bare MSPs (Fig 4a) did not modify the Young’s modulus significantly (p>0.5) at the 
concentrations studied. Although silicate species have been shown to interact 
through both electrostatic and hydrogen bonding interactions with some 
poly(amino acids) and proteins (Fernandes et al., 2011), the interactions with the 
polymeric matrix are ineffective at acidic pH (Coradin et al., 2004). Thus, because 
the gels under investigation were prepared at pH 5.5, interactions between bare 
MSP and gelatine are expected to be very weak. 
 
The same behavior was found for #-C3 particles (Fig 4b). However, when M-
N3, N-N3, and S-N3 were incorporated into the gel matrix, a significant increase in 
the Young’s modulus (p<0.05) was observed. The Young’s modulus of gels filled 
with U-N3 did not increase significantly. 
 
To be able to compare the effect of the kind of particle on the stiffness of the 
gels, values of the Young’s modulus of gels containing 0.75% of particles are 
plotted in Figure 4d. The figure shows no significant differences between gels 
filled with # and #-C3 particles. However, when gels were filled #-N3 particles, the 
effect of particle type was significant for M-, N-, and S-type particles. 
 
From these results, it could be concluded that neither the MSP type nor 
functionalization are able to affect the stiffness of the gels by themselves. 
However, when functionalization is able to decrease the size of a particle cluster, 
the particle type and amine or carboxylate functionalization become relevant to 
the final gel stiffness. This is in agreement with Fu et al. (2008) who described that 
there are three decisive factors determining the elastic modulus of a filled-
polymer gel: the elastic modulus of the filler and the matrix (the higher the elastic 
modulus of the filler, the higher the elastic modulus of the composite), the filler 
concentration, and the aspect ratio of the filler. Next to that, the interaction of 
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the filler with the matrix is an important factor, determining if the filler is active or 
inactive (Ring & Stainsby, 1982). In this particular case, the Young’s modulus of 
SiO2 is much higher than that of gelatine; however, the concentration of particles 
was not enough to raise the Young’s modulus. The most important factors were 
the size of the filler and the aspect ratio, justifying why M, N, and S made 
different contributions to the increase in the Young’s modulus. 
 
In neither case, the gel strength was negatively affected by the presence of 
the particles, indicating that the particles act as active filler. Especially for the #-
N3 particles, the interaction between particles and the gel matrix is expected to 
be strong. 
 
 
 
Figure 4. Effect of MSPs concentration on the Young’s Modulus of gelatine gels. a) Bare MSP, b) MSP 
functionalised with carboxylates. c) MSPs functionalised with amines, d) Comparison of values of 
Young’s Modulus at the concentration of 0.75%. N: Nanoparticulated MCM-41; U: UVM-7; M: 
Microparticulated MCM-41; S: SBA-15. #: Bare particle. #-C3: Carboxylate functionalised particle. #-
N3: Amine functionalised particle. 
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3.3.2 Effect on fracture stress 
The effect of MSPs content on fracture stress is shown in Figure 5. Bare MSPs 
(Fig 5a) did not modify the values of fracture stress and thus did not affect the gel 
strength. However, when particles were functionalized with carboxylates or with 
amines (Fig 5b,c), particles contributed to the increase in the final gel strength 
proportionally with concentration. In spite of the functionalization, U was the 
particle that contributed to the gel strength in a less pronounced manner. In 
contrast, N contributed the most to fracture stress values. Bearing in mind that U 
formed large aggregates that did not significantly modify their size as a 
consequence of the functionalization and that N aggregates decreased noticeably 
the size after functionalization, the importance of particle size on fracture stress 
values is confirmed. Figure 5 also displays the dependence of particle 
concentration on gel strength since for each particle a minimum concentration is 
needed to vary the value of fracture stress significantly. 
 
According to these results, it could be stated that the particle size, particle 
concentration, and organic functionalization are the three parameters that affect 
the strength of the filled gels. 
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Figure 5. Effect of MSP concentration on the Fracture Stress of gelatine gels. a) Bare MSP, b) MSP 
functionalised with carboxylates. c) MSP functionalised with amines, d) Comparison of values of 
Young’s Modulus at the concentration of 0.75%. N: Nanoparticulated MCM-41; U: UVM-7; M: 
Microparticulated MCM-41; S: SBA-15. #: Bare particle. #-C3: Carboxylate functionalised particle. #-
N3: Amine functionalised particle. 
 
3.3.3 Effect on fracture strain 
Figure 6 shows the effect of MSPs concentration on the fracture strain of 
gelatine gels. As occurred for the Young’s modulus and fracture strain, the 
addition of different concentrations of the four types of bare MSPs did not 
provoke significant changes in fracture strain values. Instead, gels filled with 
functionalized MSPs exhibited a significant increase (p<0.005) in the fracture 
strain in comparison to the control gel. The presentation of values of fracture 
strain for gels filled with different bare and functionalized particles on the same 
graph (Fig 6d) confirmed that the highest fracture strain values are apparent in 
gels filled with particles functionalized with amines, followed by gels filled with 
particles functionalized with carboxylates. Accordingly, it could be concluded that 
the functionalization is more important than the particle size or shape for fracture 
stress. 
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This improvement of the strain at the fracture of a polymer network by the 
incorporation of hybrid nanofillers (inorganic nanoparticles with organic surface) 
has also been reported by other authors (Tjong, 2006) and is related to a better 
filler-matrix interaction, increasing the integrity and stability of the gel and thus 
making it withstand more deformation before energy dissipates via (micro-) 
fracture events. 
 
 
 
Figure 6. Effect of MSPs concentration on Fracture Strain of gelatine gels. a) Bare MSPs, b) MSPs 
functionalised with carboxylates. c) MSPs functionalised with amines, d) Comparison of values of 
Young’s Modulus at the concentration of 0.75%. N: Nanoparticulated MCM-41; U: UVM-7; M: 
Microparticulated MCM-41; S: SBA-15. #: Bare particle. #-C3: Carboxylate functionalised particle. #-
N3: Amine functionalised particle. 
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3.3.4 Effect of particle size and surface modification on the filler-matrix interaction 
Two ideas are clear after evaluating the effect of the addition of #, #-C3, and 
#-N3 particles at concentrations from 0 to 1% on the textural properties of 
gelatine gels. On one hand, organic functionalization is needed to improve the 
Young’s modulus and fracture properties, while on the other hand, a minimum 
concentration of particles (different for each kind or particle) should be achieved 
to observe this phenomenon. 
 
Figure 7 tries to explain graphically the influences of particle size, shape, and 
surface modification on the filler-matrix interaction. Bare particles that are next to 
the instable zone tend to aggregate. Moreover, at acidic pH, interactions between 
bare MSP and gelatine are expected to be very weak (Fig 7a). After carboxylate 
and amine functionalization, particles add organic molecules to their surface and 
achieve a zeta potential that is able to stabilize the particle, reducing the 
aggregation tendency. These organic molecules also improve the compatibility 
between the particle and the protein matrix and generate an interfacial area in 
the surroundings of the particles (Fig 7b). The interfacial area consists of 
immobilized proteins whose structure and properties change because of the 
interaction with the particles (Pitsa & Danikas, 2011; Tjong, 2006). 
 
Large particles or small concentration will result in a small absolute number 
of particles embedded in the matrix. A small number of particles implies that the 
relative distance between them is too large and the interfacial area of each 
particle remains isolated from the rest (Fig 6b). For small particles or high volume 
fractions, the interfacial areas of each particle start to overlap (Fig 7c), resulting in 
an intensification of the interactions (Vaia & Wagner, 2004) and reinforcing the 
protein network and thus increasing both the Young’s modulus and fracture 
properties. 
 
Chapter 2 
 
194 
 
 
Figure 7. a) Scheme of the structure of a filled gel: bare MSPs (red spheres). b) Interfacial area 
formation (diffuse layer in particle surroundings) under low concentration of functionalised particles 
(large distance between interfacial areas). c) Interfacial area formation under high concentration of 
functionalised particles (overlap of interfacial areas, increase of bounding between layers). 
 
 
3.4 Effect of MSPs on gel turbidity of the gelatine gel matrix 
 
The effect of bare and functionalized MSPs at different concentrations on the 
turbidity of filled-gelatine gels expressed as the percentage of transmittance is 
shown in Fig 8. Nonfilled gels exhibited values of transmittance of 92 ± 2%. The 
subsequent addition of bare or functionalized MSPs decreased the transmittance 
of the sample as a function of particle concentration, thereby increasing the 
turbidity of the gel. At low concentrations (0.1 and 0.25%), Fig 8 allows us to 
evaluate most explicitly the different contribution of each particle to the final 
turbidity. This is consistent with light-scattering theory, which states that for 
moderately dilute suspensions of particles there is an exponential decrease in 
transmitted light with particle concentration (Gregory, 1998). However, from 
concentrations of up to 0.5% particles, the turbidity dramatically increases to 
achieve transmittance values close to 0. 
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Figure 8. Effect of MSPs concentration on gel turbidity expressed as % of transmittance. a) Bare 
MSPs, b) MSPs functionalised with carboxilates. c) MSPs functionalised with amines, d) Comparison 
of transmittance at the concentration of 0.1%. N: Nanoparticulated MCM-41; U: UVM-7; M: 
Microparticulated MCM-41; S: SBA-15. #: Bare particle; #-C3: Caroxylate functionalised particle; #-
N3: Amine functionalised particle 
 
 
To understand the effect of particle size, shape, and functionalization on gel 
turbidity, values of the turbidity of gels filled with 0.1% particles have been 
plotted separately in Figure 8d. This figure shows that gel turbidity is related to 
the particle size determined with the Mastersizer so that the contribution of small 
particles to final turbidity is higher than that of large particles. A greater absolute 
number of particles provokes a larger decrease in transmitted light. Since the 
gelatine gels are prepared based on the mass concentration of the MSP, for the 
same mass concentration there are more small particles and the transmitted light 
decreases more drastically. 
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This effect is corroborated by the fact that particles that did not alter their 
size significantly as a function of functionalization (S and M) maintained turbidity 
values independent of the functionalization. Gels filled with particles that changed 
their size by functionalization (N and U) exhibit a different turbidity when the 
particles are functionalized with amines and thereby reduced their size 
significantly. 
 
Thus, the incorporation of MSPs into gelatine gels affects the gel turbidity 
as a function of particle size and concentration, providing gel opacity at 
concentrations of up to 0.5% MSP present. To obtain transparent filled gels, a 
lower particle concentration would be needed. 
 
4. Conclusions 
 
In this study, four different MSPs have been successfully functionalized, 
characterized, and incorporated into gelatine gels. The characterization process 
stated that particles experience a significant change in their aggregation tendency 
after carboxylate or amine functionalization, therefore modifying their 
particle/cluster size. Particle functionalization also creates an organic layer on the 
surface of the particle that improves the filler-matrix interaction. This causes an 
increase in the Young’s modulus, fracture stress and fracture strain, more or less 
pronounced depending on the type of particle, functionalization and 
concentration. Gelatine gels filled with bare particles at concentrations between 0 
and 1% maintain their textural properties. The most affected property is turbidity, 
which increases with the addition of both bare and functionalized MSPs. These 
findings lead us to conclude that the mechanical properties of the filled gels 
remain or improve with the addition of MSPs and that although not being suitable 
for transparent systems, MSPs are promising delivery systems able to be 
incorporated in foodlike products. 
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Abstract 
 
In this work, we have studied the ability of a mesoporous silica support 
loaded with folic acid and functionalized with amines (S1) to modulate the 
bioaccessibility of the vitamin after its incorporation in stirred yoghurts with 
different fat content. Due to the novelty of using mesoporous silica supports in 
food matrixes, the influence of S1 addition on the physicochemical, rheological 
and lactic acid bacteria viability of these yoghurts during 21 days of refrigerated 
storage at 4°C has also been evaluated. The in vitro digestion procedure showed 
that S1 was capable of inhibiting the release of folic acid in acidic solution at pH 2 
(stomach) and controllably release their contents in neutral pH (intestine), 
thereby modulating the bioaccessibility. Moreover, the physicochemical and 
microbiological assays revealed that enrichment generally does not alter the 
physicochemical properties (pH, colour, syneresis and rheology) of either type of 
yoghurt and does not cause any effect on lactic acid bacteria survival.   
 
Keywords: Folic acid, enrichment, yoghurt, smart delivery system, bioaccessibility. 
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1. Introduction 
Folate status of women all over the world is a public-health challenge. Folate 
deficiencies during pregnancy are the cause of birth defects such as neural tube 
defects. In other stages of life, folates are  responsible for lowering the 
homocystein-level as well having an impact on preventig cardiovascular diseases 
(Lucock, 2000; Choi & Mason, 2002; Pitkin, 2007), Alzheimer (Clarke et al., 1998), 
arteriosclerotic disease (Hoag et al., 1997), or a disruption of the nucleotide 
biosynthesis which can result in colon and colorectal cancer (Choi & Mason, 2002; 
Stover, 2004).  
 
In spite of the public-health campaigns in recent years, a sizeable proportion 
of women of reproductive age remain unaware of the need to take folic acid (FA) 
periconceptionally. The most vulnerable groups are women who have unplanned 
pregnancies, young people and less-educated people. The only way to reach this 
group of women might be through fortification or enrichment of foods with FA 
(Eichholzeret al., 2006). The incorporation of this vitamin into general accepted 
and consumed products could lead to improvements in vulnerable groups.  
 
Although there are irrefutable evidences about the benefits of FA 
supplementation to prevent some diseases, recent studies suggest that massive 
exposure to high bioavailable FA is a double-edged sword. Humans have a 
reduced dihydrofolate reductase activity and a poor ability to reduce FA. Thus, 
oral doses of FA of about 260-280 μg (589-634 nmol) have been reported to lead 
to the direct appearance of untransformed FA in the systemic circulation. This is 
related to a possible role in certain cancer development (Lucock &Yates 2009).  
 
In this context, as an alternative to traditional free FA supplementation, we 
recently presented a system based on the encapsulation of FA in a mesoporous 
silica support functionalized with amines to dose FA along a simulated digestion 
process (Pérez-Esteve et al., 2015). The FA loaded and amine functionalised 
support, not only was able to hinder the release of the vitamin during the passage 
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across the stomach (simulated gastric fluid), but also was able to deliver 
progressively the vitamin when reaching the jejunum (simulated intestinal fluid), 
where it is completely absorbed (Sculthorpe et al., 2001; Younis et al., 2009), 
using a minimal quantity of the encapsulating support. Mesoporous silica supports 
are considered potential colloidal carriers with many unique features that make 
them excellent candidates for a broad range of biomedical applications, and have 
very good in vivo biocompatibility and biodegradability (Hamam & Al-Remawi, 
2014). 
 
Of all kinds of food, dairy products such as yoghurts and other fermented 
milks are great candidates to be enriched with FA. On the one hand, it is well 
known that dairy products and fermented milks are highly recommended during 
pregnancy, as they are a great source of vitamins A, B, D and E, protein and 
calcium (FAO, 2013). However, FA content in these products is negligible. On the 
other hand, dairy products have very good qualities to become enriched and/or 
fortified foods, since incorporation of nutrients is very simple, and hence the large 
number of functional dairy products have been developed to date (Estrada et al., 
2011; Vélez-Ruiz et al., 2013; Perna et al., 2014). 
 
Among dairy products, yoghurt, produced by symbiotic cultures of 
Streptococcus thermophilus and Lactobacillus delbrueckii ssp. bulgaricus, is the 
most popular and consumed due to its association with good health (Ramírez-
Sucre & Vélez-Ruiz, 2013; Wang et al., 2014; Tripathi & Giri, 2014). Moreover, 
stirred yoghurts, in which their structure is disintegrated by shearing processes 
before packing, facilitates the incorporation of new ingredients such us fruits, 
fibers and others relevant compounds. Finally, its pH close to 4, which makes it an 
appropriate matrix to incorporate porous matrices with molecular gates that 
respond to pH changes.  
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A significant body of research has focused on the evaluation of the influence 
of the addition different ingredients (minerals, dietary fiber, flavours, etc.) on the 
physicochemical properties of yoghurt (Achanta et al., 2006; Ramirez-Santiago et 
al., 2010; Ramirez-Sucre & Vélez-Ruiz, 2013). However, as far as we know, there 
are no studies dealing with the incorporation of smart delivery systems based on 
mesoporous silica supports on food matrixes. Thus, no data about the 
maintenance of controlled release efficiency after incorporation in real systems, 
as well as data related to the effect of MSPs on the physico-chemical properties of 
dairy products or on lactic acid bacteria viability are available.  
 
The objective of the present work was to evaluate the ability of the smart 
delivery system (S1) to modulate the bioaccessibility of FA once incorporated in 
different fat containing yoghurts, as well as to study the influence of S1 addition 
on the physicochemical and microbial quality of yoghurts during cold storage. 
2. Materials and methods 
2.1 Materials 
 
Tetraethylorthosilicate (TEOS), triethanolamine (TEAH3),  N-
cetyltrimethylammonium bromide (CTABr), sodium hydroxide (NaOH), the  
organosiloxane derivative N1-(3-Trimethoxysilylpropyl)diethylenetriamine (N3), 
acetic acid, sodium phosphate monobasic, sodium phosphate dibasic, 
tetrabutylammonium hydrogen sulphate (TBAHS) and acetic acid were provided 
by Sigma-Aldrich (Poole, Dorset, UK). Folic acid (FA) was purchased from Schircks 
Laboratories (Jona, Switzerland). Acetonitrile HPLC grade was provided by 
Scharlau (Barcelona, Spain). 
 
Two types of stirred yoghurts, low-fat (LF) and full-fat (FF) (Senoble, Ocaña, 
Spain) were used as raw material. Yoghurts were acquired in a local supermarket 
in 500 mL containers. The expiry date was superior to 21 days in all the cases. In 
LF and FF yoghurts the protein, carbohydrate and fat content were 4.7-4.1%, 12.2-
5.3%, and 3.4-0.1% respectively.  
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2.2 MSPs preparation and characterization 
 
Microparticulated MCM-41 particles were synthesized following the so-called 
“atrane route”, according to the method described by Pérez-Esteve et al. (2015). 
The route is based on the use of triethanolamine ligands as hydrolytic inorganic 
precursors and surfactants as porogen species. In a typical synthesis, 9.36 g of 
CTABr were added at 118 °C to a solution of TEAH3 (52.4 g) containing 0.98 g of 
NaOH in 2 mL of water. Formerly, 0.098 mol of a silatrane derivative (22 mL of 
TEOS) was added at 70 °C to the mixture. Finally, 180 mL of deionised water were 
added while being vigorously stirred at 70 °C. After a few minutes of stirring, a 
white suspension was formed. This mixture was aged in an autoclave at 100 °C for 
24h. Using filtration, the resulting powder was collected and then it was washed 
with water and ethanol. The solid was dried at 70 °C. To prepare the final porous 
material (S0), the as-synthesised solid was calcined at 550 °C for 5 h to remove 
the template phase. 
 
FA was loaded in support S0 by the impregnation method described by 
Pérez-Esteve et al. (2015). For this purpose, 15 mg of FA dissolved in 1.5 mL of 
phosphate buffer solution (PBS) were added to 100 mg of MCM-41 employing 3 
cycles of addition (0.5 mL per cycle). After each addition cycle, solid was dried at 
30 ºC to eliminate water content.  
 
The loaded solid was functionalized with N3. In a typical synthesis, 100 mg of 
the solid were suspended in 10 mL of a solution of acetic acid 5%, where an excess 
of N3 (0.43 mL, 0.015 mmol) was added. The mixture was stirred for 5.5 h at room 
temperature. The final loadead and amine-gated solid (S1) was isolated by 
vacuum filtration, washed with 300 mL of acetic acid solution, and dried at 30 °C 
for 24 h. 
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The characterization of the different mesoporous solids (S0 and S1) was 
made by powder X-ray diffraction (XRD), transmission electron microscopy (TEM), 
field emission scanning electron microscopy (FESEM), particle size distribution and 
zeta potential determinations. XRD was performed on a D8 Advance 
diffractometer (Bruker, Coventry, UK) using CuKα radiation. TEM images were 
obtained with a JEM-1010 (JEOL Europe SAS, Croissy-sur-Seine, France). FESEM 
images were acquired with a Zeiss Ultra 55 (Carl Zeiss NTS GmbH, Oberkochen, 
Germany) and observed in the secondary electron mode. The particle size 
distribution was determined using a Malvern Mastersizer 2000 (Malvern 
Instruments, Malvern, UK). For the measurements, samples were dispersed in 
distilled water. Data analysis was based on the Mie theory using refractive indices 
of 1.33 and 1.45 for the dispersant and particle, respectively. An adsorption value 
of 0.001 was used for all samples. Variation of this adsorption value did not 
significantly alter the obtained distributions. Measurements were performed in 
triplicate. A Zetasizer Nano ZS (Malvern Instruments, Malvern, UK) was used to 
determine the zeta potential (). Samples were dispersed in distilled water at 
concentration of 1 mg mL-1. The zeta potential was calculated from the particle 
mobility values by applying the Smoluchowski model. The measurement was 
performed at 25°C. Measurements were performed in triplicate. The composition 
of S1 was determined by thermogravimetrical analysis (TGA) and 1H NMR. 
Thermogravimetric analyses were carried out on a TGA/SDTA 851e Mettler Toledo 
balance, using an oxidant atmosphere (air, 80 mL min-1) with a heating program 
consisting of a heating ramp of 10 ºC per minute from 393 to 1273 K and an 
isothermal heating step at this temperature for 30 min. 1H NMR spectra were 
recorded in at RT using a Bruker AV400 spectrometer after dissolving the sample 
in NaOD/D2O in the presence of tetraethyl ammonium bromide as internal 
standard. 
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2.3 Folic acid release study 
 
To determine the effect of pH in FA release from the amine-gated 
mesoporous silica particles (S1), 10 mg of the corresponding solid were placed in 
25 mL of water at pH 2 (adjusted with HCl), pH 4 (adjusted with HCl and with lactic 
acid) and pH 7.5 (PBS). At a certain times aliquots were separated, filtered and 
analysed by HPLC to quantify the amount of FA. 
 
The maximum release capacity of the solid S1 was determined by quantifying 
the amount of FA released after reaching the equilibrium (2h at pH 7.5). This 
released FA amount was used to quantify the amount of solid S1 needed to 
provide the dietary reference intake (DRI) of FA in the population most in need of 
this nutrient (360 µg of synthetic FA per day in pregnant women) (Eichholzer et 
al., 2006). 
2.4 Sample preparation 
 
Three different batches of samples were prepared for low-fat (LF) and full-fat 
(FF) yoghurts. Yoghurts without enrichment were considered control samples (C). 
Enriched yoghurts containing the 100% of the DRI of FA by addition of free FA 
were called EF (enriched with free FA). Yoghurts containing the amount of S1 
needed to release 100% of the DRI of FA were called EE (enriched with 
encapsulated FA in S1). After addition of free FA or S1, yoghurts were stirred for 1 
min. In C yoghurts the same stirring procedure was performed to standardize 
conditions. Samples were then stored at 4 °C until they were analysed (0, 7 and 21 
days). The sample preparation procedure is schematically shown in Figure 1. 
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Figure 1. Scheme of sample preparation.  
 
2.5 Yoghurts in vitro digestion and FA bioaccessibility determination 
 
FA bioaccessibility from EF and EE yoghurts was determined by simulating a 
human digestion in mouth, stomach and small intestine adapting the procedure 
described by Versantvoort et al. (2005)1. The large intestinal track was not taken 
into account since in vivo FA absorption occurs throughout the jejunum (Younis et 
al., 2009). In a typical experiment, 5 g of the corresponding yoghurt were 
suspended in 6 mL of saliva and incubated for 5 min at 37 °C. Then, 12 mL of 
gastric juice were added. The mixture was incubated for 2 h. Finally, 12 mL of 
duodenal juice, 6 mL of bile, and 2 mL of bicarbonate solution (1M) were added 
simultaneously. After the addition, the mixture was maintained under stirring at 
37 oC for 2 h. All digestive juices were heated to 37 oC before being mixed. During 
this period, aliquots were taken, filtered using nylon filters with 0.45 m pore size 
(Scharlab, Barcelona, Spain) and analysed by HPLC to determine the amount of FA 
(vide infra). All chemicals for the digestive fluids were provided by Sigma-Aldrich 
(Poole, Dorset, UK). 
  
                                                          
1
 See composition of the fluids in appendix 3 (page 257) 
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2.6 Folic acid quantification 
 
FA was quantified by reversed-phase HPLC according to the method 
described by Pérez-Esteve et al. (2015). The HPLC instrument consisted of a 
Hitachi LaChrom Elite liquid chromatograph (Hitachi Ltd., Tokyo, Japan) equipped 
with an auto-sampler (modul L-2200) and UV detector (modul L-2400). A column 
Kromaphase 100 C18 (250 mm x 4.6 mm i.d., 5 m particle size analytical column) 
(Scharlab, Barcelona, Spain) was used for the separations. Mobile phase consisted 
of (A) 0.125 mM of NaH2PO4, 0.875 mM of Na2HPO4 and 0.4 mM of TBAHS in 
water and (B) acetonitrile-phase A 65:35 (v/v). The gradient program was as 
follows: the mobile phase was run isocraticaly for the first 5 min with 90% A and 
10% B. The percentage of B was increased linearly to reach 36% at 15 min and 
60% at 30 min. After that, percentage of B decreased linearly to the original 
composition in 5 min and remained in the initial conditions for 5 min. The 
wavelength of the UV detector was established at 280 nm. FA was quantified 
according to the external standard method using a calibration curve of the peak 
area against concentration of the compound. 
2.7 Physicochemical analysis  
 
2.7.1 pH, syneresis and colour determinations 
 
The pH measurements were performed using a pH meter (Crison Basic 20 +, 
Crison Instruments SA, Barcelona, Spain) with puncture electrode. pH 
measurements were taken directly on yoghurt samples in triplicate. 
 
For syneresis determinations, 20 g of yoghurt were centrifuged at 8000 rpm 
and 4 oC for 10 min in a 5804 Eppendorf centrifuge (Eppendorf, Hamburg, 
Germany). After centrifugation, the released serum was poured off, weighed and 
recorded as percentage of weight to the original weight of yoghurt in triplicate. 
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Colour values were obtained by measuring the reflection spectrum (Minolta, 
CM 3600D, Tokyo, Japan). CIE Lab uniform colour space was selected to calculate 
colour parameters L* (brightness), a* (red-green), b*(yellow-blue) using a 10° 
observer and D65 illuminant. The total colour differences between C and EE 
yoghurts were calculated using Eq 1. Five replicates were carried out for each 
sample. 
   ∆𝐸 = √∆𝐿∗2 + ∆𝑎∗2 + ∆𝑏∗2                             (1) 
2.7.2 Rheological determinations 
 
The rheological analyses were carried out on a controlled stress rheometer 
(RheoStress, Thermo Haake, Karlsruhe, Germany). The flow curves and the 
oscillatory assays were performed using concentric cylinder (6 cm diameter; 1 mm 
gap). The yoghurts were loaded on the inset plate and the temperature was 
maintained at 4 ± 0.1 °C during the tests. All trials were carried out in triplicate. 
The flow curves were determined by performing shear rate sweeps from 0 to 
300 s-1.  Three consecutive rising and falling cycles were made in order to evaluate 
and eliminate the effect of thixotropy. The thixotropic behaviour of the samples 
was evaluated by estimating the hysteresis loop area (Aup - Adown) between the 
upward (Aup) and downward (Adown) flow curves using the program RheoWin Data 
Manager (version 3.61, Thermo Haake). The experimental data obtained in the 
third down sweep were adjusted to the Herschel-Bulkley model for non-
Newtonian fluids (Eq 2). 
                 𝜎 = 𝜎0 + 𝐾𝛾
𝑛             (2) 
where σ0   is yield shear stress (Pa), K   the consistency index (Pa s
n), γ the 
deformation rate (s-1), and n the flow behaviour index (dimensionless). The yield 
stress value used in Herschel-Bulkley’s model was previously obtained by fitting 
the experimental data to the Casson model (Eq 3) (Tárrega & Costell, 2007). All 
measurements were carried out in triplicate. 
         𝜎0.5 = 𝜎0
0.5 + 𝐾𝛾0.5            (3) 
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2.8 Determinations of microbial viability 
To evaluate the effect of solid S1 addition on the viability of lactic acid 
bacteria naturally present in the yoghurts (i.e. Lactobacillus delbrueckii ssp. 
bulgaricus and Streptococcus thermophilus) viable cell counts were performed in 
control (LF-C and FF-C) and enriched with S1 yoghurts (LF-EE and FF-EE). 1 mL of 
yoghurt was diluted in 9 mL of 0.15% sterile buffered peptone water (Scharlau, 
Barcelona, Spain). The mixtures were thoroughly stirred and serial dilutions were 
prepared and plated on selective agar in duplicate. These selective media were 
Man, Rogosa, and Sharpe agar (MRS) (Scharlau, Barcelona, Spain) and 0.5% 
lactose M-17 media (Sigma-Aldrich, Poole, Dorset, UK) for enumeration of L. 
delbrueckii and S. thermophilus, respectively. The inoculated plates were 
incubated at 30 °C for 48 h in anaerobic conditions for the growth of L. delbrueckii 
ssp. bulgaricus by introducing the plates in anaerobic jars with gas pack 
AnaeroGen (Oxoid, Cambridge, UK). The plates with selective media for S. 
thermophilus were incubated in aerobic conditions at 37 °C for 48 h. Results were 
expressed as log colony-forming units (CFU) mL-1. 
2.9 Statistical analysis 
The differences between the samples due to the type of yoghurt, the 
addition of particles and the time of storage were determined by analysis of 
variance (ANOVA multifactorial), with a confidence level of 95% LSD (p<0.05). The 
statistical program used was Statgraphics Centurion XV (Manugistics Inc., 
Rockville, MD, USA). 
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3. Results  
3.1 Support S1. Synthesis and characterization 
 
In a first step, MCM-41 support was synthesised following well-known 
procedures using N-cetyltrimetylammonium (CTABr) as a structure director agent 
and tetraethylorthosilicate (TEOS) as a silica source. After removal the surfactant 
by calcination the starting MCM-41 support was obtained. Then, the pores of the 
MCM-41 support were loaded with FA. Finally, the FA-loaded support was reacted 
with N1-(3-Trimethoxysilylpropyl)diethylenetriamine resulting the capped mateial 
S1.  
 
The prepared solids were characterized according to standard techniques. 
Figure 2 shows the powder X-ray diffraction (XRD) patterns of the solids MCM-41 
as synthesised, MCM-41 calcined (S0) and the final mesoporous solid loaded with 
FA and functionalized with N3 (S1). The XRD of MCM-41 as-synthesised (curve a) 
shows the typical low-angle reflections of a hexagonal ordered array indexed as  
(1 0 0), (1 1 0), (2 0 0) and (2 1 0) Brag peaks. In curve b, corresponding to the 
MCM-41 calcined sample, a significant shift of the reflections in the XRD is clearly 
observed. This displacement is consistent with a cell contraction of ca. 5.5 Å and 
attributed to the condensation of silanol groups during the calcination step. The 
reflections of the S1 were practically lost due to the presence of FA in the pores. 
However, the permanence of the (1 0 0) peak indicate that the process of pore 
loading with FA, and the additional functionalization with the polyamine, did not 
modify the typical porosity of the mesoporous MCM-41 scaffold. 
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Figure 2. Powder X-ray patterns of the solids (a) MCM-41 as-synthesized, (b) MCM-41calcined (S0), 
and (c) MCM-41 loaded with FA and functionalised with N3 (S1). 
 
 
A morphologic analysis of both, S0 and S1, was performed by TEM and 
FESEM studies. Figure 3 shows that MCM-41 supports are irregular-shaped 
microparticles (Fig 3a) with porous in the range 2-3 nm (Fig 3b). Figures 3c and 3d 
revealed the preservation of morphology and the mesoporous structure in the 
final S1 solid. The particle size was confirmed by particle size analysis. S0 exhibited 
a particle size diameter (dv90) of 0.98 m. An average particle size of 0.90 m was 
observed for solid S1. 
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Figure 3. FESEM and TEM images of solids S0 (a,b) and S1 (c,d). 
 
 
The different prepared solids were also characterised by zeta potential 
determinations. Figure 4 shows zeta potential values of S0, S0 loaded with FA and 
the final S1 solid. For both, S0 and S0 loaded with FA, zeta potential achieved 
negative values of ca. -40 mV. After functionalization with amines, zeta potential 
changed from negatively to positively values (ca. 40 mv), confirming the effect of 
the functionalization on the surface charge. Content of organic matter obtained 
from elemental and thermogravimetric analysis revealed that 1 g of S1 contains 
97 mg of FA and 63 mg of N3, confirming the efficiency of FA loading as well as N3 
functionalization.   
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Figure 4. Zeta potential values (Mean ± SD) of S0 (light grey), S0 loaded with FA (dark grey) and S1 
(black). 
3.2 S1 delivery profile at different pH and maximum FA delivery calculations 
 
In order to confirm the feasibility of the FA-loaded N3-functionalised solid S1 
to modulate FA release as a function of the pH of the medium, several release 
experiments were carried out. FA release profiles from S1 at different pH values 
(pH 2 and 4 adjusted with HCl, 4 adjusted with lactic acid and PBS at pH 7.5) are 
shown in Figure 5. At pH 2 (stomach pH) a maximum release of 1 g mg-1 of FA 
(1.10 % of the maximum delivery) was reached at 4 h confirming that FA delivery 
was hindered by the effect of the low solubility of FA at acidic conditions and by 
the effect of the amines anchored to the surface of the silica support. At low pH, 
polyamines are transformed to polyammonium groups which favoured Coulombic 
repulsions among closely located polyammonium groups. These adopt a rigid-like 
conformation that block the pores and avoid the release of the vitamin 
(Bernardos et al., 2008). 
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When the release was performed in water adjusted to pH 4 with HCl a slight 
delivery of FA from the pores was observed. However it is well known that large 
anions are able to interact with the protonated polyamines forming strong 
complexes which increased pore blockage and enhanced the inhibition of the 
cargo release (Casasús et al., 2008). Having this in mind a release assay from S1 
was also performed in water solution adjusted at pH 4 with lactic acid. In these 
conditions, delivery was almost zero (ca. 2%). This experiment confirmed that the 
gate-like superstructure based in polyamine/polyammonium groups was 
additionally closed by a cooperative effect of pH and the presence in the solution 
of bulky anions such as lactate (Bernardos et al., 2008).  
 
At pH 7.5 a sustained delivery of FA was achieved in the first 2 h. The amount 
released in these conditions (i.e. 94 g mg-1) was considered 100% of the FA that 
could be released from S1. The mechanism that allows this sustained release of FA 
from S1 at neutral pH has been previously described by Pérez-Esteve et al. (2015). 
At pH 7.5 amines are less protonated and Coulombic repulsion between them and 
affinity for anions is significantly reduced. The overall effect results in a less 
effective pore blockage and in a FA delivery. On the other hand, it is known that at 
neutral pH, FA increases its solubility and this helps its delivery from the pores 
(Pérez-Esteve et al., 2015).  
 
This overall behaviour of FA release from S1 as a function of pH would 
modulate the bioavailability of FA along the digestive tract. Under yoghurt and 
stomach conditions (acidic pH) amines are protonated preventing delivery of the 
vitamin. However when the yoghurt reach the intestine, molecular gates would 
open by effect of pH changes and FA would escape from S1 in a sustained manner 
throughout the intestinal tract avoiding peaks of FA concentration. This 
mechanism would protect FA from the harsh conditions of the stomach, yet 
would favour a controlled release in the intestine.  
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Figure 5. Release profiles of S1 in water adjusted at pH 2 with HCl (- -○- -), at pH 4 with HCl (- -▲- -), 
at pH 4 with lactic acid (—∆—) and PBS at pH 7.5 (—●—). Values are Means ± SD. n=3  
 
The maximum amount of FA released from S1 was calculated from the 
release profile at pH 7.5 (Fig 5) via the determination of FA concentration after 
reaching maximum delivery (4 h). At this time, 1 mg of solid S1 releases 94 g of 
FA. In USA, the DRI for FA is stablished in 400 µg folate day-1 in adults and 600 µg 
folate per day in pregnant woman (USDA, 2010). In Europe, the European Food 
Safety Authority (EFSA) recommends a daily intake of 200-400 µg folate per day 
for adults and additional 400 µg folate per day in pregnant woman (ESFA, 2009). 
Taking into account that the bioavailability of synthetic FA is approximately twice 
that of folate found in food, the dietary folate equivalent (DFE) establishes the 
relation between dietary folate and FA from supplements. One DFE is defined as 1 
μg of dietary folate, 0.6 μg of FA supplement, or 0.5 μg of FA taken without food 
(Suitor & Bailey, 2000). Therefore to provide 360 g FA (i.e. 600 g of DFE) in only 
one standard portion of yoghurt (125 g), 3.8 mg of S1 should be added to prepare 
enriched yoghurts with FA with controlled bioaccessiblity.   
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3.3 Bioaccessibility of FA during yoghurts in in vitro digestion 
 
In order to evaluate the effect of FA encapsulation to control the 
bioaccessibility of the vitamin, the release behaviour of yoghurts enriched with 
free FA (LF-EF and FF- EF) were compared with yoghurts enriched with an 
equivalent amount of FA encapsulated in S1 (LF-EE and FF- EE). 
 
Figure 6 shows that in the four samples a very low amount of FA was 
detected during the first two hours of digestion, corresponding with the oral and 
stomach phase. The oral phase is too short to solubilize and extract FA entrapped 
in the yoghurt matrix. This explains why FA was no detected in saliva neither in 
yoghurts containing free nor encapsulated FA. Besides during the gastric phase FA 
remained mainly insoluble and thus bioinaccessible (Pérez-Esteve et al., 2015).  
 
After the addition of the intestinal juices (2 h), two different release 
behaviours were observed. Yoghurts containing free FA showed a fast increase of 
the bioaccessibility after the addition of intestinal juices that would provoke 
absorptions peaks. In contrast, samples containing encapsulated FA in S1 
exhibited a sustained release of the vitamin along the digestion time. This 
modulation of the bioaccessibility would control the bioavailability, favouring the 
metabolization of FA before reaching the bloodstream. This experiment confirms 
the suitability of the S1 for modulating the bioaccessibility of FA in real food 
matrixes. The mechanism of action of the novel smart delivery system is 
schematised in Figure 7. 
 
No differences on FA bioaccessibility between LF and FF yoghurts were 
observed. Moreover, no statistically significant differences were found in the 
release behaviour of yoghurts with different storage times, confirming the 
stability of solid S1 in the yoghurt matrix.  
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Figure 6. Bioaccessibility of FA during an in vitro digestion procedure in low-fat (LF) and full-fat 
yoghurts (FF) at 0, 7 and 21 days of storage.  EF yoghurts are represented with black dots; EE 
yoghurts with grey dots. I: oral phase; II: gastric phase; III: small intestine phase.  n=3 
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Figure 7. Illustration of the mechanism of action of the smart delivery system S1 when included in 
yoghurts and ingested 
3.4 Effect of S1 addition on the physicochemical properties of yoghurt during 
refrigerated storage 
 
The effect of the incorporation of S1 on the physicochemical properties of 
yoghurts was also studied. pH, syneresis, colour and rheology values of yoghurts 
containing S1 (LF-EE and FF-EE) were compared with those of yoghurts without 
gated mesoporous particles (LF-C and FF-C).  
 
3.4.1 pH, syneresis and colour 
 
pH values ranged from 4.08 to 4.35 in LF yoghurts and from 4.2 to 4.5 in FF 
yoghurts along the 21 days of refrigerated storage. These values are similar to 
those reported by other authors for LF and FF yoghurts (Al-Sheraji et al., 2012; 
Cruz et al., 2013) and suggest a poor post-acidification process, a desirable 
characteristic in a modern yoghurt industry. This fact is related to the choice of 
the metabolism of lactic culture used (Cruz et al., 2013). The addition of S1 did not 
affect pH in neither of both LF or FF yoghurts. 
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Syneresis values of different yoghurts are shown in Figure 8. C samples 
exhibited syneresis values of ca. 47 and ca. 52 for LF and FF yoghurts, respectively. 
These values are similar to those reported by other authors (Brennan & Tudorica, 
2008; Ramirez-Sucre & Vélez-Ruiz, 2013). For each type of yoghurt, the lowest 
syneresis values were found in samples analysed on the day 0 of storage and then 
increased throughout the storage process. It means that storage caused a loss of 
the three dimensional network of protein in both types of yoghurt. The increase 
of syneresis as a consequence of storage was lower in FF yoghurts. It was probably 
due to the presence of fat globules that difficult casein aggregation and prevents 
contraction and reorganization of the three dimensional network of protein. The 
result is a higher capacity of FF yoghurts to retain serum in the gel structure (Fox 
et al., 2000). No significant differences between C and EE samples at each of the 
storage times were found, suggesting that the presence of S1 support do not have 
any influence on synereris at the concentrations employed.  
 
 
Figure 8. Syneresis values (mean ± SD) of low-fat control yoghurts (LF-C), low-fat yoghurts enriched 
with FA encapsulated in S1 support (LF-EE), full-fat control yoghurts (FF-C) and full-fat yoghurts 
enriched with FA encapsulated in S1 support (FF-EE). 
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The colour coordinates (L*, a*, b*) of control and enriched yoghurts along a 
storage period of 21 days are shown in Table 2. Both control samples (LF-C and 
FF-C) showed high luminosity (L*≈92) and a yellowish hue (h°≈100), being these 
features characteristic of fermented milks (Ramirez-Sucre & Vélez-Ruiz, 2013). 
This similarity between the two types of yoghurts may be due to the trend in the 
industry to bring the whole products and those with reduced calories (low-fat) the 
same sensory properties. Despite the similarities, Table 4 shows how FF yoghurts 
exhibited significantly higher values for all colour coordinates than LF yoghurts. 
Table 2 also shows colour variations due to the FA enrichment through S1 
incorporation. As it can be seen, despite fortification and storage influenced 
significantly some colour parameters (Table 4), the total colour differences among 
C and EE samples for the same type of yoghurt (LF or FF) and the same day of 
storage (0, 7 or 21) are lower than ΔE=0.5. Having in mind that ΔE values between 
0-1 normally mean invisible differences for the human eye, it can be concluded 
that the enrichment of yoghurts with S1 did not alter the visual perception of the 
colour.   
 
 
3.4.2 Rheological properties 
 
Considering the rheological behaviour described by the flow curves, all the 
samples showed non-Newtonian behaviour and time dependence (thixotropy). 
Such behaviour is in agreement with previous studies by other authors in 
semisolid yoghurts and dairy desserts (Tárrega & Costell, 2007, Cruz et al., 2013). 
Nevertheless, the rheograms of control yoghurts with different fat content (LF-C 
and FF-C) were different, indicating the importance of fat in the rheological 
behaviour of a sample (Ramirez-Sucre &Vélez-Ruiz, 2013).  
 
All the analysed samples showed an hysteresis area between the curves up 
and down in one cycle. FF-C yoghurts showed greater hysteresis area than LF-C 
yoghurts (data not shown). This hysteresis area is related to the degree of 
breakdown of the structure occurred during shearing. 
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From the third up and down cycles the hysteresis area decreased 
dramatically and it was considered that from this moment rheological behaviour 
was independent of time. Thus, up curves of the third cycle were fitted to 
Herschel-Bulkley model. R2 values were greater than 0.99 in all samples 
confirming the adequacy of the model to model the rheological behaviour. 
 
Table 3 shows rheological parameters obtained using the Herschel-Bulkley 
model for control and enriched yoghurts at 0, 7 and 28 days of refrigerated 
storage. Values of the flow behaviour index (n) clearly indicates that both kind of 
control yoghurts (LF-C and FF-C) have a pseudoplastic behaviour (0<n<1). These 
results are in agreement with previous studies carried out by Ramirez-Sucre & 
Vélez Ruiz (2013). The flow index was statistically significantly higher in FF-C 
yoghurts than LF-C yoghurts. Neither the yoghurt fortification nor the storage 
period had an influence in this parameter (Table 4). 
 
All the samples exhibited yield stress (o), suggesting that all the samples had 
an initial resistance to flow (Table 3). Values of yield stress were higher in LF-C 
yoghurts. For both types of yoghurt, LF-C and FF-C, o values decreased 
significantly along the storage period. However, no significant differences were 
observed between control and enriched yoghurts. 
 
The consistency index was higher in case of LF-C yoghurts. Again, for all 
yoghurt types, k decreased significantly along the storage period and no significant 
differences were observed between control and enriched yoghurts. 
 
According to these results, addition of S1, to low fat and full fat yoghurt, did 
not provoke any modification of the rheological properties. 
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3.5  Effect of S1 addition on viable counts on Lactobacillus delbrueckii ssp. 
bulgaricus and Streptococcus thermophilus during refrigerated storage 
 
Initial count of L. delbrueckii ssp. bulgaricus and S. thermophiles were 9.10 ± 
0.03 and 9.07 ± 0.09 log CFU g-1 in LF-C yoghurt and 9.10 ± 0.03 and 9.11 ± 0.11 
log CFU   g-1 in FF-C yoghurt (Fig 9) with no significant variability between both 
types of samples. These values are in agreement with those reported by other 
authors (Ibrahim & Carr, 2006; Al-Sheraji et al., 2012). It is generally 
recommended that yoghurt or fermented milk should contain at least 108 CFU per 
serving (EFSA, 2010), which represents approximately one million viable cells per 
gram at the time of consumption. Initial microbial counts in all samples were in 
line with this recommendation. We did not find significant differences due to S1 
addition to samples indicating that S1 do not affect microbial growth.   
 
Recent studies suggest that biocompatibility of mesoporous silica with 
human cells and tissues is very high. Moreover it has been reported that toxicity 
of mesoporous silica is minimized or eliminated by using microparticles and by 
functionalizing them with certain organic molecules (He et al., 2012; Tang, Li & 
Chen, 2012). Nevertheless, as far as we know, there are few studies evaluating the 
biocompatibility of mesoporous silica particles with acid lactic bacteria (LAB).  
 
In yoghurt and fermented milks it is important not only to control initial LAB 
population but also to maintain these numbers. In this sense, it is essential to 
follow viability during yoghurt storage. To specifically analyse the effect of S1 
addition on the survival of LAB during storage process, the viability of both 
microorganisms, L. delbrueckii ssp. bulgaricus and S. thermophiles, in S1 free 
yoghurts (LF-C and FF-C) and in S1 containing yoghurts (LF-EE and FF-EE) was 
followed during 21 of cold storage. As it can be observed, the number of CFU g-1 
decreased significantly (p<0.001 Table 4) along the storage in both yoghurt types 
(Fig 7a and 7b); however, this effect was independent of the presence or absence 
of S1 (Table 4). Thus, S1 support is biocompatible with the yoghurt microflora at 
the concentrations needed to provide the 100% of the DRI of FA.  
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These results confirm that the S1 do not have any effect in the viable LAB 
population. Microbial growth continues during storage and the number of viable 
microorganisms is a critical factor in the final product in terms of the nutritional 
health benefits attributed to yoghurt starters as probiotics (EFSA, 2010). The 
yoghurt nutritional content, physical properties, appearance and texture are 
important aspects for consumer acceptability. Note that if the amount of S1 to 
provide 100% of DRI did not provoke any change in viable counts, yoghurts 
prepared to cover 25, 50 or 75% of this DRI should not experience any affection. 
 
 
 
 
Figure 9. Viability of a) L. delbrueckii ssp. bulgaricus and b) S. thermophilus in control (C) and 
encriched (E) low-fat (LF) and full-fat (FF) yoghurts during 21 days of refrigerated storage at 4C.  
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Table 4. ANOVA F-ratio for each of the parameters and its interactions. 
 
   Main effects  Binary interations  Tertiary 
interactions 
Parameter   Y E S  Y*E Y*S E*S  Y*E*S 
pH   396.0*** 1.83ns 539.17***  0.4168ns 0.4783ns 0.1447ns  0.8813ns 
Syneresis   3.53ns 1.91ns 9.21***  0.17ns 0.83ns 0.72ns  1.62ns 
L*   139.43*** 0.29ns 2.86 ns  0.71ns 2.47ns 0.39ns  0.21ns 
a*   1043.49*** 15.53*** 21.79***  0.11ns 31.46*** 0.40ns  3.15* 
b*   0.26ns 8.33** 99.85***  1.80ns 12.56*** 2.94***  1.05ns 
C*   60.92*** 16.50*** 18.50***  0.71ns 29.51*** 1.32ns  1.51ns 
h*   11265.65*** 64.63*** 35.04***  0.67ns 1.53ns 5.48**  1.32ns 
0   779.69*** 0.09ns 12.38***  0.01ns 2.87ns 0.21ns  1.08ns 
K   728.24*** 0.46ns 15.37***  0.68ns 3.97ns 1.90ns  1.70ns 
n   406.00*** 0.60ns 0.88ns  0.82ns 1.47ns 0.76ns  0.64ns 
V.L   1.76ns 2.64ns 38.74***  0.02ns 3.87ns 0.87ns  2.27ns 
V.S.   0.63ns 1.07ns 43.34***  0.87ns 2.32ns 1.91ns  0.72ns 
 
Y = yoghurt, E = enrichment, S = storage. o = yield stress,  k = consistency index, n = flow behavior 
index, V.L. = Viability of Lactobacillus delbrueckii ssp. bulgaricus , V.S. =  Viability of Streptococcus 
thermophilus. Significance level (): *** (p<0.001). ** (p<0.01). * (p<0.1). ns (no significant). 
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4.Conclusions 
 
A novel preparation of FA-enriched yoghurts with controlled bioaccessibility 
is reported. pH-responsive mesoporous silica particles functionalised with 
polyamines and loaded with FA were able to modulate the release kinetics of FA 
during the in vitro digestion. Sensory analysis were not performed because 
mesoporous silica particles have not been yet declared as an authorised food 
ingredient or recognized as “Generally Recognized As Safe products” by the FDA. 
Nevertheless, physico-chemical characterization of enriched yoghurts with S1 
particles, suggest that S1 addition did not have any impact neither in pH, 
syneresis, colour or rheology. Moreover, the addition of S1 to yoghurts did not 
have any significant impact on the survival of starting cultures of yoghurts during 
refrigerated storage. We believe that the results obtained  in this work should be 
easily extrapolated to other bioactive molecules and put forward that 
encapsulation of bioactive components in mesoporous silica carriers opens new 
opportunities for the development of novel functional dairy products with added 
value.  
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The general objective of the present PhD thesis was to design, fabricate and 
evaluate different porous silica supports, capped with molecular gates responsive 
to changes in pH, to act as smart delivery systems capable of modulating the 
bioaccessibility of folic acid (FA) during a digestion procedure when incorporated 
into food matrices. The findings of all the studies carried out to assess this general 
objective have been discussed in detail in one review paper and in five original 
research papers. They all pursue the same ultimate goal. However, being divided 
into independent articles can lead to the thread of the argument being lost. 
Therefore, this section aims to holistically and comprehensively discuss all the 
results obtained in this thesis. 
 
FA is an essential vitamin for numerous bodily functions and is especially 
indispensable in pregnancy. Although there is irrefutable evidence for the benefits 
of FA supplementation, recent studies have suggested that massive exposure to 
high bioavailable FA is a double-edged sword. Thus controlling FA dosage and 
modulation of FA bioavailability (e.g. by adjusting its bioaccessibility along the 
gastrointestinal tract) are apparently vital for maintaining positive effects of 
fortification, while avoiding massive exposure-related problems. 
 
Mesoporous silica materials have proved remarkably potential in the design 
of efficient smart delivery systems for biomedical, agriculture and food sciences. 
The surface of MSPs presents a high concentration of structural defects in the 
form of silanol (Si-OH) groups, which can easily react with trialkoxysilane 
derivatives to allow the possibility of generating organic−inorganic hybrid 
materials. One appealing concept in this area is the development of “molecular 
gates”. The gastrointestinal tract (GIT) offers a wide variety of stimuli that can be 
used to design capped MSPs for controlled release purposes triggered by digestive 
stimuli. Specifically, changes in pH along the GIT seem an easy way to trigger FA 
release along the GIT. 
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An extensive review of the possibilities of mesoporous silica particles for 
designing smart delivery systems is provided in the Introduction. The human 
gastrointestinal tract offers many possibilities for developing controlled delivery 
systems in response to digestive trigger stimuli, such as pH, ionic strength, redox 
potential or enzyme activity. Controlled release in the stomach might be based on 
the action of acid-responsive molecules, and also on food components sensitive to 
proteases and lipases. Controlled delivery in the small intestine may combine 
(neutral or basic) pH with the presence of emulsifier molecules and a wide variety 
of digestive enzymes (saccharidases, peptidases and lipases). Finally, specific 
delivery in the colon should address the use of materials that respond to the 
action of the enzymes delivered by colonic bacteria or to the particular redox 
potential in the colon. The conclusions of this review were the basis used to plan 
the following studies of Chapters 1 and 2. Among the various possibilities of 
inorganic supports and molecular gates, we selected four different silica supports 
(MCM-41, Hollow Silica, SBA-15 and UVM-7) as inorganic carriers and pH as a 
triggering stimulus.  
 
Chapter 1 examines FA encapsulation by a nutritional (or even physiological) 
approach. In a first step, FA was encapsulated in the commonest mesoporous 
silica particle (i.e. MCM-41). The efforts made in these first studies (Article 1) 
focused on optimising loading efficiency. The literature offers a wide variety of 
MSPs loaded with different dies or bioactive molecules. However, most works are 
shown as proof of concept. Thus the amount of final solid needed to accomplish 
the function is not that important. Contrarily in this thesis, reducing the amount 
of solid needed to release 100% of the RDI of FA was our priority. The more FA 
delivered by a unit of mass of solid, the less solid required to provide the RDI. The 
less solid used, the lower the cost, the less marked the toxicological effect and, 
thus, fewer technological problems associated with adding encapsulating systems 
to real matrices appear.  
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To ensure that folic acid is encapsulated in the voids of different silica 
supports, molecular dynamics calculations on FA were done. On a larger 
dimension, FA exhibited a length of 1.45 nm, whereas the calculated volume was 
1.16 nm3. These calculations were used to determine the total theoretical amount 
of vitamin that could be encapsulated in all the different silica supports employed 
in Articles 1 and 2.  
 
Having proved the theoretical feasibility of FA to be entrapped in the voids of 
MCM-41 (pore size 2.5 nm and pore volume 0.9 cm3 g-1), different loading 
conditions were tested. The results showed that the best loading efficiency was 
achieved by an impregnation procedure. Besides the loading conditions, the 
subsequent functionalisation method with the molecular gate seemed important 
to avoid pore emptying in this step. According to the results found in these 
sections, the most efficient conditions to load FA in MCM-41 were impregnation 
of the solid with the FA dissolved in PBS (10 mg mL-1) in 3 cycles (0.5 mL per cycle) 
and functionalising the solid in acetic solution media. 
 
In order to evaluate the efficacy of N1-(3-
Trimethoxysilylpropyl)diethylenetriamine (N3) as a molecular gate able to control 
FA release according to pH, two different solids with and without N3 anchored to 
the outer surface of the solid were prepared. A comparison of the delivery 
kinetics from both solids at two different pH values led to the conclusion that the 
bare solid was able to hinder FA release, but not very efficiently at an acid pH 
given the lack of solubility of FA under acidic conditions, but could deliver its 
content very quickly at pH 7.5 given the solubilisation of FA. In contrast, the solid 
that contained the molecular gate was tightly capped at pH 2 and displayed 
sustained delivery when pH was switched to 7.5. This confirms the efficacy of 
amines to control the transport of mass from support voids according to pH. 
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In another step, the efficiency of the developed smart delivery system, based 
on FA encapsulated in an MCM-41 support functionalised with amines to 
modulate the bioaccessibility of the vitamin in a more real context, was evaluated 
by simulating a human digestion procedure. The FA delivery results obtained 
under these conditions confirmed that vitamin release was hindered during the 
simulated pass through the stomach. In contrast, after adding the simulated 
intestinal fluid, FA delivery increased progressively to a maximum value of 94 g 
of FA mg-1 of solid at 4 h of digestion. The most important point was that 1 mg of 
solid BB3, the release of ca. 95 mg of FA during the whole simulated digestion 
process was possible. This means that higher recommended dietary intakes in 
human nutrition, established for pregnant woman as 600 g per day of folates or 
360 g of synthetic PGA (1 g of dietary folate equivalent = 0.6 g of folic acid), 
could be achieved by orally administering only ca. 4 mg of the smart delivery 
system, which is a remarkably small amount. 
 
Bearing in mind that by tuning the synthesis conditions of mesoporous silica 
particles, different silica supports with various particle sizes, shapes and porous 
structures can be obtained. The main objective of Article 2 was to compare 
different silica supports (MCM-41, SBA-15, UVM-7 and Hollow Silica Shells) in FA 
loading efficiency and release kinetics terms. In all cases, the capping system 
consisted in polyamines (N3) anchored to the external surface of silica supports. 
 
The four capped materials were capable of hindering FA delivery at a low pH 
(i.e. stomach), whereas FA release was found at a neutral pH (i.e. small intestine). 
Data from the release kinetics at pH 7.5 were fitted to the Higuchi model to obtain 
Higuchi constants (kH). This analysis showed that kH increased in this order: MCM-
41 < UVM-7 < SBA-15 < Hollow Silica Shells: which indicates that MCM-41 was the 
inorganic support that reached the most sustained delivery and was, thus, the 
most appropriate one to modulate FA bioaccessibility.  
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The complete characterisation of hybrid materials was carried out to 
correlate the physical features of the supports with their loading capacity and 
release kinetics. Bearing in mind that Hollow Silica is the support with the highest 
kH, which coincides with the larger cavity, and that SBA-15, UVM-7, and MCM-41 
were ordered according to their pore size, the pore size effect seems important 
for modulating the release kinetics of FA from different supports. The bigger the 
pore diameter, the easier the solution enters voids (or the main cavity for H). Thus 
there are fewer diffusional problems of FA escaping from the entrapping support.  
 
In this study, the cell viability assays on HCT116, HEPG2, HK2 and HeLa cells 
indicated that all the cell lines exhibited a high level of cell viability (ca. 100% cell 
proliferation) after 24 h upon treatment with the four FA-loaded capped silica 
supports, with a concentration of up to 200 g mL-1. Although this study has 
shown that the developed particles did not cause acute toxicity in cell cultures, 
further research is necessary to evaluate the more extensive chronic toxicity of 
these studies. 
 
Beyond its loading efficiency, and its capacity to modulate the bioaccessibility 
or biocompatibility, the suitability of MSPs to be used in oral controlled release in 
in vivo applications relies on the chemical stability of the supports through the 
whole digestive tube. It is well-known that silica can be biodegraded into silicic 
acids, including monomeric silicic acid and various polysilicic acids at different 
degrees of polymerisation. Yet as far as we know, hardly any attempts have been 
made to understand the degradation of MSPs in biologic fluids. Based, therefore, 
on the objective of understanding the effect of saliva, gastric or intestinal fluids on 
the stability of different porous materials, the experiments reported in Article 3 
were run. 
  
In this work, apart from evaluating the stability of the particles used in 
previous experiments (MCM-41 micro, SBA-15, UVM-7), the nanoparticulated 
MCM-41 support was included. MCM-41 micro and MCM-41 nano share the same 
porous structure, but their morphology and size differ. The comparison of both 
General discussion 
 
242 
 
particles enabled the evaluation of the influence of particle size on greater or 
lesser degradation tendency. The hollow silica particles were not included 
because it was a commercial particle that proved unaffordable at the time this 
work was completed. 
 
The results showed that bare MCM-41 microparticulated and SBA-15 were 
very stable against degradation. However, the structure of the supports based on 
nanoparticles (i.e. MCM-41 nanoparticulated and UVM-7) only slightly degraded, 
while functionalisation with N3 resulted in greater particle stability in all cases. 
 
 To conclude the first chapter, it can be stated that MCM-41, Hollow Silica, 
UVM-7 and SBA-15 loaded with FA and functionalised with amines (N3) exhibited 
good properties for the encapsulation and controlled release of FA. Specifically, all 
the designed supports presented good properties to develop smart delivery 
systems: a) they all exhibited good loading capacity; b) all the supports were able 
to hinder FA release at an acid pH (i.e. in the stomach) and to efficiently deliver 
the cargo at a neutral pH (i.e. in the intestine); c) none of them exhibited non-
specific toxicity; d) after functionalisation, they were all very stable against 
degradation. 
 
However when comparing the release profile of the four supports, the MCM-
41 capped with polyamines should be considered the support with the best 
capability to release FA in a more controlled manner. This sustained release is 
essential for modulating the bioaccessiblity of the vitamin before its absorption in 
the jejunum and to, thus, avoid problems related to FA absorption peaks, which 
lead to untransformed FA appearing in blood. By considering these results, the 
development of the final food product that contains FA encapsulated in MSPs 
(Article 5) was based on using MCM-41 microparticles as an encapsulating 
support. 
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Based on the results obtained in Chapter 1, there is very little doubt that 
MSP-based delivery systems open up new alternatives to food supplementation 
with FA. This new formulation of novel functional foods also offers novel 
strategies for the food industry at the same time. Yet before proposing foods that 
contain MSPs as novel foods, the influence of adding supports on the physico-
chemical properties of the final food should be evaluated. The general 
introduction of new ingredients or additives to a food matrix can affect the 
product’s physico-chemical and sensory properties. However, a delivery system is 
considered suitable for a particular application if it is compatible with the food or 
beverage matrix that it is to be incorporated into, and when it has no adverse 
effects on product appearance, flavour, texture, mouth feel or shelf life. Indeed 
evaluating the use of MSP-based delivery systems by a technological approach 
was the aim of Chapter 2 (the technological approach).  
 
Article 4 studied the effect of adding different mesoporous silica particles 
(MCM-41 nano and micro, UVM-7 and SBA-15), either bare or functionalised with 
amines or carboxylates, on the physical properties of gelatine gels (5% w/v). The 
effect of incorporating different MSPs on the texture properties of gelatine gels 
was studied by comparing the modulus and fracture properties of the gelatine 
gels that contained different percentages of MSPs with those gels without 
particles.  
 
The incorporation of bare MSPs had no influence on mechanical properties. 
However with functionalised MSPs, the strength of the gels remarkably increased 
and their brittleness slightly diminished. This effect was attributed to an organic 
layer being created on the surface of the particle, which improved the filler-matrix 
interaction. Turbidity of gels was also affected by the addition of all the tested 
MSPs, and the particles that formed smaller aggregates greatly contributed to 
turbidity. Given these findings, it can be stated that despite the addition of MSPs 
not worsening the physico-chemical properties of gels, the smaller the amount of 
the smart delivery system needed to provide a percentage of the RDI of a 
bioactive molecule, the slighter the effect on matrix properties. 
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Finally, the MCM-41 support was selected for the final work because MCM-
41 was the support that best displayed the capacity to modulate FA delivery with 
time. Nor was this support affected by digestive fluids, and it was one of the 
supports that least affected the physico-chemical properties of the matrix. Along 
these lines, Article 5 achieved the final thesis goal: preparing functional food 
enriched with FA encapsulated in a pH-responsive porous silica support capable of 
modulating the bioaccessibility of the vitamin along the gastrointestinal tract 
without altering the properties of yoghurt.  
 
In the first part of this work, the ability of the MCM-41 microparticle loaded 
with FA and functionalised with amines to modulate the bioaccessibility of FA 
after its incorporation into two types of stirred yogurt (low-fat and full-fat) was 
evaluated. The results of the in vitro digestion procedure showed that the 
proposed smart delivery system was capable of inhibiting the release of FA in 
acidic solution at pH 2 (stomach) and of controllably releasing its contents at a 
neutral pH (intestine) to thus modulate bioaccessibility. 
 
In the second part of this work, the influence of adding FA encapsulated in 
the MCM-41 support on the physico-chemical, rheological and lactic acid bacteria 
viability of these yogurts during 21-day refrigerated storage (4°C) was evaluated. 
The physico-chemical and microbiological assays revealed that enrichment with 
this support neither altered the physico-chemical properties (pH, colour, syneresis 
and rheology) of both types of yogurt nor caused any effect on lactic acid bacteria 
survival.   
 
In conclusion, this thesis presents the design of a controlled delivery system 
that has been optimised specially for a food application, and includes studies into 
the loading optimisation, encapsulation capacity, release kinetics, toxicology 
assessments and evaluation of the influence of the encapsulating matrix on the 
properties of the food matrix. This global approach seems a suitable procedure to 
improve encapsulation efficiency and to ensure the compatibility of the delivery 
system with both the final consumer’s food and organism.  
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CONCLUSIONS AND FUTURE PERSPECTIVES 
 
Different smart delivery systems for controlled FA release have been 
successfully prepared. These systems were based on using several MSPs with 
different morphologies and porous systems (MCM-41, Hollow Silica, SBA-15 and 
UVM-7) loaded with FA and functionalized with amines. A loading optimization 
process allowed us to obtain a system capable of delivering 100% of FA DRI with a 
very small amount of the delivery system (ca. 4 mg).  
 
All the developed systems were tightly capped at pH 2 and displayed 
sustained FA delivery when pH was switched to 7.5. This sustained release is 
essential for modulating the bioaccessiblity of the vitamin before its absorption in 
the jejunum, and to thus avoid problems related to FA absorption peaks, which 
lead to untransformed FA appearing in blood.  
 
The WST-1 cell viability assay indicated that all the cell lines exhibited a high 
level of cell viability (ca. 100% cell proliferation) after 24 h upon treatment with 
solids up to a concentration of 200 g mL-1. This assay suggested that the 
developed supports loaded with FA and functionalized with N3 were well-
tolerated by cells.  
 
Bare MCM-41 microparticulated and SBA-15 remained very stable during a 
digestion procedure. However, the structure of the supports based on 
nanoparticles (i.e. MCM-41 nanoparticulated and UVM-7) exhibited slight 
degradation. Nevertheless, functionalization with N3 resulted in the increased 
stability of particles.  
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The incorporation of the different MSPs into gelatine gels allowed us to 
conclude that bare MSPs have no influence on mechanical properties. However 
after the functionalization with amines, particles were able to create an organic 
layer on the particle surface that improved the filler-matrix interaction. This led to 
an in increase in Young’s modulus, fracture stress and fracture strain, which was 
more or less pronounced depending on the kind of particle, functionalization and 
concentration.  
 
Of all the supports, one stood out for showing remarkable advantages in 
controlling FA bioaccessiblity. Specifically, microparticulated MCM-41 capped with 
polyamines was the only support able to sustain cargo release for at least 1 h. 
Thus MCM-41 was the support selected for preparing enriched yoghurts. 
 
MCM-41, microparticulated and loaded with FA and functionalized with 
polyamines, was able to modulate the release kinetics of FA after being added to 
two different yoghurts (low-fat and full-fat) during in vitro digestion. The physico-
chemical characterization of yoghurts enriched with the particles suggested that 
their addition had no impact on pH, syneresis, color or rheology. Moreover, the 
addition of particles to yoghurts had no significant impact on the survival of the 
starting cultures of yoghurts during refrigerated storage.  
 
In summary, it can be concluded that gated MSPs have the potential to act as 
FA-based smart delivery systems. This strategy can avoid problems related to 
overexposure of the vitamin, while maintaining food fortification advantages. 
Moreover, its addition to real food matrices did not provoke any undesired 
change in the physico-chemical properties. This new encapsulation approach 
offers new opportunities for the development of novel functional food. We also 
hope that the results obtained in this thesis will inspire the future design of new 
advanced hybrid materials for nutritional applications. 
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Appendix I. Abbreviations and Acronyms 
 
ANOVA Analysis of variance   
BET Brunauer, Emmett and Teller Model   
BJH Barret, Joyner and Halenda Model   
BPE Bovine Pituitary Extract   
C3 N1-3-(trimethoxysilyl)propyl ethylenediamine triacetic acid trisodium salt   
CFU Colony-Forming Unit   
CTAB Hexadecyltrimethylammonium bromide   
D2O Deuterium oxide   
DMEM Dulbecco's Modified Eagle's medium   
DMSO Dimethyl sulfoxide   
DSMZ German Resource Centre for Biological Material   
DNA Deoxyribonucleic acid   
DRI Dietary Reference Intake   
dv90 90th percentile of the size distribution   
EGF Epidermal Growth Factor    
FA Folic acid    
FBS Fetal Bovine Serum   
FESEM Field Emission Scanning Electron Microscopy    
FF Full Fat   
FSM Folded Sheet Mesoporous Materials    
GI Gastro Intestinal   
GRAS Generally Recognized As Safe   
HCT116 Human colon carcinoma cells   
HeLa Human cervix carcinoma cells   
HEPG2 Human liver carcinoma cells   
HMS Hexagonal Mesoporous Silica    
HK2 Human kidney epithelial cells   
1H NMR Proton nuclear magnetic resonance   
HPLC High liquid performance chromatography   
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IUPAC International Union of Pure and Applied Chemistry   
KH Higuchi constant   
LF Low Fat   
LSD  Least Significant Difference   
MCM Mobil Crystalline Material   
MSU Michigan State University Material   
MSPs Mesoporous Silica Particles   
N3 N1-(3-trimethoxysilylpropyl)diethylenetriamine   
NAD(P)H Nicotinamide adenine dinucleotide phosphate   
NaOD Sodium deuteroxide   
NaOH Sodium hidroxyde   
PBS Phosphate Buffer Solution   
PMOs Periodic Mesoporous Organosilicas   
RLE Relative Loading Efficiency   
RT Room Temperature   
SBA Santa Barbara Amorphous Material   
SEM Scanning Electron Microscopy   
TEAH3 Triethanolamine   
TEM Transmission Electron Microscopy    
TEOS Tetraethylorthosilicate   
P123 Pluronic 123   
SiO2 Silicon Dioxide   
TUD Technische Universiteit Delft material   
UVM Universidad Valencia Material   
XRD X-ray diffraction   
 
  
Appendices 
 
253 
 
Appendix II. Key definitions 
 
Bioactive compound 
Compound that has an effect on a living organism, tissue or cell. 
 
Bioactivity 
Beneficial or adverse effects of a bioactive compound on living matter. Bioactivity 
includes events linked to how the is transported and reaches the target tissue, 
how it interacts with biomolecules, the metabolism or biotransformation that it 
may undergo, and the generation of a biomarker and the physiologic response it 
causes. 
 
Bioaccessibility 
Fraction of a compound that is released from its matrix in the gastrointestinal 
tract and thus becomes available for intestinal absorption. Bioaccessibility 
includes the entire sequence of events that take place during the digestive 
transformation of food into material that can be assimilated by the body, the 
absorption/assimilation into the cells of the intestinal epithelium, and lastly, the 
presystemic metabolism (both intestinal and hepatic).1mismo que bioactivity 
 
Bioavailability 
Fraction of a given nutrient (or bioactive compound) in a given food or diet 
ingested that is available for use in physiologic functions or to be stored. The 
therm bioavailabity is thus  a sum of bioaccessibility and bioactivity. 
 
Controlled release 
Process of releasing an encapsulated component with a specific concentration-
time profile at the site of action. The release process may follow a number of 
different profiles, including: 
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 Burst release: rapid release of most of the encapsulated component over 
a short time. 
 Sustained release: prolonged release of the encapsulated component at a 
relatively constant rate. 
 Triggered release: release of the encapsulated component in response to 
a specific environmental trigger (e.g., pH, ionic strength, enzyme activity, 
temperature). 
 Targeted release: release of the encapsulated component at a specific 
location (e.g., mouth, stomach, small intestine, colon). 
 
Delivery system 
Formulation or system designed to encapsulate, deliver and release one or more 
active components after targeting specific areas of the body. 
 
Dietary Reference Intake 
Daily intake level of a nutrient that is considered to be sufficient to meet the 
requirements of 97-98% of healthy individuals in every demographic in the United 
States (where it was developed, but has since been used in other places). 
 
Encapsulation 
Process of entrapping a specific component (the “active”) within some kind of 
matrix (the “encapsulant”).  
 
Folate 
Generic term for a water-soluble group of B vitamins including folic acid and 
naturally occurring folates. 
 
Folic acid 
Synthetic folate compound used in vitamin supplements and fotified food because 
of tits increased stability. Folic acid , chemically pteroylglutamuic acid, consist of a 
pteridine ring system, p-aminobenzoic acid and one molecule of of glutamic acid. 
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Food fortification 
The process of addition micronutrients to foodstuffs, during or after processing, 
to bring micronutrient levels over and above amounts in the original food 
product. An example is adding C vitamin to an orange juice after the pasterization 
process. 
 
Food enrichment 
The process of addition of micronutrients to foodstuffs, during of after processing, 
that were not originally in the food. An example is adding vitamin D to milk. 
 
Functional food 
Food or food ingredient that may provide a health benefit beyond the nutrients it 
contains. 
 
Mesoporous materials 
A mesoporous material is a material containing pores with diameters between 2 
and 50 nm. Porous materials are classified into several kinds by their size. 
According to the International Union of Pure and Applied Chemistry (IUPAC) 
notation, microporous materials have pore diameters of less than 2 nm and 
macroporous materials have pore diameters of greater than 50 nm; the 
mesoporous category thus lies in the middle. 
 
Mesoporous Silica Particle (Mesoporous Silica Support) 
Partices form of silica with porous in the range from 2-50 nm recent developed by 
nanotechnology. The most common types of mesoporous nanoparticles are 
MCM-41 and SBA-15. Research continues on the particles, which have applications 
in catalysis, drug delivery and imaging. 
 
Molecular gate 
Nanoscopic supramolecular-based devices, attached to certain solid supports, in 
which mass transport can be triggered by a target external stimulus that can 
control the state of the gate (closed or open) at will.  
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Nanotechnology 
Manipulation of matter on an atomic, molecular, and supramolecular scale. 
 
Rheology 
Study of the flow of matter, primarily in a liquid state, but also as 'soft solids' or 
solids under conditions in which they respond with plastic flow rather than 
deforming elastically in response to an applied force 
 
Supplementation 
Provision of nutrients either via a food ar as a tablet, capsule, syrup, or poder to 
boost the nutrional conten of the diet. 
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Appendix III. Constituents and concentrations of the various 
synthetic juices of the in vitro digestion model  
 
 Saliva Gastric juice Duodenal juice Bile juice 
In
o
rg
an
ic
 s
o
lu
ti
o
n
 
10 ml KCl 89.6 g L
-1
 15.7 ml NaCl 
175.3 g L
-1
 
40 ml NaCl               
175.3 g L
-1
 
30 ml NaCl              
175.3 g L
-1
 
10 ml KSCN 20 g L
-1
 3.0 ml NaH2PO4 
88.8 g L
-1
 
40 ml NaHCO3 
84.7 g L
-1
 
68.3 ml NaHCO3 
84.7 g L
-1
 
10 ml NaH2PO4 
88.8 g L
-1
 
9.2 ml KCl 89.6 g L
-1
 10 ml KH2PO4 8 g L
-1
 4.2 ml KCl 89.6 g L
-1
 
10 ml NaSO4 57 g L
-1
 18 ml CaCl2 · 2H2O 
22.2 g L
-1
 
6.3 ml KCl 89.6 g L
-1
 150 μl HCl 37% g g
-1
 
1.7 ml NaCl              
175.3 g L
-1
 
10 ml NH4Cl               
30.6 g L
-1
 
10 ml MgCl2 5 g L
-1
  
20 ml NaHCO3 
84.7 g L
-1
 
6.5 ml HCl 37% g g
-1
 180 μl HCl 37% g g
-1
  
O
rg
an
ic
 s
o
lu
ti
o
n
 
8 ml urea 25 g L
-1
 10 ml glucose           
65 g L
-1
 
4 ml urea 25 g L
-1
 10 ml urea 25 g L
-1
 
 10 ml glucuronic 
acid 2 g L
-1
 
  
 3.4 ml urea 25 g L
-1
   
 10 ml glucoseamine   
 hydrochloride             
33 g L
-1
 
  
A
d
d
 t
o
 m
ix
tu
re
 
o
rg
an
ic
 +
 in
o
rg
a
n
ic
 s
o
lu
ti
o
n
 
290 mg α-amylase 1 g BSA 9 ml CaCl2 · 2H2O 
22.2 g L
-1
 
10 ml CaCl2 · 2H2O 
22.2 g L
-1
 
15 mg uric acid 2.5 g pepsin 1 g BSA 1.8 g BSA 
25 mg mucin 3 g mucin 9 g pancreatin 30 g bile 
  1.5 g lipase  
pH 6.8 ± 0.2 1.30 ± 0.02 8.1 ± 0.2 8.2 ± 0.2 
 
The inorganic and organic solutions are augmented to 500 mL with distiled water. After mixing of 
the inorganic and organic solutions, some further constituents are added and disolved. If necessary, 
the pH of the juices is adjusted to the appropiate interval. Source: Versantvoort, C. H., Oomen, A. G., 
Van de Kamp, E., Rompelberg, C. J., & Sips, A. J. (2005). Applicability of an in vitro digestion model in 
assessing the bioaccessibility of mycotoxins from food. Food and Chemical Toxicology, 43(1), 31-40. 
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